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Somatic stem cell populations display a remarkable capacity to self-renew and 
generate specialised cell types throughout the life of the organism. In my thesis 
I examined extrinsic and intrinsic factors that regulate stem cell quiescence, a 
reversible state of growth arrest crucial to the preservation of somatic stem cell 
number and function in many systems. Skeletal muscle-specific stem cells, 
known as satellite cells (SCs) are responsible for skeletal muscle regeneration. 
The ability of skeletal muscle to regenerate declines with age. I identify 
fibroblast growth factor 2 (FGF2) as a potent mitogenic factor that is up-
regulated in the aged muscle fibre and causes a loss of SC quiescence and 
depletion of the stem cell pool. Deletion of a negative regulator of FGF 
signalling, Sprouty1 (Spry1), in SCs increases stem cell loss, whereas over-
expression of Spry1 partly prevents depletion. These experiments show that an 
age-associated change in the SC niche is partly responsible for stem cell 
depletion during ageing. 
In the adult forebrain, new neurons produced from neural stem cells (NSCs) in 
the hippocampus play an important role in learning and memory formation. I 
show that deletion of the chromatin remodelling enzyme chromodomain 
helicase DNA-binding protein 7 (CHD7) in NSCs results in a severe reduction in 
neurogenesis. I identify CHD7 as an essential regulator of NSC quiescence and 
self-renewal. Collectively, my results suggest that the regulation of the intrinsic 
chromatin landscape and the extrinsic niche environment are essential for 



















1.1. Stem cell function in embryonic development and adult 
tissue 
Stem cells are characterised by two essential properties: 
1. The ability to generate daughter cells capable of differentiation into 
multiple cells types, known as multipotency, and 
2. The ability to undergo numerous rounds of cell division whilst maintaining 
an undifferentiated pool, known as self-renewal. 
During embryonic development, embryonic stem (ES) cells from the inner cell 
mass of blastocysts can proliferate extensively and can differentiate into 
ectoderm, mesoderm and endoderm [1]. ES cells form all the cell types of adult 
organisms indirectly through the generation of other stem cell populations. 
However, many embryonic cells lose their stem cell properties as differentiation 
ensues and the signals that promote growth decline. By adulthood, stem cells 
are no longer dispersed throughout the organism but, instead, exist in discrete 
niches in many tissues. Somatic stem cells retain the ability to self-renew and 
generate different specialised cell types [1, 2]. 
Generally, somatic stem cells divide infrequently under homeostatic conditions. 
Instead, they form lineage-restricted progenitors with a greater proliferative 
output. Progenitors then form an immature differentiated cell type, often with 
migratory capabilities, which mature into a new fully functional cell type [2, 3]. 
Quiescence is a reversible state of growth arrest crucial to the preservation of 
somatic stem cell number and function in many systems [4-6]. Limiting the 
proliferative output of somatic stem cells prevents the accumulation of DNA 
replication errors in stem cells, and also stops the depletion of the stem cell pool 
through replicative senescence [7]. The niche is a critical factor in the 
maintenance of somatic stem cell function and provides the proper cues needed 
for stem cell quiescence under homeostatic conditions [6, 8]. Aberrant changes 
in the niche can lead to a loss of stem cell quiescence and an alteration in stem 





Ageing is a physiological process whereby the composition of many somatic 
stem cell niches is disrupted and the stem cells display intrinsic changes [9]. An 
'adult' stage of life is generally considered to be when stem cells become 
quiescent but before any large loss in the stem cell pool later in life. In mice, 
skeletal muscle is generally accepted as being in an adult stage between 3-8 
months old [10, 11], and the adult forebrain is considered adult between 2-5 
months old [12]. 'Aged' is considered to be a stage where stem cells exhibit an 
impaired function in the absence of any other diseases. Murine skeletal muscle 
is considered to be aged at around 24 months old [10, 11], based on a 
decrease in skeletal muscle function as assessed by contractile properties. The 
adult murine forebrain is considered aged as early as 12 months old as it 
exhibits a large decrease in stem cell self-renewal and proliferation which has 
been associated with cognitive defects [12-16]. 
Ageing leads to alterations in stem cell number and function, often having a 
negative impact on tissue homeostasis. In addition, the numbers of stem cells 
present in various tissues generally decline with age [17-20]. The notable 
exception to this general rule is the haematopoietic system, which exhibits an 
increase in the number of haematopoietic stem cells with age [21]. Despite this, 
aged haematopoietic stem cells display a loss in self-renewal potential and 
skewed fate decisions [21]. 
Very little is known about age-related changes in mammalian stem cell niches 
and how this impacts on stem cell number. Furthermore, the mechanisms 
controlling stem cell quiescence and fate decisions are not completely 
understood. Current literature indicates that intrinsic changes in somatic cells, 
such as epigenetic changes [22, 23], and extrinsic influences, such as the stem 
cell niche [12, 19, 24], clearly play an important role in the regulation of stem 
cell number and function. 
This thesis examines fundamental properties of somatic stem cells in two well-
characterised types of stem cells: skeletal muscle stem cells and neural stem 





explored in the context of homeostasis and also in a state of physiological 
disease, such as ageing. 
 
1.2. Formation of vertebrate limb skeletal muscle 
Muscle is composed of elongated, multinucleated myofibres that are capable of 
contracting. Skeletal muscle is transversely striated and principally attached to 
bone to allow for skeletal movement. Skeletal muscle contraction is achieved 
through the interaction between myofibrillar proteins, which temporarily bind to 
each other and release, generating force [25]. 
In vertebrates, skeletal muscle forms from paraxial mesoderm, which segments 
and form pairs of transitory structures on either side of the neural tube called 
somites [26]. Somites differentiate into dermatome, myotome and sclerotome. 
Cells in the dermatome form the skin of the back, the sclerotome forms the 
vertebrae and rib cartilage, and cells in the myotome become specified as 
skeletal muscle progenitors. Cells migrating from the myotome begin to express 
myogenic determination genes, such as MyoD and Myf5, once they reach the 
limb [27]. These muscle progenitor cells undergo extensive proliferation in the 
limb and fuse to form the first multinucleated muscle fibres around embryonic 
day (E) 11-14 in mouse [28]. Throughout the first weeks of postnatal life in mice, 
skeletal muscle undergoes great muscle growth, with little addition of myonuclei 
to myofibres from postnatal day (P) 14, although the extensor digitorum longus 







1.3. Satellite cells 
Somatic stem cells are present in adult skeletal muscle. These cells are referred 
to as satellite cells (SCs) by virtue of their distinct location on the surface of the 
myofibre, underneath the basal lamina. SCs are capable of producing 
proliferative myoblasts which can differentiate into myotubes. SCs are also able 
to maintain their own population through self-renewal, hence they fit the 
definition of stem cells (Figure 1). 
 
 
Figure 1 - Schematic illustration of the myogenic lineage of satellite cells. Under 
homeostatic conditions SCs are completely quiescent. However, in response to myotrauma they 
activate and proliferate to form myoblasts, becoming positive for markers of cell cycle entry such 
as Ki67 and upregulating MyoD and Myf5. As myoblasts become more committed to 
differentiation and form myotubes, they upregulate myogenin and mature into new myofibres. A 







1.3.1. Formation of a satellite cell pool 
Most SCs are formed from the somites, with the notable exception of the head 
muscles, which have a distinct embryonic origin and form from the pre-chordal 
mesoderm and other cell lineages [31-33]. SCs are widely accepted as forming 
from a distinct subset of a large population of myogenic progenitors, which 
retain multipotency and self-renewal capacity throughout adulthood [34]. 
Tritiated thymidine labelling studies have shown that SCs are mitotically active 
and contribute to new myonuclei during postnatal growth before P21 [35]. After 
P21, most SCs become mitotically quiescent and do not contribute to new 
myonuclei [35-37]. Quiescent SCs express Pax7, which is essential for their 
proper function in growth of postnatal skeletal muscle and regeneration of adult 
muscle after myotrauma [34]. Collectively, these data indicate that the majority 
of developmental and postnatal myogenesis is completed by P21 as SCs enter 
a quiescent state. 
 
1.3.2. Satellite cells are stem cells in adult skeletal muscle 
The stem cell properties of SCs were first hypothesised in the 1960s as it was 
demonstrated that SCs underwent cell division in regenerating muscle [38, 39]. 
However, it was not until myofibres were isolated and cultured  ex vivo that SCs 
were shown to generate myoblast progeny that could fuse and differentiate into 
myotubes [40, 41]. 
More recently, inducible genetic lineage tracing studies, taking advantage of 
Pax7 as a marker of SCs, have further demonstrated that SCs can generate 
myoblasts for muscle growth and repair in vivo. Using different Pax7CreER/+ 
mouse lines crossed with R26RlacZ/+ mice, activation of CreERT2 by tamoxifen 
administration confirmed β-galactosidase activity specifically in SCs. During 
muscle regeneration, however, β-galactosidase activity was readily detected in 
de novo muscle fibres, indicating differentiation and fusion of SC-derived 





detected in a similar number of SCs as was seen prior to injury suggesting that 
the SC pool is replenished by self-renewal [42]. 
Transplantation into injured skeletal muscle has reinforced the stem cell nature 
of SCs. Donor-derived SCs are able to occupy a SC niche on the periphery of 
the myofibre and remain quiescent and undifferentiated whilst retaining the 
ability to activate and proliferate in response to myotrauma [44, 45]. Even after 
serial transplantations, grafted myogenic cells are able to contribute myonuclei 
and retain proliferative potential [46-52]. In addition, it has been observed that 
engraftment of a single myofibre, or a single isolated SC, can repopulate the 
host muscle with new myonuclei and SCs, firmly showing that SCs are a source 
of myogenic precursors with self-renewal capability [53, 54].  
 
1.3.3. The satellite cell response to myotrauma 
Adult skeletal muscle displays the remarkable capability to regenerate after 
injury, a phenomenon that relies on Pax7+ SCs. Indeed, even after severe 
myofibre necrosis, rat skeletal muscle is able to re-establish full contraction 
power potential as soon as three weeks after injury [55]. Muscle fibre 
regeneration involves the activation of SCs to form myoblasts with a concurrent 
upregulation of the basic helix-loop-helix (bHLH) myogenic determination factor 
MyoD. MyoD+ myoblasts continue to proliferate and amplify their population as 
they downregulate Pax7. Through fusing with each other and existing 
multinucleated cells, myoblasts are able to form immature myotubes, identified 
by myogenin (MyoG) expression. Myotubes continue to mature into new 
myofibres. A subset of activated SCs are able to retain Pax7 expression, 
downregulate MyoD expression and return to quiescence through a process of 
self-renewal, retaining the ability to undergo the same processes of muscle 






1.3.3.1. Pax7+ satellite cells are essential for muscle regeneration 
SCs have been widely implicated as the main stem cell responsible for muscle 
regeneration. However, until recently, the necessity of SCs for regeneration had 
not been fully demonstrated. Utilisation of CreER driven by a Pax7 promoter 
has allowed for the genetic ablation of Pax7+ SCs in a specific and temporal 
manner when used in combination with alleles that express diphtheria toxin A 
(DTA) flanked by a floxed 'stop' signal. Upon tamoxifen-induced cre-mediated 
recombination of floxed stop sequences, the R26RDTA mouse line constitutively 
expresses DTA, a potent inhibitor of protein synthesis that kills the cells in which 
it is produced [57]. Hence, crossing mice where CreER is driven by Pax7 with 
mice where DTA is flanked by floxed stop signals have allowed groups to 
analyse the contribution of SCs to homeostatic muscle function and muscle 
regeneration. Studies employing this technique have shown that skeletal 
muscle lacking SCs displayed no regenerating myofibres after injury [58-61]. 
Furthermore, the few cells which escaped Cre-mediated recombination were 
unable to regenerate the muscle, suggesting there may be a minimum threshold 
for the number of SCs in skeletal muscle, or per myofibre, required for proper 
regeneration  [58-61]. These data show an absolute requirement for Pax7+ SCs 
in muscle regeneration. Without SCs, skeletal muscle is unable to form new 
myofibres after injury. 
 
1.3.3.2. Signalling cascades in the satellite cell response to myotrauma 
The process of repair and regeneration of adult skeletal muscle shares many 
similarities with developmental myogenesis. However, unlike in development, 
SCs are quiescent in adulthood and so they require an orchestrated set of cues 
to activate and proliferate, followed by signals to their progeny to differentiate 
into myotubes to form new muscle fibres. Various secreted growth factors have 
been shown to play an important role in the up and down-regulation of muscle 
specific genes and the sequence of growth factor release appears to be highly 
regulated in order to enable efficient muscle repair without activating SCs under 





Many growth factors play a stimulatory role in myogenic proliferation and 
differentiation. Hepatocyte growth factor (HGF), for example, is released from 
regenerating myotubes and activated SCs and can act in an autocrine manner 
to enhance SC proliferation [63]. Insulin-like growth factor (IGF) has a unique 
dual role in muscle regeneration, inducing both the proliferation of SCs (which 
express the IGF receptor) as well as their differentiation throughout the 
regenerative response [64-67]. Transforming growth factor β (TGFβ) is released 
by platelets and myoblasts and acts to depress SC proliferation and 
differentiation in vitro, possibly to maintain a pool of undifferentiated progenitors 
in regenerating muscle  [68, 69]. The effect of TGFβ in vivo, however, is more 
varied, and can induce or inhibit SC proliferation depending on the presence of 
other growth factors [70, 71].  
The immune system plays an essential role in muscle regeneration with 
inflammation being a key response to muscle damage. Tumour necrosis factor-
α (TNFα) is a well-characterised cytokine partly responsible for the activation of 
the inflammatory response. TNFα is released by activated leukocytes, 
macrophages, and injured muscle fibres and acts not only as a chemoattractant 
and activator of other leukocytes, but is also involved in the degeneration and 
regeneration of damaged muscle fibres [72, 73]. By binding to TNF receptor, 
TNFα promotes the activation of the transcription factor nuclear factor κB 
(NFκB) in muscle fibres, leading to the catabolism of muscle proteins and 
induction of reactive oxygen species (ROS) [74, 75]. Additionally, TNFα has 
been shown to directly activate SCs and enhance expression of MyoD to aid 
muscle regeneration [73]. Interleukin-6 (IL-6) plays a similar role to TNFα, 
regulating muscle protein breakdown and activating SCs [73, 76]. Platelet-
derived growth factor-BB (PDGF) is released from platelets, macrophages, and 
injured blood vessels, and can signal to myoblasts to stimulate their proliferation 
and inhibit their differentiation [68, 77]. By modulating angiogenesis, PDGF can 
also indirectly regulate skeletal muscle regeneration [68]. These studies show 





Wnt proteins belong to a large family of secreted molecules that can signal 
through distinct canonical and non-canonical pathways. β-catenin, the 
downstream effector of canonical Wnt signalling, has been shown to be 
expressed by cultured rat and mouse myoblasts [78, 79] and by the mouse C2 
cell line [80] where it interacts with cadherins to regulate the early steps of 
myoblast differentiation and fusion [78, 80-83]. Recent studies have shown that 
β-catenin can interact with the myogenic determination factor MyoD and this 
interaction is essential for muscle differentiation [84]. Furthermore, canonical 
Wnt signalling has been implicated in the regulation of SC proliferation after 
myotrauma, with induction of proliferation or quiescence dependent on the Wnt 
ligands present and the localisation of stabilised β-catenin [79].  
Notably, not only secreted factors can modulate regenerative behaviour. Notch 
signalling involves the binding of a transmembrane ligand to the extracellular 
domain of a Notch receptor (see Figure 10). In mammals there are four Notch 
receptors (Notch1-4) which can interact with their ligands delta-like 1 (Dll1), dll3 
and dll4, and jagged1 (Jag1) and Jag2. Ligand binding to Notch receptor leads 
to the proteolytic cleavage of the Notch intracellular domain (NICD) by γ-
secretase. The NICD can then translocate to the nucleus and activate target 
gene transcription through interaction with the transcription factor RBPJ (see 
Figure 10). Notch signalling has been shown to aid the homing of SC 
precursors to a SC position [85] and prevent precocious differentiation of 
myogenic precursors during development [86, 87]. Notch signalling plays a 
similar role in adult SCs. SCs express Notch1-3 as well as Dll1 and Jag1 [88, 
89]. Activation of Notch1 promotes the activation of postnatal and adult mouse 
SCs and prevents their differentiation, with mutant mouse models of increased 
Notch signalling showing compromised muscle regeneration [88, 90]. In 
agreement with these findings, loss of Notch signalling through loss of Rbpj 
function leads to the spontaneous differentiation of quiescent SCs and depletion 
of the stem cell pool [91].  
The balance between proliferation and differentiation of myogenic cells is 





rely on crosstalk between Notch and Wnt signalling cascades [92]. Brack et al. 
showed that activation of postnatal myogenic precursors through Notch 
signalling is antagonised by Wnt3a to promote differentiation [92].  Crosstalk 
between the two pathways converge on glycogen synthase kinase 3β, which is 
maintained in an active state by Notch signalling and inactivated by Wnt 
signalling [92].  Interestingly, asymmetric distribution of Numb, a negative 
regulator of Notch signalling, in some SC divisions has been hypothesised to 
lead to different transcriptional programs and cell fates [88, 93]. This suggests 
that localisation of Numb and abrogation of Notch signalling may alter the 
balance between an activated SC self-renewing or differentiating [88, 93]. 
 
1.3.3.3. Fibroblast growth factor signalling in muscle regeneration 
Fibroblast growth factors (FGFs) are a large family of heparin-binding proteins, 
consisting of twenty-two members in vertebrates. They have diverse roles in 
regulating cell proliferation, migration and differentiation. FGF1-10 and FGF15-
23 elicit their effect by binding to FGF receptors (FGFRs), and activating their 
receptor tyrosine kinase activity. So far, four genes encoding FGF receptors 
have been identified (Fgfr1 - 4). FGFRs consist of three domains: an 
extracellular ligand binding domain; a transmembrane domain; and an 
intracellular tyrosine kinase domain. FGF binding to FGFRs leads to the 
formation of a receptor complex composed of two FGF molecules linked by 
heparin sulphate proteoglycans (HSPG) and bound to the FGFR. Formation of 
this complex leads to receptor dimerisation and tyrosine phosphorylation on its 
intracellular domain. Receptor phosphorylation allows for the binding of adaptor 
proteins on the intracellular domain of the receptor, which become 
phosphorylated by the receptor heterodimers. Other intracellular signalling 
molecules bind the receptor and adaptor proteins and are phosphorylated 
themselves, leading to an intracellular signalling cascade. Activation of FGFRs 
engages several second messenger pathways, which include Protein Kinase C, 





The strength and type of pathway activated can be modulated by many different 
factors. These include the expression and levels of ligands and cognate 
receptors, and modifications of HSPGs which can differentially modulate ligand-
receptor specificity [94]. Additionally, interactions of FGFRs with adhesion 
molecules, such as neural cell adhesion molecule (NCAM) and N-Cadherin [95, 
96], and other receptors, can further modify downstream signalling events. 
Skeletal muscle expresses all four FGFRs, with FGFR2 and 3 being expressed 
only at low or negligible levels [97-99]. Myoblast cultures express FGFR1 and 4, 
and tend to upregulate Fgfr1 after mitogen addition [98]. In vitro, FGFs tend to 
stimulate myoblast proliferation. FGF2 has a potent mitogenic effect and 
stimulates SCs to enter the cell cycle [100-102]. FGF2 can maintain the 
proliferation of myoblast cultures whilst not altering the transition from 
proliferation to differentiation in isolated myofibres [100-102]. FGF1, 4, and 6 
can also enhance SC proliferation on ex vivo myofibre cultures, and, 
additionally, FGF6 slows down the transition to differentiation in myogenic cells 
[97]. FGF6 is expressed in cultured isolated rat myofibres, suggesting that the 
myofibre can act as a source of FGFs under certain conditions [97]. 
Interestingly, rat myoblast cultures express Fgf1 and Fgf2 suggesting that 
myogenic precursors themselves can enhance their proliferation through an 
autocrine mechanism of action of these ligands in vitro [103, 104]. In addition, 
FGFs may elicit their effect by modulating the expression of other factors. 
Rosenthal et al. showed that treatment of myoblasts with FGF2 resulted in a 
reduction of IGF-II expression, leading to the hypothesis that FGF2 inhibits 
muscle cell differentiation through inhibition of IGF-II expression [105].  
Under normal homeostatic conditions in skeletal muscle fibres there is very little 
FGF present [106]. FGFs are associated with the extracellular matrix (ECM), 
outside of the basal lamina, and it is not until the muscle is damaged that the 
muscle fibre and SCs are exposed to FGFs in the surrounding area. A large 
amount of FGFs are released after muscle injury in the inflammatory phase of 
regeneration. These mitogenic factors act to induce the proliferation of SCs and 





Husmann et al. showed that FGFs also possess potent angiogenic capabilities, 
which may aid their regenerative effects [68]. FGF2 protein is found in the 
perimysium and ECM surrounding muscle fibres [107], and has been shown to 
be produced by infiltrating macrophages of the inflammatory response and 
many mononuclear cells in regenerating rat muscle [68, 108]. Upregulation of 
FGF2 seen in mouse models of Duchenne muscular dystrophy (DMD), where 
skeletal muscle undergoes repeated rounds of degeneration and regeneration 
due to the lack of functional dystrophin protein, could partly explain the 
persistent skeletal muscle regeneration seen in these animals [68]. 
Concomitantly, inhibition of FGF signalling through the blockade of FGFR 
results in a large decrease in muscle mass and this has been attributed to 
premature terminal differentiation causing a depletion of the pool of myogenic 
progenitors [109-111]. Genetic overexpression of Sprouty (Spry) proteins, 
negative regulators of receptor tyrosine kinase (RTK) signalling, prevents 
embryonic myogenic progenitor cells from proceeding down the myogenic 
differentiation program and instead encourages self-renewal, further showing a 
role for FGF signalling in myogenesis [112]. 
The role of FGF2 in vivo after muscle injury appears to be mainly restricted to 
the initial activation and proliferation of SCs. The injection of neutralising 
antibodies to FGF2 at the time of muscle injury reduced the number and 
diameter of regenerating myofibres, suggesting a delay in the activation of SCs 
and / or myoblast fusion [113]. Taken together, these data show that FGF2 
exhibits mostly a mitogenic role. FGF6 plays a prominent role in regeneration in 
vivo and is induced in response to muscle injury [114]. Mutant mice null for 
FGFR4, FGF6, and both FGF6 and FGF2, display severely impaired 
regeneration with increased fibrosis after injury, attributed to a lack of SC 
activation and defective migration to damaged areas [99, 114, 115]. 
Strict control of FGF signalling in the SCs of injured adult skeletal muscle is 
essential for efficient regeneration and the return to quiescence of myogenic 
progenitors [42]. Shea et al. showed that deletion of Spry1, which encodes for a 





increased FGF signalling, causing a subset of myogenic progenitors to 
apoptose [42]. These data demonstrate a critical role for regulation of FGF 











Figure 2 - Schematic of FGF-ERK signalling. FGF signalling is initiated by FGF ligand binding 
to FGFR. This leads to dimerisation of FGFRs and the cross phosphorylation of tyrosine 
residues intracellularly. These phosphorylated residues are then bound specifically by several 
intracellular signal transduction proteins such as GRB2 and FRS2. These initiate several 
signalling pathways such as PLCγ pathway (not shown), PI3K/PKB pathway (not shown) and 
the Ras/ERK pathway. After activation by addition of GTP, Ras initiates signal transduction 
through a series of 3 tyrosine-serine/threonine kinases (MAPKKK to MAPK) that culminates in 
the phosphorylation and activation of several transcription factors such as activating protein-1 
(AP-1), and signal transducer and activator of transcription (STAT). The downstream effectors 
of Ras/ERK signalling include Erm, Pea3, and Sprouty. Sprouty proteins negatively regulate 
receptor tyrosine kinase signalling somewhere around the level of Ras or Raf. FGF signalling 
can be inhibited by the addition of a chemical inhibitor of FGFR called SU5402 which binds to 
the intracellular kinase domain of FGFR. The addition of a blocking antibody to FGFs (αFGF) 
can inhibit FGF-mediated FGFR signalling. ERK, extracellular-signal related kinase; FRS2, 
fibroblast growth factor receptor substrate 2; Gab, Grb2-associated protein; Grb2, growth factor 
receptor-bound protein 2; MEK, mitogen-activated protein kinase kinase; Raf, v-raf-leukaemia 
viral oncogene homologue 1; Ras, rat sarcoma; SHP2, SH2 domain-containing tyrosine 
phosphatase 2; SOS, son of sevenless. 
 
1.3.4. Heterogeneity of the satellite cell pool 
Many studies propose that the SC pool is functionally heterogeneous, 
suggesting that not all SCs have stem cell characteristics. For example, deletion 
of Spry1 specifically in adult SCs caused the apoptosis of not all, but a subset of 
muscle progenitors after injury [42]. Indeed, in many adult stem cell populations 
there is growing evidence that stem cells with different proliferative kinetics, 
differentiation potentials and mitogenic responsiveness exist in the same tissue. 
In adult skeletal muscle there is clear evidence for heterogeneity in SC 
populations from different muscles and also between SCs within the same 
tissue. For example, SCs associated with extraocular muscles continue to 
proliferate and contribute myonuclei to the tissue in the absence of damage, 
unlike limb SCs, and, strikingly, these muscles are not affected in DMD [116, 
117]. Comparing various limb muscles, SCs also present with different 
proliferation and differentiation kinetics [118], suggesting a large degree of 





1.3.4.1. Self-renewal heterogeneity 
In transplantation studies of irradiated mice, some transplanted SCs were able 
to give rise to many clones and new muscle whereas some grafts did not give 
rise to any, suggesting that a subset of SCs may have a limited capacity for 
self-renewal [53, 54]. This idea is supported by ex vivo studies. In isolated 
single muscle fibres MyoD is rapidly induced as SCs activate and proliferate. 
Most cells downregulate Pax7 expression and commit to differentiation through 
activation of MyoG. However, a subset of activated SCs are able to maintain 
Pax7 expression, downregulate MyoD expression, and return to quiescence 
[119, 120]. This progression suggests that all cells enter a Pax7 and MyoD co-
expression stage before a subset self-renew. 
Kuang et al. and Brack et al. proposed that a subset of SCs which did not 
express a reporter driven by the Myf5 promoter are the true stem cell of skeletal 
muscle as they have never activated the myogenic differentiation program [83, 
121]. The cells which did express the reported gene, on the other hand, are 
their myoblast progeny [83, 121]. In support of these data, around 10% of SCs 
were found to have no Myf5 protein at all [122]. Further evidence for this 
heterogeneity come from studies which have noted that only a subset of SCs 
undergo asymmetric divisions [88, 93, 123, 124]. For example, asymmetric 
distribution of Numb, an inhibitor of Notch signalling, was found to take place in 
some but not all SC divisions [88, 93]. However, contradictory data came from 
Kanisicak et al. who used a MyoDiCre/+ mouse line to drive YFP or β-
galactosidase expression [125]. The authors showed that all SCs were labelled 
with this mouse line, suggesting that all SCs have activated the myogenic 
differentiation program at some point [125]. Therefore, further study into 
heterogeneity based on the stage of differentiation of SC populations is needed. 
Sacco et al. analysed heterogeneity based on the expression of certain genes 
of fluorescence-activated cell sorting (FACS)-isolated single SCs from the same 
muscle [54]. Whilst all cells expressed Pax7 and Myf5 transcript,  25% of SCs 
expressed MyoD, indicating a degree of differentiation commitment, and a small 





and myoblasts [54]. Collectively, these data show that there is heterogeneity 
within the SC pool with regards to gene transcription, degree of differentiation, 
and self-renewal capability. 
 
1.3.4.2. Proliferative heterogeneity 
Heterogeneity of cells in the SC position can be seen during postnatal growth, 
with cells separated into either a rapidly proliferative majority or slowly 
proliferative minority pool [126]. In these stages of postnatal myogenesis, the 
slow-dividing SCs are thought to be the self-renewing population [126]. The 
fast-dividing population, on the other hand, act as transit amplifying cells and 
undergo limited divisions before continuing through the myogenic program 
[126]. This is also seen in ex vivo systems in adult muscle with label retaining 
experiments [124]. Cells which proliferate slowly and retain a dye or DNA-
replication label are known as label-retaining cells (LRCs), whereas cells which 
proliferate more rapidly and dilute the label to undetectable levels are known as 
non-LRCs. Shinin et al. demonstrated that LRCs have an increased tendency to 
self-renew rather than differentiate in ex vivo cultures and therefore appear to 
be more stem cell-like [124]. Ono et al. added to this concept and showed that 
transplantation of LRCs in injured muscle led to more efficient muscle 
regeneration than transplantation of non-LRCs [127].  Furthermore, the authors 
demonstrated that, upon a second injury, more newly regenerated fibres were 
only observed in the LRC-transplanted muscle compared to the primary 
engraftment [127]. These data suggest that the less proliferative SCs are true 
muscle stem cells, whilst the more proliferative SCs are progenitors with limited 
self-renewal capacity [127]. 
 
1.4. The satellite cell niche 
SCs reside in a microenvironment that maintains stem cell quiescence during 
homeostasis but also allows for efficient activation, proliferation, and 





of ECM, the myofibre, vascular cells, neural cells, inflammatory cells, other 
surrounding cells such as adipocytes and fibroblasts, diffusible molecules, and 
the SC itself (Figure 3). 
Experiments in the early 1990s identified the muscle fibre as an essential 
component of the SC niche. Upon destruction of the myofibre, whilst leaving the 
basal lamina intact, SCs rapidly entered the cell cycle and proliferated [128]. 
These experiments described a role for the myofibre in the maintenance of SC 
quiescence, a feature of many stem cells that allows for maintenance of the 
stem cell pool and proper function throughout life [128]. More recent studies 
have reported many SC regulatory factors to be expressed by myofibres. 
Myofibres secrete stromal cell-derived factor-1 which binds to chemokine 
receptor type 4 on the surface of SCs to stimulate their migration to areas of 
high chemokine gradients [129]. Furthermore, the Notch ligand Delta is 
expressed by myofibres and is upregulated following muscle injury [130]. Delta 
binds to Notch receptor on SCs and stimulates their proliferation [130]. 
Growth factors also constitute an important part of the SC niche and their 
effects are discussed in Section 1.3.3.2 and Section 1.3.3.3. Many growth 
factors are associated with ECM proteins, in close contact with the basal 
lamina, and can be activated by proteolytic enzymes, enabling them to carry out 
the highly orchestrated processes of SC activation, proliferation and 
differentiation upon muscle injury [131-134]. Basal lamina components, 
including laminin and fibronectin, support SC proliferation and it has been 
proposed that the basal lamina functions as a scaffold for the formation of new 
myofibres [8].  
Mononucleated interstitial cells and growth factor-secreting fibroblasts are major 
components of the stromal tissue in adult skeletal muscle. Tcf4+ fibroblasts and 
their interactions with SCs have recently been shown to be essential for efficient 
muscle regeneration and also affect the differentiation potential of myogenic 





The vasculature plays an important role in SC regulation, perhaps exemplified 
by the fact that many SCs are closely associated with capillaries [136, 137]. 
Endothelial cells promote proliferation of myoblasts by secreting a panel of 
growth factors such as vascular endothelial growth factor (VEGF), IGF-1, HGF, 
and PDGF. In addition, angiopoietin-1 (Ang-1) is secreted by perivascular cells 
and binds to its cognate receptor Tie-2 on SCs to promote a return to 
quiescence of a subset of SCs after activation [137, 138]. 
Under homeostatic conditions the immune system plays little or no role in the 
regulation of SC behaviour, and only a small number of immune cells reside 
within homeostatic skeletal muscle. However, upon muscle injury, immune cells 
are recruited and, in addition to removing necrotic tissue, they secrete factors 
that encourage SC activation, inhibit apoptosis, and remodel the ECM to allow 
for efficient muscle regeneration [139]. 
The SC niche is also subject to peripheral nervous input from the motor neuron. 
In the 1970s, Schultz et al. showed that acute denervation results in activation 
and proliferation of SCs, mimicking the proliferation seen after myotrauma [140]. 
Chronic denervation results in progressive skeletal muscle atrophy and a large 
decline in stem cell number, thought to be due to exhaustion of the satellite cell 
pool, decreased ability of SCs to enter the cell cycle, and increased apoptosis 
[141-144]. The mechanisms responsible for these phenotypes remain largely 
unknown, however it has been suggested that denervation may influence 







Figure 3 - Schematic illustration of the satellite cell niche. The SC is in close contact with 
the muscle fibre and the basal lamina. Under homeostatic conditions the SC is shielded from 
potent activatory stimuli such as factors in the ECM secreted by fibroblasts, interstitial cells, and 
macrophages. The systemic environment of blood vessels, endothelial cells, and associated 
cells such as pericytes (not shown) can influence SC function. The motor neuron can influence 






1.5. Ageing in skeletal muscle 
Ageing is associated with impairment of skeletal muscle regeneration following 
injury (Figure 4). Furthermore, as age progresses, there is a decrease in 
skeletal muscle mass (sarcopenia) and muscle fibres are replaced by fat and 
fibrous tissue, leading to reduced physiological function [146]. Because SCs 
appear to be solely responsible for skeletal muscle regeneration, these 
hallmarks of ageing are associated with a progressive loss of stem cell number 
and function. During regeneration of aged muscle, SCs exhibit a large decrease 
in activation and proliferation at the population level and generate fewer 
myoblasts compared with adult muscle [147, 148].  There is a large volume of 
evidence suggesting that the decline in SC function is attributable to both cell-
intrinsic and cell-extrinsic factors. However, the issue of whether the number of 
SCs declines with age is still somewhat controversial, with studies documenting 
increased and decreased numbers of SCs depending on the species, muscle, 
and technique of observation [146]. Despite this, there is accumulating evidence 
that limb skeletal muscle exhibits a decline in the number of SCs present 
throughout ageing under homeostatic conditions [149-151]. Furthermore, what 
drives a change in SC number and whether a change in stem cell number 
results in an age-related decline in regenerative capacity has not been 
investigated. Regardless of changes in stem cell number, it has been shown 
that SCs in aged tissue are able to effectively participate in muscle regeneration 







Figure 4 - Schematic illustration of impaired muscle regeneration in old age. In response 
to injury, SCs from adult skeletal muscle are able to rapidly activate and form myoblasts which 
then fuse to form new myofibres. However, as ageing progresses, SCs display an impaired 
ability to regenerate damaged myofibres due to impaired function. There may be fewer SCs 
present in the muscle which are less able to proliferate and form  myoblast progeny and, 
furthermore, myoblasts fuse to form thinner, more fragile myotubes. Collectively this leads to a 
decline in skeletal muscle function. Adapted from [152]. 
 
1.5.1. Age-associated intrinsic changes in satellite cells 
SCs, like other somatic stem cells, have a limited proliferative capacity and 
undergo replicative senescence after a finite number of divisions [153]. 
Telomeres are repetitive nucleotide sequences at the ends of chromatids and 
are implicated in cellular ageing and chromosome stability [154]. As cells divide 
their telomeres become slightly shorter, and so telomere length can be an 
indication of replicative history. In vitro studies using SCs of different ages, and 
from DMD patients, noted that cells isolated from older donors or DMD patients, 
where SCs would have been forced to proliferate more, have a decreased 
proliferative capacity and increased tendency to become senescent, and this 





mouse model of telomere shortening on a muscular dystrophy model 
background and noted that these mice presented with severe muscular 
dystrophy and impaired SC proliferation both in vivo and in vitro [152]. This 
suggested that shortened telomeres may caused impaired SC function [152, 
157]. 
Experiments examining changes in gene expression in human cells have 
demonstrated that the transcriptional profile of SCs is altered during ageing 
[158]. However, this was performed at the population level and so it is unknown 
if some aged SCs retain transcriptional signatures of young SCs. Additionally, it 
is not known if these intrinsic changes are permanent or reversible. It is possible 
that the age-associated decline in SC function is from epigenetic changes which 
are reversible. 
Aged myoblasts in culture display a slow response to mitogenic factors [159, 
160]. However, over time in culture and after many passages, aged myoblasts 
proliferate at almost a similar rate to young myoblasts [151, 160]. This suggests 
that age-related cell-intrinsic changes in SCs are responsible for reduced 
proliferative output. Despite this striking result it is possible that passaging of 
the cells may select for a subpopulation of myoblasts with similar proliferative 
potential from both the young and aged animals. Alternatively, these data may 
suggest that reversible epigenetic changes may be responsible for the delayed 
activation of aged SCs. 
Activation and lineage progression of SCs to myoblasts is dependent on Notch 
signalling. Insufficient upregulation of the Notch ligand Dll1 after muscle injury 
has been proposed to be one of the major factors implicated in impaired SC 
proliferation after muscle injury in aged animals [130]. Furthermore, forced 
expression of Notch signalling in aged homeostatic muscle restores 
regenerative potential to that of an adult muscle [130]. 
SCs have the ability to differentiate into non-myogenic cells, including 
fibroblasts and adipocytes, under certain conditions [161-164]. With ageing, 





and inhibition of Wnt signalling in progenitors blocked the increase in fibrosis 
that is usually seen after injury of aged skeletal muscle [164, 165]. Interestingly, 
this is different to the role of Wnt signalling in regeneration of adult skeletal 
muscle, where it promotes proliferation and the early phases of myogenic 
differentiation (See Section 1.3.3.2). These differences could be due to the 
effects of signalling through different Wnt proteins and receptors, or perhaps the 
SC response to Wnt signalling may change with age. 
The differentiation of myogenic cells is also impaired with ageing as SCs fuse to 
form thinner, more fragile myotubes [155]. Furthermore, fewer aged myogenic 
cells expressed markers of more mature myofibres after being placed in 
differentiation conditions compared to adult cells, consistent with impaired 
differentiation [150, 166]. Interestingly, after multiple passages myoblasts were 
capable of efficient differentiation, suggesting that reversible cell-intrinsic 
changes in myogenic cells result in impaired differentiation capability [10]. 
 
1.5.2. Age-associated changes in the satellite cell niche 
In invertebrate stem cell systems, age-associated changes in the niche have 
been shown to negatively impact on stem cell maintenance and function [167, 
168]. The niche is an important regulator of stem cell quiescence, a reversible 
state of proliferative inactivity essential for maintenance of stem cell number 
and function in many mammalian systems [20]. The environment can reverse 
cell-intrinsic changes that occur with age, suggesting that the niche can 
influence SC function. Heterochronic transplantation studies, where aged or 
young whole muscle was transplanted into either aged or young hosts, 
demonstrated that the systemic environment can affect regeneration. 
Engraftment was successful when old muscle was transplanted into young 
hosts, whereas regeneration was impaired when young muscle was 
transplanted into aged hosts [148, 169]. Furthermore, the regeneration of a 
single aged fibre transplanted into a young irradiated host was comparable to 





suggesting that the host environment affects stem cell function and 
regeneration. 
Parabiotic studies have been used to examine the effect of the aged and adult 
environment on stem cell function in different systems, including skeletal muscle 
SCs. These experiments involve surgically joining together two animals so that 
they develop a single, shared circulatory system, followed by inflicting muscle 
injury to examine SC activation and differentiation. In heterochronic pairs, where 
aged mice were paired with adult mice, injury to the aged mice resulted in 
increased activation of their SCs and improved regeneration [10, 164]. Aged 
SCs exposed to an adult systemic environment were also less prone to adopt a 
fibrotic fate [10, 164]. These studies also showed that the aged systemic 
environment may inhibit muscle regeneration as regeneration of the skeletal 
muscle of adult heterochronic pairs was impaired compared to adult 
homochronic pairs and adult SCs had an increased tendency to adopt a fibrotic 
fate [10, 164]. Aged skeletal muscle also displays decreased capillarisation 
compared to young muscle, suggesting that the ability of systemic factors to 
contact the myofibre and SC may be decreased [170]. These studies show that 
the young systemic environment has a pro-proliferative effect on SCs, whereas 
the aged systemic environment is detrimental to SC function during 
regeneration. 
Changes in the composition of the ECM with age may also have detrimental 
effects on skeletal muscle regeneration. A thickened basal lamina and an 
increase in connective tissue between muscle fibres have been noted in aged 
compared to young muscle [171-173]. A thicker basal lamina would result in 
more collagen surrounding the fibre, possibly changing the physical properties 
and stiffness of the niche and altering SC function [146]. 
As ageing progresses there are changes in the expression of circulating factors 
important for muscle regeneration. An increased level of TGFβ occurs with age, 
and this has been suggested to impair SC activation [174-176]. Administration 
of neutralising antibodies to the downstream effector of TGFβ signalling, 





signalling also enhances the adoption of a fibrotic or adipogenic cell fate, 
possibly in part due to driving the expression of periostin, a protein produced by 
interstitial fibroblasts [164, 165, 177, 178]. Enhanced TGFβ signalling combined 
with decreased Notch signalling (see Section 1.5.1) with ageing will collectively 
promote the expression of cell cycle inhibitors such as p15, p16, p21, and p27 
in SCs, supporting the idea that the balance between signalling pathways is 
crucial to ensure proper stem cell function [174, 175]. 
A functional deficit in the immune response with age can affect SC function. In 
vitro studies suggest that many of the immune cells' key responses, such as 
phagocytosis and chemotaxis, are impaired with age [179]. This would hamper 
the regenerative response and SC activation as immune cells can influence SC 
behaviour through the release of cytokines, such as IL-6, and the removal of 
damaged tissue. 
The neuromuscular junction also undergoes age-related changes, with electron 
microscope examination revealing decreases in nerve terminal area and 
occasional denervated postsynaptic regions in aged skeletal muscle [180]. The 
resulting activation and exhaustion of the stem cell pool may potentially be one 
of the causes of decreased SC number with age [141-143, 181]. 
These data demonstrate that it is possible to restore regenerative potential to 
aged SCs through modulation of the niche. However, although many of these 
studies have examined aged SCs in the context of muscle injury and 
regeneration, few studies have looked at the internal and external changes 
under homeostatic conditions. This analysis will be necessary to prevent, or 








Despite originating from different cell populations during embryonic 
development and serving different tissue systems, there are similarities in the 
regulation of adult skeletal muscle stem cells and neural stem cells. Both stem 
cell populations are relatively quiescent and form specified mature cell types 
through the generation of transit amplifying daughter cells [182, 183]. 
Furthermore, both stem cell populations reside in well-defined niches which can 
modulate their function under homeostatic conditions and under traumatic 
conditions [8, 183]. Interestingly, skeletal muscle stem cells and neural stem 
cells both exhibit a decline in number with ageing [8, 184]. Investigating the 
extrinsic and intrinsic mechanisms which regulate the maintenance and self-
renewal of these two stem cell populations may therefore provide an insight into 
the common mechanisms by which somatic stem cell number and function are 
regulated. 
Neurogenesis is the formation of new neurons that are able to functionally 
integrate into synaptic circuitry. In mammals, neurogenesis occurs throughout 
embryonic developmental stages to form the CNS. Neurogenesis also occurs in 
discrete regions of the postnatal and adult forebrain at a much lower level. 
Neural stem cells (NSCs) are multipotent cells capable of self-renewal, and are 







1.6.1. Embryonic neurogenesis 
During development, radial glia (RG) in the neuroepithelium form the neurons 
and glial cells of the entire CNS in a defined manner [185]. By the end of 
development most RG convert into mature astrocytes [185]. However, some RG 
cells form somatic NSCs instead, which retain many of the stem cell markers 
seen in RG cells. Adult NSCs  have many morphological characteristics of RG 
cells and indeed serve a similar function as the primary progenitors of new 
neurons and glia [186]. 
 
1.7. Adult neurogenesis and adult neural stem cell properties 
NSCs have been shown to persist in at least two specialised niches of the adult 
forebrain of many mammalian species: The subgranular zone (SGZ) of the 
dentate gyrus (DG), and the subventricular zone (SVZ) of the walls of the lateral 
ventricles [183]. NSCs in these regions continue to generate new neurons 
throughout life [187-189]. Although NSCs in the SGZ and SVZ are separated 
spatially and give rise to neurons that serve different systems and purposes, 
there are common themes that define the adult NSCs and their niches. Adult 
NSCs in both systems have a radial morphology [190] and express astrocytic 
markers such as glial fibrillary acidic protein (GFAP) [191, 192], brain lipid-
binding protein (BLBP), vimentin, and glutamate aspartate transporter (GLAST), 
as well as expressing stem cell markers such as Sox2 and Nestin, much like 
RG cells [193]. In addition, there is some overlap between signalling pathways 
that modulate SGZ and SVZ systems, and also embryonic RG function [194]. 
Adult NSCs in both niches display the capacity for self-renewal throughout life, 
as well as the ability to generate neurons and glia [195]. This has been shown 
by in vivo labelling studies and in vitro culture assays in many mammalian 
species, including humans [189, 196-200]. However, unlike their embryonic 
counterparts, adult NSCs are relatively quiescent and divide infrequently under 
homeostatic conditions. Doetsch et al. demonstrated the quiescent nature of 





killed the rapidly-dividing NSC progeny in the SVZ, but did not affect the slowly-
dividing NSCs [201]. Upon removal of AraC, the NSCs were able to generate 
immature precursors and new neurons [201]. These data show that radial 
astrocyte-like cells in the SGZ and SVZ are the true neural stem cells of the 
adult forebrain. 
 
1.8. Subventricular zone - olfactory bulb neurogenesis 
The SVZ is the layer of cells around the walls of the lateral ventricle, outside of 
the ependymal layer (Figure 5a,b). The SVZ is the major source of adult 
neurogenesis in the mouse and is responsible for short-term olfactory memory 
and long-term associative olfactory memory [202-204]. In addition, olfactory 
bulb neurogenesis regulates olfaction dependent sex responses and predator 
avoidance, implicating SVZ neurogenesis in pheromone-related behaviours and 
olfactory fear conditioning [202]. Cells born in the SVZ traverse a long distance 
anteriorly via chain migration through a well-defined pathway called the rostral 
migratory stream (RMS) towards the olfactory bulb (OB) [205, 206]. Once they 
reach the OB, the immature neurons then migrate radially to different OB layers 
and differentiate into new interneurons (Figures 5a-c) [205]. This process is 
functionally correlated with olfactory learning and it has been shown an 
increased number of newborn OB interneurons survive during olfactory 
behaviours [201, 207]. It is estimated that the number of newly formed 
interneurons that are added to the OB ranges from 10,000 to 30,000 per day in 
adult mice [208], to 80,000 in young adult rats [209]. This correlates to around 
1% of the olfactory granule cell population per day in a young adult rodent [209, 
210]. The size of the OB does not change substantially throughout life, 
suggesting that SVZ-OB neurogenesis must be accompanied by cell death 
[210-212]. Indeed, large levels of apoptosis are observed in the OB, which 







Figure 5 - Schematic illustration of adult subventricular zone neurogenesis. a, Illustration 
of a coronal section of the adult mouse brain showing the lateral ventricles (LV). The boxed 
area is shown enlarged in b. b, Composition of the SVZ niche. The LV is lined by ependymal 
cells (grey) and SVZ cells are ensheathed by a basal lamina (BL - yellow). Type B cells (dark 
blue) are the NSCs of the SVZ and have many features of astrocytes. Some contact the 
ventricle through a single cilium and may contact a blood vessel (BV). Type B cells give rise to 
type C cells (green) which are rapidly dividing. Type C cells give rise to type A cells (red). Type 
A cells migrate via chain migration through the rostral migratory stream (RMS) towards the 
olfactory bulb (OB; c). Once in the OB, type A cells migrate radially to different areas of the OB 






1.8.1. The neurogenic lineage in the adult subventricular zone 
Different types of neurons are generated by SVZ cells. The vast majority 
newborn cells are GABAergic glomerular cells (Figure 6) [215-220]. A minority 
of newborn cells become GABAergic periglomerular cells [215, 216, 218-220], 
and one study also noted the formation of glutamatergic juxtaglomerular 
neurons (see Figure 11) [221]. Parenchymous astrocytes and oligodendrocytes 
of the corpus callosal white matter are also produced to a limited extent by SVZ 
cells (Figure 6) [216]. The primary precursors for the generation of these cells 
are SVZ NSCs, also called type B cells [201]. These NSCs exist along the 
lateral, medial, and dorsal walls of the lateral ventricle in the SVZ, as well as in 
the RMS and corpus callosum [201, 222, 223]. Type B cells are relatively 
quiescent but divide infrequently to form transit-amplifying progeny, also known 
as type C cells [183]. Type C cells divide rapidly to amplify their population and 
they give rise to neuroblasts, also known as type A cells. Type A cells are 
ensheathed by astrocytes and migrate along the RMS to the OB [183]. Type A 
cells then mature into new granule or periglomerular neurons after arrival in the 






Figure 6 - Schematic illustration of the multipotency of adult neural stem cells in the 
subventricular zone. SVZ NSCs are capable of forming interneurons in the olfactory bulb (OB), 
mature astrocytes in the parenchyma, and oligodendrocytes in the corpus callosum (CC). GL, 







Figure 7 - Schematic illustration of the adult subventricular zone cell lineage. Type B cells 
are relatively quiescent and express astrocytic markers such as GFAP, vimentin and BLBP as 
well as Notch receptor, Tlx, Nestin, and Sox2. Upon activation, type B cells upregulate EGFR 
and become positive for cell cycle markers such as Ki67. MASH1 marks activated type B cells 
and their progression to type C cells. Type C cells downregulate astrocytic markers and Notch 
receptor and upregulate Notch ligand to induce Notch signalling in type B cells. Type C cells 
proliferate rapidly and form type A cells which express doublecortin (DCX) and polysialic acid 
neural cell adhesion molecule (PSA-NCAM). Type A cells downregulate stem cell markers such 
as Nestin and Sox2 as well as EGFR, MASH1 and Notch ligand. In addition they are much less 
proliferative than type C cells and few are positive for Ki67. Type A cells migrate to the OB 
where they form different types of interneurons. All interneurons are positive for NeuN but these 
can be further categorised into interneuron type by their expression of calretinin (CalR), 






1.9. Adult hippocampal neurogenesis 
Neurogenesis in the DG plays an important role in hippocampus-dependent 
learning tasks and memory formation. Blocking hippocampal neurogenesis 
leads to decreased performance in various learning and memory tasks and, 
conversely, increasing neurogenesis in this region leads to improved 
performance [224-227]. Cells born in the SGZ migrate only a small distance 
through the granular layer (GL) and, unlike in the OB, cells mature and become 
only one type of neuronal population: granule neurons (Figure 8) [228]. 
Generation of astrocytes and, to a very limited extent, oligodendrocytes from 
SGZ cells have also been observed under certain conditions [229-233]. The 
production of new neurons in the hippocampus is much lower than in the SVZ-
OB system, with the formation of new cells estimated to be around 9000 per 
day in an adult rat [232, 234], corresponding to 0.03% of the total hippocampal 
dentate neuronal population [235]. Interestingly, in the DG old neurons are not 
just replaced but SGZ neurogenesis contributes to the increase in the volume of 








Figure 8 - Schematic illustration of adult subgranular zone neurogenesis. a, Illustration of 
a coronal section of the adult mouse brain showing the dentate gyrus (DG) of the hippocampus 
(HP). The boxed area is enlarged in b. b, Composition of the SGZ niche. Type 1 cells (dark 
blue) are the NSCs of the SGZ. They are usually in close contact with a blood vessel (BV) and a 
basal lamina (yellow stripes). Type 1 cells are relatively quiescent and give rise to type 2a cells 
(orange). Type 2a cells proliferate rapidly and form type 2b cells (light green) which are less 
proliferative and more committed to differentiation. Type 2b cells give rise to type 3 cells (purple) 
which migrate to deeper layers of the granular layer (GL) and divide infrequently. Type 3 cells 






1.9.1. The neurogenic lineage in the adult subgranular zone 
Dentate granule neurons are generated throughout life by SGZ cells in many 
species, including humans [189]. The primary precursors for adult born dentate 
cells are SGZ NSCs, also called type 1 cells. Type 1 cells have a unique 
morphology compared to other cells in the hippocampus as they have their cell 
body in the SGZ and extend astrocytic projections through the granular layer 
and into the molecular layer of the DG (see Figure 8) [228]. These cells share 
many similarities with type B cells in the SVZ, however, the two cell types are 
not identical. Type 1 cells and Type B cells serve different brain systems and 
functions, so the regulation of the NSCs in the different niches may be different. 
 NSCs in the SGZ divide very infrequently and can form transit amplifying 
progeny collectively known as type 2 cells [228]. Type 2 cells are divided into 
two subtypes corresponding to consecutive stages of cell development based 
on proliferative output and stage of differentiation and are called type 2a and 
type 2b cells. It is thought that type 2a cells are the primary daughter cells of 
type 1 cells as they have a relatively high proliferative output and express few 
differentiation markers [228]. Type 2a cells then form type 2b cells, which are 
more limited in their proliferative output and express markers consistent with a 
greater commitment to differentiation (Figure 9) [228]. Type 2b cells give rise to 
neuroblasts, also called type 3 cells, which migrate to deeper layers of the DG. 
Type 3 cells proliferate much less and exit the cell cycle and give rise to 
postmitotic immature granule cells which form nascent network connections 
(see Figure 8 and Figure 9) [233]. Some of these immature neurons eventually 
mature into new granule cells which project axons to the CA3 region of the 







Figure 9 - Schematic illustration of the adult subgranular zone lineage. Type 1 cells are 
relatively quiescent and express astrocytic markers such as GFAP, vimentin and BLBP as well 
as Notch receptor, Tlx, Nestin, and Sox2. Upon activation, type 1 cells upregulate EGFR and 
become positive for cell cycle markers such as Ki67. MASH1 marks activated type 1 cells and 
their progression to type 2a cells. Type 2a cells downregulate astrocytic markers and Notch 
receptor and upregulate Notch ligand to induce Notch signalling in type 1 cells. Type 2a cells 
proliferate rapidly and form type 2b cells. As type 2b cells become more committed to the neural 
lineage they begin to upregulate NeuroD1 and downregulate EGFR. Type 2b cells form type 3 
cells which express doublecortin (DCX) and polysialic acid neural cell adhesion molecule (PSA-
NCAM). Type 3 cells downregulate stem cell markers such as Nestin and Sox2 as well as 
MASH1 and Notch ligand. Type 3 cells form new granule cells which express NeuN and low 
levels of Notch receptor. Immature granule cells initially express calretinin (CalR) and as the cell 







1.10. Adult neural stem cell niches 
The ability of SVZ and SGZ NSCs to act as the primary progenitors in the 
generation of new neurons is partly due to signalling that occurs in the NSC 
niche, and partly due to intrinsic differences between these stem cell astrocytes 
and non-stem cell astrocytes. When adult SVZ cells are transplanted to non-
neurogenic regions they usually differentiate into parenchymous astrocytes 
[238]. Lim et al. discovered that transplantation of NSCs in the striatum 
accompanied by ectopic expression of an inhibitor of bone morphogenic protein 
(BMP) signalling, Noggin, promoted the cells to differentiate into neurons [239]. 
This suggests that the environmental signals around neurogenic astrocytes are 
essential for part of their function. However, when parenchymal tissue is 
transplanted to the SVZ of adult mice these astrocytes do not become 
neurogenic, suggesting that environmental signals, although important for NSC 
proliferation and differentiation, do not confer a neurogenic phenotype on 
astrocytes [240]. The adult NSC niches are thus able to instruct NSCs towards 
neurogenesis and gliogenesis. In addition to this, the hippocampal 
microenvironment has been shown to have an instructive role in stem cell fate. 
Studies by Shihabuddin et al showed that adult spinal cord stem cells 
transplanted into the hippocampus were instructed towards a neurogenic and 
gliogenic lineage characteristic of the hippocampus [241]. This suggests that 
common features may be present in the microenvironments of CNS stem cell 
niches [241]. 
Astrocytes, vascular cells, NSC progeny and mature neurons are the major cell 
types of the neurogenic niches, which can influence the behaviour of neural 
progenitors. Astrocytes have been shown to play roles in modulating NSC 
proliferation and differentiation as well as migration and differentiation of 
progenitors [242-245]. Mature neurons near the neurogenic site regulate 
neurogenesis in response to neuronal activity, and many neurotransmitters 
have been shown to play a role in regulating NSC proliferation [246-248]. 
Vascular cells are also thought to play a role in regulating proliferation of NSCs 





with it, displaying a modified blood-brain barrier devoid of astrocyte end-feet 
and pericyte coverage [249-251]. The SGZ and SVZ niches therefore provide 
important signals to regulate neurogenesis. 
 
1.10.1. Notch signalling in the neurogenic niches 
NSCs are mostly quiescent and only certain subpopulations appear to be 
proliferating and forming transit-amplifying cells [252, 253]. Notch signalling has 
been shown to be an essential regulator of NSC quiescence and inhibition of 
NSC differentiation. Notch1-4, their cognate ligands, Jagged (Jag) 1, and Delta-
like ligand (Dll) 1, and downstream effectors, Hes1 and Hes5, are expressed in 
the SVZ and SGZ [252, 254, 255]. Notch signalling is highly active in type B 
cells in the SVZ and type 1 cells in the SGZ [252, 253, 256]. Pro-neural gene 
products, such as the bHLH transcription factors Mash1 and Neurogenin 1 and 
2, induce the expression of Notch receptor ligands as well as initiating the 
neuronal differentiating program [257, 258]. The downstream effectors of Notch 
signalling, Hes1 and Hes5, then repress the expression of pro-neural genes and 
Dll1 thereby inhibiting neuronal differentiation (Figure 10) [259]. This lateral 
inhibition by a committed neural progenitor cell prevents neighbouring NSCs 
from differentiating [259]. Therefore, Notch signalling represents a mechanism 
by which the proliferation and differentiation of NSCs is regulated by the 
production of transit amplifying progeny.  
Imayoshi et al. inhibited Notch signalling in the SVZ by deleting RBPJκ, a DNA-
binding protein that forms a complex with NICD to initiate Notch-dependent 
signalling (Figure 10), specifically from adult NSCs [256]. The authors showed 
that loss of Notch signalling resulted in a transient increase in SVZ proliferation 
and neurogenesis, followed by a depletion of the NSC pool [256]. This was 
caused by loss of NSC quiescence and exhaustion of the NSC pool due to 
premature conversion of type B cells to type C cells [256]. A similar phenotype 
was found by Ehm at al. in the hippocampus, where deletion of RBPJ in adult 
NSCs led to a loss of NSC quiescence and a transient increase in neurogenesis 





different phenotype with the loss of Notch1 receptor in adult hippocampal NSCs 
which resulted in the eventual loss of type 1 cells but without a transient 
increase in proliferation [260]. The reason for this difference is probably due to 
Notch signalling being inactivated to a greater level in RBPJ mutants, and also 
due to the fact that other Notch receptors are present in the SGZ  [252, 261]. In 
addition, Androutsellis-Theotokis et al. demonstrated that NSCs are also 
regulated by RBPJ-independent Notch signalling [262]. The authors showed 
that Notch receptor activation can induce the expression of Hes3 and Shh 
through rapid activation of STAT3, thereby promoting the survival of neural 
stem cells [252, 262]. These data depict an important role for Notch signalling in 












Figure 10 - Schematic illustration of Notch signalling in neural stem cells. The proneural 
proteins Mash1 and Ngn2 upregulate the expression of Notch ligands such as Dll1. Ligands 
activate Notch signalling in neighbouring cells. Upon Notch activation, Notch receptor is 
proteolytically cleaved by γ-secretase, freeing the Notch intracellular domain (NICD) from the 
cell membrane. The NICD then translocates to the nucleus where it forms a complex with RBPJ 
and induces the transcriptional activation of Notch target genes such as Hes1 and Hes5. Hes1 
and Hes5 repress proneural gene expression. Adapted from [263]. 
 
1.11. Survival of neural stem cell progeny in the hippocampus 
The SVZ and SGZ produce a large number of immature neuroblasts, yet many 
do not go on to mature into new neurons and form stable synaptic contacts. In 
the hippocampus, programmed cell death is largely responsible for the numbers 
of new neurons formed and it has been shown that less than 30% of newborn 
cells in the hippocampus survive to be mature neurons [229, 233, 264]. There 
are two critical periods of survival of precursors and neurons, with most 
apoptosis taking place at the transit-amplifying to neuroblast stage, where newly 
born cells are between 2 and 4 days old, and a second period at the stage of 
maturation of immature neurons, where cells are between 1 and 3 weeks old 
[264]. The first period of survival is thought to limit the number of new neurons 
able to proceed down the neurogenic lineage, whereas the second period 
appears to be dependent on excitatory input, perhaps allowing for the selection 
of neurons with ideal electrophysiological properties [264, 265]. The few 
newborn neurons that do survive have been shown to remain integrated into the 
hippocampal synaptic circuitry for at least 11 months [266]. 
Just as there are mechanisms in place to limit the number of new neurons 
formed, there are also physiological stimuli that can increase the survival of 
newborn cells. Hippocampal dependent learning tasks can aid the survival of 
newborn cells up to one week old [267, 268]. Physical exercise has been shown 
to increase the proliferation and survival of type 2 and type 3 cells respectively, 
due, in part, to increased uptake of serum IGF1 in the brain parenchyma, 
leading to increased dentate neurogenesis [269-271]. In addition, exposing 





neurons in the SGZ without affecting SVZ neurogenesis [235]. Interestingly, 
these physiological stimuli only affect the behaviour of the progeny of NSCs and 
do not affect NSC behaviour. This suggests that NSCs are not responsive to 
acute fluctuations in changes in the environment, but are instead governed by 
NSC-specific genetic programs. 
 
1.12. Survival of neural stem cell progeny in the SVZ-OB 
system 
Between 15 and 45 days after being born approximately half of all newly 
generated SVZ cells undergo apoptosis, however, those that do survive are 
integrated into the OB for up to a year in mice [211, 219]. Hippocampal-
dependent learning tasks, physical exercise, and an enriched environment all 
affect dentate neurogenesis but do not have any impact on OB neurogenesis. 
Instead, activity from the OB aids cell survival and causes an increase in 
proliferation of NSCs and their progeny in the SVZ [272-275]. Conversely, naris 
occlusion causes a decrease in neurogenesis by affecting the survival of new 
interneurons, mostly between two and four weeks after birth [273, 276]. Mice 
partaking in olfactory learning tasks show an increase in the survival of new 
interneurons involved with processing the odourants in the learning task [274]. 
Olfactory learning tasks involve training mice to associate a particular odour 
with a reward (a reinforced odour) as well as introducing a second odour that is 
not associated with a reward (non-reinforced odour). Interestingly, Alonso et al. 
showed that survival of newborn cells was also increased in the area of the OB 
responsive to the non-reinforced odour [274]. Additionally, exposure of animals 
to odourants without a learning paradigm (i.e. without a reward) did not affect 
new cell survival [274], suggesting there is an interplay between many factors in 






1.13. Heterogeneity of neural stem cells 
Growing evidence suggests that the population of NSCs in both the SVZ and 
SGZ are heterogeneous in terms of their proliferative output and neurogenic 
potential. Due to inefficient lineage tracing however, it is not always possible to 
determine if activated NSCs represent a continuum in the neurogenic lineage or 
are instead discrete and separate populations. Instead, heterogeneity within the 
NSC pool is often inferred by morphological differences and surface marker 
expression. 
 
1.13.1. Heterogeneity of SVZ NSCs  
The morphology of SVZ B cells has been extensively studied to determine the 
ultrastructural characteristic differences between different types of stem cells, 
specifically activated and quiescent type B cells. A small subpopulation of B 
cells have an apical process that contacts the ventricle, and the number of cells 
contacting the ventricle appears to be increased when SVZ proliferation is 
stimulated, most probably allowing the stem cell to respond to activatory signals 
from the cerebrospinal fluid (CSF) [201]. Activation of SVZ stem cells is also 
associated with increased EGFR expression so that activated astrocytes are 
GFAP+EGFR+ [277]. Addition of EGF to NSC cultures increases the proliferation 
of progenitors, however there is a heterogeneous population of cells in these 
cultures and it is thought that type C cells are the main cells responding to EGF 
in these conditions [277]. 
Recent work shows that the plasticity of NSCs and progenitors in the SVZ is 
subject to regional specification. Postnatal RG and adult type B cells in different 
areas of the SVZ generate different types of OB neurons (Figure 11). This has 
been shown through the fate mapping of cells expressing different transcription 
factors in the SVZ and RMS in combination with lineage tracing of RG cells in 
restricted regions of the walls of the lateral ventricle in postnatal mice [278-282]. 
These data confirmed that NSCs from different regions of the SVZ ultimately 





example, cells in the dorso-lateral aspect of the SVZ and RMS had a greater 
tendency to form tyrosine hydroxylase (TH)-positive interneurons in the 
glomerular layer of the OB (Figure 11) [207]. Thus, SVZ B cells have a regional 
limit to their plasticity as they inherit a regional pattern of gene expression from 
embryonic RG. Grafting experiments suggest that this specification is cell-
autonomous and not dependent on the regional SVZ environment [223, 282, 
283]. However, whether there is one stem cell population in the adult 








Figure 11 - Schematic illustration of the regional specification of SVZ cells. Labelling 
postnatal stem cells has shown that cells in the dorso-lateral aspect of the SVZ (dashed oval 
with red circles) produce mostly superficial glomerular cells (GCs; green) and TH+ glomerular 
cells (red). TH+ and some CalR+ periglomerular (PGC) OB interneurons are derived from Emx1-
expressing progenitors (red arrow and red area). Deep GCs (blue) and CalB+ PGCs (purple) are 
produced primarily by lateral and ventral SVZ cells (dashed oval and purple circles). Some 
NSCs in this region express the transcription factors Gsh2 and Nkx2.1 (light blue and purple 
areas, respectively).  Gsh2+ progenitors primarily produce CalB+ PGCs (light blue arrow). 






1.13.2. Heterogeneity of SGZ NSCs 
Two stem cell populations in the SGZ have been identified that possess 
different proliferative potentials and may be responsible for the neurogenic 
responses to different physiological stimuli. The quiescent NSC in the DG 
resides in the SGZ and extends processes perpendicularly through the granular 
layer and often into the molecular layer (Figure 12). In addition, a stem cell with 
horizontal astrocytic processes, running parallel to the SGZ, exists, and is much 
less quiescent (Figure 12) [233, 253, 284]. Studies by Lugert et al. have 
suggested that under homeostatic conditions, Notch-activated radial type 1 cells 
contribute very little to active dentate neurogenesis. Instead, Notch-activated 
horizontal NSCs are much more proliferative and may divide asymmetrically to 
form type 2 cells at a much greater rate than radial cells [253]. Whether 
horizontal astrocytes are derived from radial astrocytes is unknown, but during 
ageing this activated pool of NSCs is lost, resulting in decreased neurogenesis 
[253].  Despite both pools sharing a common dependence on Notch signalling, it 
is has yet to be uncovered whether they have different requirements for their 
maintenance and differentiation [253]. However, it has been shown that Notch-
dependent radial NSCs respond to physical exercise and proliferate, without 
affecting the horizontal population [253]. In addition, seizures, a well 
documented stimulator of neurogenesis, increased proliferation of both Notch-
dependent radial and horizontal NSCs (Figure 12) [253]. These findings are in 
contradiction with earlier studies, which suggests that radial SGZ NSCs do not 
respond to physical exercise [235, 267, 268]. Instead, these data indicate that 
Notch-activated NSCs may represent a distinct type of NSC, different from non-
Notch-activated NSCs. Further study into these two populations with lineage 







Figure 12 - Schematic illustration of radial and horizontal neural stem cells in the 
subgranular zone. Radial type 1 cells that have their cell body in the SGZ and extend 
astrocytic processes through the granular layer (GL) have long been proposed to be the NSC of 
the dentate gyrus. Under homeostatic conditions they are relatively quiescent. In response to 
physical exercise or seizures, Notch-dependent radial type 1 cells proliferate. Also in the SGZ 
resides a horizontal astrocyte, with astrocytic processes extending parallel to the SGZ. Under 
homeostatic conditions, Notch-dependant horizontal NSCs are relatively proliferative. They 
further increase their proliferative activity in response to seizures, but do not respond to physical 






1.14. Epigenetic control of adult neurogenesis 
Epigenetic regulation of stem cell function is an emerging concept in the field of 
stem cell biology, and involves the regulation of gene transcription by DNA 
methylation, histone modifications, chromatin remodelling, and gene translation 
by microRNAs [285, 286]. These epigenetic changes permit cells to rapidly 
respond to internal and external physiological cues to coordinate the transition 
from one cellular state to another [286]. Chromatin remodelling has been shown 
to play a role in the differentiation and self-renewal of embryonic and postnatal 
neural stem and precursor cells [286], but there is now an emerging role for 
chromatin remodelling in the regulation of adult neurogenesis in both the SVZ 
and SGZ [287, 288]. 
 
1.14.1. Chromatin structure and remodelling proteins 
Chromatin is structured in a way that not only allows great compaction of DNA 
within a nucleus, but also allows for the rapid activation and repression of 
potentially large sets of genes. Chromatin consists of DNA wrapped around 
histones to form nucleosomes and linker DNA in between nucleosomes (Figure 
13). Tightly packed DNA in heterochromatic regions will generally be harder to 
access by transcription factors and polymerases (silenced chromatin regions), 
whereas DNA within linker regions and in a euchromatic state will generally be 
much easier to access (active chromatin regions). Chromatin can be silenced or 
activated through the action of proteins called chromatin remodellers. Some 
chromatin remodellers utilise energy from ATP hydrolysis to open up chromatin 
by evicting nucleosomes or inducing nucleosome sliding, as well as by 
mediating chromatin looping, and this can potentially have diverse effects on 
gene transcription (Figure 13). 
There are two general groups for chromatin remodellers: trithorax group (TxG) 
proteins which usually cause the activation of their target loci, and polycomb 
group (PcG) proteins which tend to repress gene activation [289]. PcG and TxG 





structure. PcG proteins usually belong to one of at least two complexes: 
Polycomb repressive complex (PRC) 1 and PRC2, whereas the composition of 
TxG complexes is heterogeneous. PcG and TxG proteins are antagonistic, 
evolutionary conserved chromatin complexes that can maintain gene 
expression states over many cell divisions [290] and often mediate gene 
expression through different histone modifications. For example, PRC2 contains 
Ezh2 (among other PRC2 components) which can catalyse histone H3 lysine 
27 tri-methylation (H3K27me3), leading to gene silencing. PRC1 can contain 
Ring1, an E3 ubiquitin ligase that mono-ubiquitinylates histone H2A at lysine 
119 (H2Aub1), also resulting in gene silencing [291, 292]. The interplay 
between these two complexes can also lead to stable gene suppression [293, 
294]. One model by which this happens involves the recruitment of PRC2 to 
specific loci where it catalyses H3K27me3. The modified histones in turn recruit 
PRC1, which catalyses H2Aub1 and thereby impedes gene transcription [295, 
296]. In addition to these two complexes, other PcG complexes with different 
enzymatic activities can further regulate cellular biological processes [297]. 
TxG complexes can catalyse H3K4me3 resulting in gene expression. However, 
it is unclear if TxG proteins cause gene activation by antagonising PcG function 
or by globally activating gene expression. The yeast SWI/SNF (switch/sucrose 
nonfermentable) subfamily was the first TxG chromatin remodelling complex to 
be discovered [298]. Mammalian SWI/SNF complexes comprise of the 
assembly of at least 14 subunits, allowing for an extensive diversity of 
complexes with specialised functions in specific tissues [299]. SWI/SNF 
complexes regulate the chromatin structure of a large number of genes involved 
in cell cycle regulation, cell signalling, and proliferation [299].  SWI-like ATP-
dependent chromatin remodelling complexes are broadly divided into four main 
families based on the sequence and structure of the ATPase subunit: SWI/SNF, 
imitation-switch (ISWI), INO80, and CHD complexes. In addition, many 
predicted SWI-like proteins do not yet fit any of these classes and need further 
study [299]. Members of the SWI/SNF family are characterised by the presence 
of a bromodomain, which recognises acetylated lysine residues on histone tails 





functions as a histone-binding module [301]. The INO80 member is the only 
chromatin remodelling enzyme in which DNA helicase activity has been 
observed [302]. Lastly, members of the CHD family are characterised by the 
presence of tandem N-terminal chromodomains and a central SNF2-like 
ATPase domain [303].  
Many studies of histone modifications in ES cells have found that almost all 
sites of PcG activity not only carry the repressive H3K27me3 modification, but 
also carry the activating, TxG-associated H3K4me3 modification [304, 305]. 
These genomic regions are termed 'bivalent domains' and keep target loci in a 
silenced but poised state. Upon ES cell differentiation, many bivalent domains 
resolve. Induced genes become enriched for H3K4me3 and lose H3K27me3, 
while many non-induced genes retain H3K27me3 but lose H3K4me3 [305, 306]. 
These data show the dynamic modulation of histone modifications in stem cell 
maintenance and differentiation. 
Chromatin remodelling can engage or maintain particular genetic programs and 
therefore likely plays a critical role in both stem cell maintenance as well as 
daughter cell differentiation. Maintaining stem cell properties involves the 
epigenetic suppression of pro-neural and glial genes and the activation of genes 
involved in self-renewal and quiescence. Conversely, NSC differentiation 
involves the removal of pro-neural gene suppression and instead involves the 
inhibition of genes involved in NSC maintenance. Recently, Lim et al. showed 
that the expression profiles of many epigenetic genes, such as genes encoding 
chromatin remodelling proteins, is altered along the adult neural lineage in the 
adult SVZ-OB system [287]. These data implicate the process of chromatin 
remodelling in playing a critical role in adult neurogenesis [287]. 
One of the most well studied PcG proteins in adult and postnatal neurogenesis 
is Bmi1 (B lymphoma Mo-MLV insertion region 1 homolog). Bmi1 is a member 
of the PRC1 complex and positively regulates H2Aub1 [307]. Mice deficient for 
Bmi1 (Bmi1-/-) displayed a loss of SVZ NSCs [308]. In contrast, lineage-
restricted progenitors were not affected and this was shown to be mediated at 





knockdown of Bmi1 in the post-natal SVZ showed that Bmi1 does negatively 
influence progenitor proliferation in vitro [288, 309]. This was shown to be partly 
due to elevated p21 levels, suggesting that NSC and progeny devoid of Bmi1 
throughout development may develop compensatory mechanisms to maintain 
neurogenesis, albeit to a much lesser extent [288, 309]. Furthermore, it has 
been found that loss of Bmi1 leads to increased astrocyte formation both in vivo 
and in vitro [310, 311]. Conversely, lentiviral-mediated overexpression of Bmi1 
in vitro increased the self-renewal of NSCs, and increased SVZ proliferation and 
neurogenesis in vivo [312]. Interestingly, overexpression of Bmi1 also led to the 
presence of large growths in the brain, indicating that prolonged expression of 
Bmi1 could result in tumour formation [312]. Indeed, Cui et al. showed that Bmi1 
is expressed at high levels in several human neuroblastoma cell lines, but at 
very low levels in many glioblastoma lines [313]. When Bmi1 levels were 
reduced via short interfering RNA (siRNA) in neuroblastomas, cells gave fewer 
tumour colonies, and formed a smaller number and size of tumours when 
injected into mice [313]. However, one study found no effect of Bmi1 
overexpression on NSC proliferation in either the SVZ or SGZ in vivo, 
suggesting that further analysis may be required [314]. 
Mixed-lineage leukemia 1 (Mll1) is a TxG member with H3K4 methyltransferase 
activity [315]. Mll1 is expressed by cells in the SVZ and has been shown to play 
a role in postnatal neurogenesis [316]. Loss of Mll1 from embryonic and 
postnatal NSCs revealed a role for Mll1 in neuroblast migration and 
differentiation [316]. This was due to a direct effect of Mll1 on suppressing the 
accumulation of repressive H3K27me3 at the locus of gene encoding the 
neuron-specific transcription factor Dlx2 [316]. Loss of Mll1 resulted in the 
accumulation of H3K27me3 and repression of Dlx2, causing impaired 
neuroblast differentiation and migration [316]. 
As well as regulating stem cell self-renewal and differentiation, chromatin 
remodelling enzymes and other epigenetic factors can also regulate cell fate 
choices [317-319]. BRG1 (brahma-related gene 1, also called SmarcaA2) is a 





belongs to the SWI/SNF family of complexes [289]. BRG1 has been shown to 
play a role in the regulation of the waves of neurogenesis and gliogenesis in 
embryonic development. Loss of Brg1 caused premature neuronal 
differentiation and little gliogenesis, with cells being unable to respond to 
gliogenic cues [317]. This suggests that BRG1 is required to repress neuronal 
differentiation in NSCs as a means of permitting glial cell differentiation in 
response to gliogenic signals [317]. Taken together these data show that 
chromatin remodelling can potentially affect many areas of stem cell biology, 







Figure 13 - Schematic illustration of the action of chromatin remodelling complexes. 
Chromatin consists of DNA associated with histones to form nucleosomes and linker DNA in 
between nucleosomes. a, DNA and transcription factor binding sites associated with 
nucleosomes will generally be harder to access by transcription factors and polymerases 
compared to DNA in linker regions. Some large multi-subunit chromatin remodelling complexes 
can utilise the energy of ATP-hydrolysis to physically move nucleosomes or alter the structure of 
DNA within a nucleosome (b). This can lead to the exposure of previously inaccessible 
transcription factor binding sites and the silencing of others (c) leading to potentially diverse 






1.14.2. CHD proteins 
The CHD (chromodomain-helicase-DNA-binding) family are SWI-like ATP-
dependent chromatin remodelling proteins that have been predicted to act as 
part of large multi-subunit complexes [321, 322]. The CHD family consists of 
nine members divided into three subfamilies based on the presence of 
structural protein motifs [322]. The first subfamily includes CHD1 and CHD2, 
which contain a C-terminal DNA-binding domain. The second subfamily 
includes CHD3 and CHD4 which lack a DNA-binding domain and instead 
contain a pair of N-terminal PHD domains which may bind to nuclear proteins 
and nucleosomes [323]. The third subfamily includes CHD5 to CHD9. Members 
of this subfamily possess additional functional motifs such as SANT domains, 
BRK domains, CR domains, and a DNA-binding domain [303, 324-326]. 
However, these additional domains are not shared between subfamily 
members. Mutations in CHD genes have recently been implicated in human 
diseases. For example, mutations in CHD8 has been shown to play a role in 
autism spectrum disorder, and may account for up to 0.4% of cases [327]. 
Additionally, mutations and deletions in CHD5 have been associated with 
neuroblastoma development [328, 329]. 
 
1.14.3 CHD7 
Mutations in CHD7 have recently been implicated in human diseases. De novo 
mutations in CHD7 is one of the leading causes of CHARGE syndrome, a 
congenital defect characterised by coloboma of the eye, heart defects, atresia 
of the nasal choanae, retardation of growth, genital and ear abnormalities and 
deafness [330]. Mutations in CHD7 have also been implicated in Kallman 
syndrome, characterised hypogonadism and anosmia [331]. 
The CHD7 protein contains functional domains such as a chromodomain, 
SNF2-related helicase / ATPase and two tandem C-terminal BRK domains 
[321] (Figure 14). CHD7 binds to  areas of methylated H3K4, with the majority 





regions distal to the transcription start site that show features of gene enhancer 
elements including hypersensitivity to DNase I digestion and colocalisation of 
the enhancer binding protein, p300 [332-335]. This interaction is predicted to be 
mediated by tandem N-terminal chromodomains and is thought to function to 
fine-tune cell type-specific gene expression (Figure 14) [332, 333]. 
ChIP-Seq data from mouse ES cells combined with global gene expression 
profiles obtained from Chd7+/+, Chd7+/−, and Chd7−/− ES cells shows that CHD7 
can either repress or stimulate gene expression, although negative regulation 
appears to be the more direct effect of CHD7 binding [332]. The Chd7 
Drosophila ortholog, Kismet, encodes a TxG protein [336-338]. Kismet 
stimulates transcriptional elongation by RNA polymerase II and may counteract 
PcG repression by recruiting the histone methyltransferases ASH1 and TRX to 
target loci [339]. Kismet itself is unable to bind methylated histone tails and was 
not found associated with methylated H3K4 [339]. Interestingly, Melicharek et 
al. showed that adult flies with decreased Kismet protein, displayed defects in 
gross motor coordination and defective learning and memory, and showed 
multiple neuronal populations to have defects in cell and axonal migration [340]. 
In mouse ES cells, CHD7 binding sites colocalise with binding sites of ES cell 
master regulators OCT4, Sox2, and NANOG, suggesting that CHD7 may have 
a wide variety of roles in ES cell maintenance and differentiation [332]. Indeed, 
in embryonic NSCs, CHD7 was shown to directly interact with Sox2 to regulate 
target gene expression, with common target genes including downstream 
effectors of the Notch and Sonic hedgehog (Shh) signalling pathways [341]. 
In addition to stem cell maintenance, CHD7 has been implicated in regulation of 
cell fate specification from adipogenesis to osteoblastogenesis of bone marrow 
mesenchymal stem cells during development [342]. CHD7 has also been shown 
to cooperate with PBAF (polybromo- and BRG1-associated factor-containing 
complex) to promote neural crest gene expression and cell migration during 
embryogenesis [343]. These data show that CHD7 has diverse roles in the 





Mice homozygous for a Chd7 loss-of-function allele die before E10.5 [344], thus 
the use of a conditional allele or heterozygous lines are necessary to study the 
effect of CHD7 later in development and in adulthood. Adult mice heterozygous 
for Chd7 (Chd7+/-) display a decreased brain size and decreased OB length 
[345, 346]. In addition, studies by Layman et al. showed that Chd7+/- mice 
displayed a reduction in TH expression in the OB [345]. The authors showed 
that CHD7 was expressed by MASH1+ stem cells in the olfactory epithelium, 
and reduction in Chd7 expression led to decreased proliferation of the epithelial 
stem cells [345]. This resulted in a decrease in the number of mature olfactory 
sensory neurons, which normally signal to dopaminergic interneurons [345]. 
Hence, a loss of signal to dopaminergic interneurons resulted in a decrease in 
TH-production (see Figure 35) [345]. These data implicate CHD7 in regulation 
of stem cells in adults. However, due to the role of postnatal and adult SVZ-OB 
neurogenesis in formation of OB interneurons, misregulation of olfactory 
epithelial stem cells may not be the sole cause of the OB defects seen in these 
mice (see Figure 36). 








Figure 14 - Overview of the protein structure of CHD7. CHD7 is a large protein over 300kDa 
in size (CHD7_HUMAN, Q9P2D1). It contains tandem N-terminal chromodomains (red) that 
mediate binding to methylated histones, specifically all methylated forms of H3K4 [333]. It 
contains a helicase / ATPase domain (blue) that defines the ATP-dependent chromatin 
remodelling proteins and mediates chromatin remodelling [321]. It contains three conserved 
region domains (CR1-3; yellow) and a switching-defective protein 3, adaptor 2, nuclear receptor 
corepressor, transcription factor IIIB (SANT) domain (green) which is believed to function as a 
histone tail-binding module [301]. CHD7 has tandem N-terminal BRK domains (black), the 
function of which is still unknown, but may allow binding of CHD7 to certain proteins such as the 






1.15. Aims and objectives 
The maintenance and differentiation of somatic stem cells is strictly controlled. 
Extrinsic signals, such as from the niche, and intrinsic changes, such as from 
chromatin remodelling, can greatly impact stem cell function. Still many 
questions remain in understanding somatic stem cell function: 
• What is the role of chromatin remodelling in somatic stem cells? 
• How are the steps of activation and repression of key genes orchestrated 
with regards to stem cell activation, proliferation, differentiation and self-
renewal? 
• How does the niche influence somatic cell function under homeostatic 
conditions? 
• How do age-related changes in mammalian stem cell niches drive 
changes in stem cell number, and how does this influence stem cell 
function? 
This thesis aims to examine intrinsic and extrinsic regulators of two different 
somatic stem cell systems; skeletal muscle satellite cells and neural stem cells. 
This will help to better understand the regulation of stem cell quiescence and 
cell fate decisions, which are two fundamental properties of somatic stem cells 
and allow for the maintenance of a functional stem cell pool throughout life. I will 
examine the consequences of an altered stem cell niche on stem cell number 
and function. Additionally, I will analyse the effects of an altered intrinsic 














2.1. Solutions and reagents 
Unless otherwise stated, all PBS and water solutions used in RNase-sensitive 
protocols were treated with 0.05% diethyl pyrocarbonate (DepC; Sigma) and 
autoclaved. All other stock solutions were sterilised by autoclaving. All water 
used was double distilled/deionised (ddH2O). 
 
2.1.1. General reagents 
1x PBS Phosphate buffered saline tablets (Sigma) were 
dissolved  in ddH2O 
 
PBSTx 1ml TritonX (Sigma) was added to 1l of PBS prior 











Goat serum (Sigma) heat inactivated at 50°C for 






solution (Ab block) 
 
Blocking solution for 
antibodies raised in goat 
 
Ab block for antibodies 
raised in goat 
 






0.1M Borate buffer pH8.5 
 
10% heat-inactivated goat serum, 0.2% gelatin 
type A, made up with PBSTx 
 
5% heat-inactivated goat serum, 0.2% gelatin 
type A, made up with PBSTx 
 
5% bovine serum albumin (BSA; Sigma) made up 
with PBSTx 
 
2% BSA made up with PBSTx 
 
 
Paraformaldehyde (PFA; Sigma) was dissolved in 
PBS with stirring and heating at 60°C. Aliquots 
were stored at -20°C 
 
Made by diluting 11N HCl (Sigma) in ddH2O 
 
Made by dissolving sodium borate (Sigma) in 







2.1.3. Plasmid linearisation and mRNA probe synthesis reagents 







1mM TRIS-HCl, pH 7.5 
0.1mM EDTA 
Made in ddH2O 
 
Made according to manufactures specifications 
(NEB): 
10µl plasmid (~5µg) 
2µl restriction endonuclease; EcoR1, EcoRV, SpaI 
5µl 10x buffer 
















Made according to manufacturer's (Roche) 
specifications: 
10µl sterile, distilled water 
4µl 5x transcription buffer  
2µl 0.1M DTT  
2µl DIG nucleotide mix, pH8  
1µl linearised plasmid at 1µg/µl  
0.5µl Rnase inhibitor  
1µl RNA polymerase enzyme; SP6 (Promega), T3 
(Promega) or T7 (Promega) 
 
 





Probe synthesis from 
PCR primers 
specifications: 
0.5ml sterile, distilled water 
4µl 5x transcription buffer  
2µl 0.1M DTT  
2µl DIG nucleotide mix, pH8  
10µl DNA  
0.5µl RNase inhibitor  
1µl RNA polymerase enzyme; SP6 (Promega), T3 














Proteinase K solution 
 
625µl trietholamine (Fluka) 
130µl 11N HCl (Sigma) 
125µl acetic anhydride (Fisher scientific) 
Made up to 50ml with DepC-treated sterile water 
immediately prior to use. 
 
20µg/ml proteinase K in PBS 
Section hybridisation 
buffer 
To make 100ml: 
50ml formamide  
20ml Dextran sulphate (Millipore) 
1ml Denhardt’s solution (Sigma) 
2.5 ml 10mg/ml yeast tRNA (Invitrogen) 
6ml 5M NaCl  
2ml 1M Tris-HCl, pH8  
1ml 0.5M EDTA  
1ml 1M NaPO4  
5ml 20% Sarcosyl (Sigma) 
11.5ml ddH2O. 
Aliquots were stored at -20°C 
 
5x standard saline 
citrate (SSC)  






2xSSC 20xSSC was diluted 10 times in ddH2O. 
 
0.1xSSC 20xSSC was diluted 200 times in ddH2O. 




Formamide (Sigma) and 2xSSC were mixed in equal 
measures to produce the required volume of His. 
RNase buffer  100ml 5M NaCl 
10ml 1M Tris-HCl, pH7.5 
10ml 0.5M EDTA 













100µl 1M Tris-HCl, pH7.5 
30µl 5M NaCl 
9.8ml distilled water 
100mg RNaseA (Roche) 
Boiled for 15 minutes before aliquoting and storing at 
-20oC. 
 







Antibody block 10% heat inactivated goat serum in PBSTw 
 





1ml 5M NaCl 
5ml 1M Tris-HCl, pH9.5 
1.25ml 2M MgCl2 
5ml 10% Tween20 
100µl 20mg/ml Levamisole 






2.1.5. Wholemount in situ hybridisation reagents 
50% methanol 
 
Methanol (Sigma) diluted in PBSTw 
30% methanol 
 











Maleic acid buffer 










125ml 20x SSC 
2.5ml 20% Tween 20 
 
495ml Hyb- mix 
2.5g yeast tRNA (Sigma) 
5ml 50µg/ml Heparin (Sigma) 
 
4ml Hyb+ mix with 2µg probe 
 
For a 5x stock: 
500ml maleic acid pH 7.5 (Sigma) 
750mM NaCl 
0.5% Tween 20 
 
10% BSA 
2% Foetal calf serum (Sigma) 






2.1.6. Satellite cell isolation and culture reagents 
DMEM Dulbecco's modified eagle's medium (Sigma) 
supplemented with 1% penicillin-streptomycin 
(Invitrogen) 
 












FACS-isolated SC basal 
media 
 






90% foetal calf serum (Invitrogen) 
10% dimethyl sulfoxide (DMSO) 
 
Non-enzymatic cell dissociation solution (Sigma) 
 
20% heat-inactivated foetal bovine serum (FBS) 
5ng/ml FGF2 (R&D Systems) 
In Ham's F10 media 
 
DMEM + 5% Horse Serum (HS; Sigma) 
 
 
0.2% Collagenase II (Invitrogen) 

















Single fibre digest 
solution 
 
RSC generation media / 
SC differentiation media 
 
Cell sorting media 
10% HS 
2mM HEPES 
In Ham's F10 media 
 
0.015% Collagenase II  
0.07% Dispase (invitrogen) 
In 7ml Rinsing solution 
 
0.2% Collagenase I (Invitrogen) 
Made in DMEM 
 
3% HS 
Made in DMEM 
 
10% HS 







2.1.7. Neural stem cell culture reagents 





















90% foetal calf serum (Invitrogen) 
10% dimethyl sulfoxide (DMSO) 
 
1x Trypsin EDTA made by diluting 10x Trypsin-
EDTA (Invitrogen) in DMEM 
 
20ng/ml human FGF2 (Peprotech) 
20ng/ml human EGF (Peprotech) 




0.5% N2 supplement 
1% B27 supplement (Invitrogen) 
In Euromed-N 
 
After the 3day neuronal differentiation step: 
10ng/ml FGF2 
20ng/ml BDNF (Peprotech) 
0.5% N2 supplement 







Line Description Reference 
Pax7CreERT2/+ The CreERT2 cassette was placed within the 3′ 
untranslated region of the Pax7 gene following the 
stop codon in exon 9. 
[349] 






Consists of chicken β-actin gene (CAG) promoter-
loxP-GFP-loxP-Spry1ORF with a myc/his tag. The 
Spry1OX construct constitutively expresses GFP, 
and upon Cre-mediated recombination, Spry1 
expression is induced, with concomitant loss of 
GFP marker expression. 
[351] 
FgfR1/2flox/flox For FgfR2flox/flox, a 5′ loxP site was inserted in the 
intron between exon 7 and 8, and a 3′ loxP site 
was inserted in the intron downstream of exon 10. 
For FgfR1flox/flox, exons 8–15 encoding the 
transmembrane domain, juxtamembrane domain 
and most of the tyrosine kinase domain of 
FGFR1, are flanked by loxP sites. 
[352, 353] 
GLAST::CreERT2 The CreERT2 expression cassette was inserted 
into a BAC with GLAST genomic DNA by 





The genetrap construct contains a beta-geo 
cassette with a floxed splice acceptor. The 
Chdxk403 line has a genetrap insertion site 
between exons 36 and 37, and produces a protein 
containing all exons, except 37 and 38, fused to 
the gene trap cassette. Cre-mediated 
recombination results in deletion of the splice 






Chd7flox Exon 3 of Chd7 flanked by LoxP sites EUCOMM ID: 
35714 
NestinCre Tansgenic mouse line. [357] 
Table 1 - Mouse lines used 
 
2.3. Methods for Chapter 3 and Chapter 4 
2.3.1. Satellite cell in vivo cell division analysis 
To assess cell proliferation and label retention character, aged (24-28 months 
old) and adult (3-8 months old) C57BL/6, Ctrl, Spry1null and Spry1OX mice 
were fed BrdU (Sigma; 0.5 mg/ml supplemented with 5% sucrose) continuously 
for six weeks. For label retention studies, Spry1null mice were given three daily 
intraperitoneal (I.P.) injections of tamoxifen (see Section 2.3.9.) following BrdU 
loading and placed on regular drinking water to chase label. For cell 
proliferation and label retention studies, SCs were sorted, immediately fixed and 
processed for immunostaining with Pax7 and BrdU antibodies after sodium 
citrate antigen retrieval. For label retention studies, BrdU+ SCs were classified 
as label retaining on the basis of quantification of BrdU fluorescent intensity. 
 
2.3.2. In vivo FGFR inhibition 
Prolonged pharmacological inhibition of FGF activity in vivo was conducted as 
previously described [358]. Initially, anion exchange resin beads (AG1x2, 200-
400, CL, CAT# 1401251, BioRad) were reconstituted at a beads/PBS ratio of 
1:2. Half of the PBS–bead mixture was pelleted at 2,400g for 5 minutes. Pellets 
were then incubated with 500 μM SU5402 (Calbiochem) or an equivalent 
volume of vehicle (DMSO) for 60 minutes on a nutator at room temperature. 
Loaded pellets were washed in PBS and reconstituted into 50% w/v PBS before 
I.P. injection of 300μl into aged and adult mice using a 25G5/8 1-ml insulin 
syringe (BD Biosciences). After injection, mice were fed BrdU continuously for 





for BrdU immunostaining via sodium citrate antigen retrieval. For quantification, 
300–600 cells were counted per condition. 
 
2.3.3. Purified myofibre extract 
All reagents used to obtain purified myofibre extract are shown in Section 2.1.6. 
Initially, forelimb and hindlimb muscles were cut into smaller longitudinal pieces 
and digested into single or smaller groups of muscle fibres using digest solution 
1 in a horizontal shaking water bath at 37 °C for 90 minutes [42]. Isolated 
muscle fibres were gentley triturated and repeatedly washed in PBS (×6) to 
ensure removal of interstitial cells or other contaminating debris. Purified fibres 
were then incubated in a high-salt extraction buffer (400 mM NaCl, 1 mM EGTA, 
1 mM EDTA, 10 mM Tris pH 7.5, 1mg/ml PMSF) to dissociate any ligands 
bound to receptors or the extensive basal lamina network of skeletal muscle 
fibres [359]. Dissected muscles in extraction buffer were further triturated with a 
glass Pasteur pipette to dissociate bound ligands. The muscle fibre mixture was 
centrifuged at 2,500g for 10 minutes to remove cytoskeletal and nuclear 
elements that compromise the majority of skeletal muscle fibre cytosol. The 
resultant supernatant was collected and spun at 375g for 5 minutes. 
Supernatant was then collected and transferred into Eppendorf tubes and spun 
at 16,500g for 30 minutes at 4 °C. The supernatant was pooled and 
subsequently drawn up into a 20-gauge syringe and filtered through a 0.45-μm 
filter into Amicon Ultra centrifugal filter columns (10,000 relative molecular mass 
cut-off; UFC901008, Millipore). Exchanges with PBS were done at 2,050g for 
20 minutes until the solution was translucent and concentrated into a volume of 
approximately 1 ml PBS. Protein concentration and purity was determined with 
a nanodrop analyser. 
To assess cycling-inducing activity, cultures of RSCs and SCs in basal medium 
(3% HS for RSCs and 5% HS for satellite cells in DMEM) were incubated with 
10 μg total PME for 24 hr. For inhibition of FGF activity, RSCs and SCs were 
incubated with 10 μM SU5402 (Calbiochem) or DMSO as carrier control for 1 





incubated with 15 ng/μl FGF2blocking antibody (Millipore) for 1 hour at 37°C 
before being added to RSC or SC cultures. Unless otherwise stated, three to 
five experiments were performed in triplicate and 300–600 RSCs or SCs were 
counted. PMEs were obtained from n = 5 different aged and adult mice and 
examined. 
 
2.3.4. Single muscle fibre isolation 
All reagents used for single muscle fibre isolation are shown in Section 2.1.6. 
Single fibres were isolated as previously described [360]. Briefly, EDL muscle 
was dissected and lightly digested in single fibre digest solution and incubated 
at 37°C shaking for 45 minutes to 1.5 hours. Following digestion, the muscle 
was transferred to a petri dish containing DMEM and triturated with a fire-
polished Pasteur pipette pre-flushed in 10% HS to stop fibres from sticking to 
the pipette. Fibres were cleaned by transferring them to fresh petri dishes four 
times. Single fibre assays were performed using DMEM+3%HS and stated 
concentrations of FGF2 and/or PME. 
 
2.3.5. Tibialis anterior muscle preparation 
Dissected tibialis anterior (TA) muscle was fixed in 4% PFA for 20 minutes on 
ice and cryoprotected in 30% sucrose at 4°C overnight. Muscle was then frozen 
in OCT and sectioned in 10µm steps. For FGF2 immunohistochemistry, TA 
muscle was sectioned and stained immediately after cryoprotection and 
freezing without being fixed in PFA. 
 
2.3.6. Myoblast isolation 
All reagents used for myoblast isolation are shown in Section 2.1.6. SCs were 
isolated from bulk fibres as previously described [42] with modifications. Bulk 





digest solution 1 at 37°C for 75 minutes shaking. Contaminating adipose tissue 
was then removed through rinses in rinsing solution. Muscle was then physically 
dissociated by triturating with a jagged-edged glass Pasteur pipette in rinsing 
solution. To further remove any contaminating cells, the solution was 
centrifuged at 375g for 5 minutes and washed in rinsing solution 3 times. To 
remove individual fibres and associated SCs from the muscle tissue, the 
solution was resuspended in Digest solution 2 and incubated at 37°C for 30 
minutes. Cells were dislodged from fibres by drawing and releasing the solution 
through a 20g needle 5 times. The solution was then centrifuged at 375g for 5 
minutes and washed in rinsing solution 3 times. Cells were resuspended in 20% 
foetal bovine serum (FBS; Sigma), 5ng/ml FGF2 (Peprotech) with 1% Pen/Strep 
(Invitrogen) in Ham's F-10 (Growth media) and plated on uncoated tissue 
culture dishes for 5 minutes to remove fibroblasts. SCs in the supernatant were 
collected, centrifuged at 375g for 5 minutes, resuspended in growth medium 
and strained through a 20µm filter. To further remove fibroblasts, the Easy Sep 
Kit (Invitrogen) was used in combination with a Biotin-tagged anti-Sca1 antibody 
(BD Pharmingen; 1:400). Cells were then grown in growth media on 1:1000 
ECM-coated tissue culture dishes (Nunc) with media changed every 1.5 days 
and passaged at 80% confluency using 1x cell dissociation solution (Sigma). 
 
2.3.7. Myogenic cell preparation 
To generate RSC cultures [361], low-passage primary myoblasts were plated in 
1:500 ECM-coated eight-well Permanox chamber slides (Lab-Tek) at 80–90% 
confluency and maintained in growth medium (20% FBS, 5 ng/ml FGF2 in 
Ham’s F-10). Subsequently, cells were switched to differentiation medium (3% 
HS in DMEM) for two to three days to allow for the formation of myotubes and 
SC-like RSCs expressing Pax7 that had escaped differentiation and returned to 
a quiescent state [361]. RSC cultures were then treated with appropriate PMEs 
for 24 hours. For adenovirus experiments, cells were infected after formation of 
myotubes and RSCs and allowed to recover for 24 hours before treatment with 





2.3.8. In vitro activation of Cre recombinase 
Cultures of RSCs were infected with either Ad5CMVCre-eGFP or Ad5CMV-
eGFP-control adenovirus (Gene Transfer Vector Core, University of Iowa) 
(diluted 1:1000 in growth media from a stock titer of 1 × 1010 pfu/ml) with 
1:1000 Polybrene Transfection Reagent (Chemicon) for 1.5 hours at 37 °C. 
Cells were washed in PBS and incubated in fresh differentiation medium for an 
additional 48 hours. 
 
2.3.9. In vivo activation of Cre recombinase 
Aged and adult mice were given one I.P. injection of 300µl of 10mg/ml 
tamoxifen (Sigma) diluted in corn oil (Sigma) daily for 3 days [42]. 
 
2.3.10. Fluorescence-activated cell sorting 
All reagents used for fluorescence activated cell sorting (FACS) are shown in 
Section 2.1.6. To obtain highly purified myogenic cells, mononucleated cells 
were isolated from muscle as described previously [42] with modifications. After 
incubating cells in Digest solution 2 in Section 2.3.6, cells were dislodged from 
fibres by drawing and releasing the solution through a 20g needle 5 times. The 
solution was centrifuged at 375g for 5 minutes and washed in rinsing solution 3 
times. Cells were incubated in sorting medium (10% HS, in Ham’s F-10) for 
10 minutes and then incubated in biotin-conjugated anti-VCAM1 (Novus) and 
anti-mouse integrin-α7 (1:200; MBL) for 30 minutes. Cells were washed in 
sorting medium and spun at 375g for 5 minutes. Cells were stained in CD31-PE 
(BD Biosciences), CD45-PE (BD Biosciences), Pacific Blue (Invitrogen) and 
streptavidin-647 (Invitrogen), all at 1:200, for 30 minutes. Propidium iodide (PI) 
was added at 1:500 before sorting to enable the identification of dead cells. 
Myogenic cells had the following profile: VCAM1+, integrin-α7+, CD31−, 






2.3.11. SC and skeletal muscle histology and immunofluorescence 
All reagents used for immunohistochemistry are shown in Section 2.1.2. 
Cultures of RSCs, satellite cells and tibialis anterior tissue sections were fixed in 
4% PFA for 5 minutes, washed and processed for immunohistochemistry as 
previously described [42]. Briefly, samples were washed in PBS followed by 
2x10 minute washes in PBSTx to permeabilise samples. Non-specific antibody 
binding was blocked by incubating samples with blocking solution for 30 
minutes. Primary antibody was diluted in Ab block and incubated with samples 
at 4°C overnight. The next day, unbound antibody was washed off with PBS 
washes and fluor-labelled secondary antibody (1:1500), diluted in Ab block, was 
incubated with samples for 1 hour at room temperature. Dapi (1:3000, Sigma) 
was also added. After secondary antibody incubation, samples were washed in 
PBS and mounted with Fluormount G (Fisher Scientific). For detection of FGF2 
in transverse orientation, sections were not fixed. For longitudinal sections, 
samples were processed for primary FGF2 antibody before fixation. For BrdU 
detection, cultures of SC, RSCs and tissue sections were fixed in 4% PFA, 
washed in PBS and then antigen-retrieved with sodium citrate buffer (10 mM, 
0.05% Tween in PBS) at 95 °C for 30 minutes before immunostaining as 
described above. 
 
2.3.12. Analysis of satellite cells and their progeny 
Muscles sections were stained with a cocktail of antibodies to determine the 
number of Pax7+ SCs that were quiescent (Pax7+, Ki67-) or cycling (Pax7+, 
Ki67+) underneath the basal lamina (laminin+). The total number of Pax7+ cells 
was quantified in a minimum of ten serial sections per muscle in three separate 
regions from the mid-belly of the muscle [42]. The number of Pax7+ cells was 
quantified on freshly isolated single EDL muscle fibres. A minimum of 20–30 
muscle fibres were counted per animal [42]. Cultures of RSCs and SCs in eight-
well Permanox chamber slides (Nunc) were stained with a panel of antibodies 
to characterise myogenic cells with self-renewal potential (Pax7+), cycling 





[42]. For fate analysis, quantification of three to five experiments was performed 
in triplicate and 300–600 cells were counted per condition. To assess cell 
growth, satellite cells were plated at clonal density (10–12 cells per well, Nunc 
eight-well Permanox chamber slides) and the number of cells present in each 
individual well was determined after four days in culture (10% HS in DMEM). 
For cell growth experiments, 21–28 clonal density cultures were examined per 
condition. Wells with no cells present after four days of culture were not 
included in quantification.  
 
2.3.13. Whole-mount in situ hybridisation 
RNA in situ hybridisation and riboprobe synthesis were performed as previously 
described [362]. Briefly, Digoxigenin-labelled anti-sense and sense riboprobes 
of Fgf2 were synthesised from a plasmid preparation [363]. All details of the 
Fgf2 plasmid can be found in Section 2.3.15. Purified isolated myofibres were 
fixed in PFA and washed in 100% methanol.  Fibres were rehydrated in a series 
of methanol / PBS + 0.2% Tween 20 (PBSTw) washes, starting with 50% 
methanol for 5 minutes, then 30% methanol for 5 minutes, and then fibres were 
taken into PBSTw. For pre-hybridisation, muscle fibres were rinsed in PBSTw 
and then incubated with Hyb- mix for 5 minutes at 70 °C, and then Hyb+ for 4 
hours at 70°C. For hybridisation, fibres were incubated with 5µg/ml of either 
anti-sense or sense (control) Fgf2 riboprobe in Hyb+ mix overnight at 70°C. The 
following day, any unbound probe was removed in a series of formamide / SSC 
washes and maleic acid buffer containing 0.2% Tween 20 (MABT) washes. 
These washes consisted of 55% formamide / 2x SSC containing 0.2% Tween 
20 (SSCTw) for 30 minutes, then; 55% formamide / 1x SSCTw for 30 minutes, 
then; 1x SSCTw for 30 minutes, then; 2 washes of 0.2x SSCTw for 30 minutes 
each, then; 4 washes in MABT for 30 minutes each. Unspecific antibody binding 
was blocked using a solution of MABT with 2% Blocking Reagent (Roche) for 4 
hours at room temperature. Bound riboprobe was then detected by staining 
fibres with anti-Digoxigenin antibody (1:5000 in blocking solution; Roche) at 4°C 





10% FCS, followed by 6 washes in MABT for 15 minutes each. Fibres were 
then washed twice for 5 minutes each in NTMT and signal was detected using 
NBT/BCIP solution (Roche). After a signal appeared, fibres were washed 3 
times for 5 minutes in PBSTw and then fixed in 4% PFA for 10 minutes. 
Following two further PBS washes, fibres were mounted onto coverslips. In 
some cases, after fixation and before mounting, muscle fibres were further 
processed for Pax7 immunostaining as described above. 
 
2.3.14 Plasmid digestion and DNA extraction  
Plasmid digests were carried out according to the manufacturer's 
recommendations (New England Biolabs) using the reaction mix detailed in 
Section 2.1.3. Plasmids were typically digested at 37oC overnight, unless the 
manufacturer's specification suggested otherwise. 
After digestion, the linearised DNA was precipitated from the digest solution by 
centrifugation with an equal volume of phenol chloroform, and incubated at -20 
oC for 1 hour with 0.1 volumes of 3M sodium acetate and 2.5 volumes of 
ethanol. The solution was centrifuged at max speed for 30 minutes to produce a 
DNA pellet which was washed with ethanol then stored in solution with 0.1 
volumes of TE or DepC water. Linearised DNA was stored at -70oC until 
required for RNA probe synthesis. 
 
2.3.15. Probe synthesis 
Probes were synthesised using the reaction mix detailed in Section 2.1.3. The 
probe synthesis mix was left for 2 hours at 37°C. 1µl of the mix was then 
resolved on a 1.5% agarose gel to check for an RNA band, and to estimate the 
concentration of the probe against a 1µl sample of the linearised plasmid. If a 
RNA band was observed, 2µl of DNase I was added to the remaining mix, and 
the reaction left at 37°C for 15 minutes in order to digest any DNA still present. 





reaction Cleanup columns (Sigma) according to the manufacturer's 
recommendations. 
For Fgf2, antisense probe was made by linearising plasmid with NotI and 
synthesising probe with T3 [363]. Sense probe was made by linearising plasmid 
with EcoRI and synthesising probe with T7 [363]. 
 
2.3.16. RNA isolation and RT-qPCR 
RNA extraction from approximately 10,000 FACS-isolated satellite cells and 50 
single muscle fibres was done with Trizol (Invitrogen) according to the 
manufacturer’s recommendations. Briefly 1ml of Trizol was added to samples 
and samples were homogenised by vortexing. 200µl of chloroform (Sigma) was 
added and mixed by vortexing. The solution was left to settle on ice for 5 
minutes before phases were separated through centrifugation at 13000g for 15 
minutes at 4°C. The aqueous phase containing RNA was transferred to a new 
Eppendorf tube and RNA was precipitated by adding 500µl isopropanol 
(Sigma), and 20-40µg of Ultrapure Glycogen (Invitrogen). RNA was left to 
precipitate at -80°C overnight. The following day, the RNA suspension was 
centrifuged at 13000g for 20 minutes. Any contaminants were then removed by 
washing the RNA pellet in ice-cold 75% ethanol and centrifuging at 13000g for 
10 minutes. This step was performed twice. All trances of ethanol were 
removed and the RNA pellet was left to air dry for around 5 minutes. RNA was 
resuspended in RNase-free water and stored at -80°C. RNA concentration was 
determined using a nanodrop. 
Purified RNA was then prepared for RT-qPCR analysis or array analysis. First-
strand complementary DNA was synthesised from 4 μl (200 ng) of RNA using 
the SuperScript First-Strand cDNA Synthesis Kit (Invitrogen) according to 
manufacturer's recommendations. RT-qPCR was performed on a Step One 
Plus Real Time PCR machine (Applied Biosystems), with Platinum SYBR 





against Pax7, Fgf2, Stat1, and Gapdh as a housekeeping control. Primer 
sequences are as follows: 
Fgf2 forward - 5'-CGGCTTCTTCCTGCGCATCC-3' 
Fgf2 reverse - 5'-GGTACCGGTTGGCACACACTCC-3' 
Pax7 forward - 5'-GTGGAATCAGAACCCGACCTC-3' 
Pax7 reverse - 5'-GTAGTGGGTCCTCTCAAAGGC-3' 
Gapdh forward - 5'-AGGTCGGTGTGAACGGATTTG-3' 
Gapdh reverse - 5'-TGTAGACCATGTAGTTGAGGTCA-3' 
All reactions for RT-qPCR were performed using the following thermal cycler 
conditions: 50 °C for 2 minutes, 95 °C for 2 minutes, 40 cycles of a two-step 
reaction, denaturation at 95 °C for 15 seconds, annealing at 60 °C for 
30 seconds. Analysis of FGF ligands was conducted with the mouse growth 
factor RT2Profiler PCR array system (SABiosciences) according to the 
manufacturer’s recommendations, with the exception that RNA was extracted 
by the Trizol method. Unless otherwise stated, data are from three separate 
reactions performed in triplicate from n = 4–6 mice per condition. 
 
2.3.17. Antibodies and reagents 
The antibodies used are as follows: rat anti-BrdU (1/500, Abcam), rabbit anti-
Ki67 (1/500, Abcam), mouse anti-Pax7 (1/100, DSHB), rabbit anti-myogenin 
(1/250, Santa Cruz), rabbit anti-cleaved caspase-3 (1/500, Cell Signaling 
Technologies), chick anti-laminin (1/5,000, Abcam), VCAM (1/100), mouse anti-
integrin-α7 (1/200, MBL), CD31-PE and CD45-PE (1/200, BD), and rabbit anti-
FGF2 (1/500, Abcam). The corresponding species-specific Alexa-conjugated 
(Pacific Blue, 488, 546, 647) secondary antibodies (Molecular Probes) were 







Details of all primer sequences and the sizes of products produced from 
polymerase chain reaction (PCR) amplification can be found in Table 2. 
Genotyping was carried out by PCR amplification using a FastStart Taq DNA 
polymerase kit (Promega), according to the manufacturer’s recommendations.   
PCR reactions were carried out in 20µl reactions using Promega reagents as 
follows: 
4µl 5x transcription buffer 
1.2µl MgCl2 solution 
1µl primer solution, containing 10µM of each primer 
1µl DNA sample to be amplified 
0.15µl dNTPs (25mM) 
0.15µl Hot Start taq 
12.5µl sterile water 
 
All samples were amplified using the following program: 
95oC for 10 minutes 
40 cycles of:  94oC for 45 seconds 
57oC for 45 seconds 
72oC for 1 minute 
Followed by 72oC for 7 minutes. 
After PCR amplification, samples were resolved by electrophoresis, using a 





Gene of interest Primers 
Cre 
Primer A: CCTGGAAAATGCTTCTGTCCG 
Primer B: CAGGGTGTTATAAGCAATCCC 
 
Cre: Primer pair A+B = 390bp 
Wildtype: No product 
 
Spry1flox 
Primer A: GGGAAAACCGTGTTCTAAGGAGTAGC 
Primer B: GTTCTTTGTGGCAGACACTCTTCATTC 
Primer C: CTCAATAGGAGTGGACTGTGAAACTGC 
 
Spry1flox: Primer pair A+C = 342 bp 
Wildtype: Primer pair A+C = 311 bp 
Null: Primer pair A+B = 150 bp 
 
Spry1OX 
Primer A: GAGGAAATGCTGCGCACAATGTATACTCGG 
Primer B: GGATACTGACACATTGTGCCTCAGCCTTTC 
 
Spry1OX : Primer pair A+B = 920bp 
Wildtype: No product 
 
FgfR1flox 
Primer A: GTATTGCTGGCCCACTGTTC 
Primer B: CTGGTATCCTGTGCCTATC 
Primer C: CAATCTGATCCCAAGACCAC 
 
FgfR1flox : Primer pair B+C = 387 bp 
Wildtype: Primer pair B+C = 327 bp 
Null: Primer pair A+C = 300 bp 
 
FgfR2flox 
Primer A: TGCAAGAGGCGACCAGTCAG 
Primer B: ATAGGAGCAACAGGCGG 
 
FgfR2flox: Primer pair A+B = 207 bp 
Wildtype: Primer pair A+B = 142 bp 
 





2.3.19. Statistics and data 
Unless otherwise stated, all data are represented as mean ± s.e.m.; *P < 0.05 
**P<0.01 ***P<0.001, student's t-test. For multiple comparisons, analysis of 
variance with Bonferroni’s multiple-comparison post hoc test was used. 
 
2.4. Methods for Chapter 5 and Chapter 6 
2.4.1. Isolation, growth, and differentiation of NSCs 
All reagents used for NSC cultures are shown in Section 2.1.7. Foetal-derived 
NSCs were isolated, grown, and differentiated as previously described [364, 
365] with modifications. Briefly, the cortex and striatum from E16.5 embryos 
generated from a mating between NestinCre;Chd7f/+ and Chd7f/f mice were 
dissected and put in to ice-cold PBS. Tissue pieces were centrifuged at 800g for 
3 minutes, the supernatant was removed and the tissue was dissociated by 
incubating on ice for 10 minutes, flicking the side of the tube every 3 minutes to 
aid dissociation. 1ml of PBS was added and cells were then dissociated by 
triturating with a pipette tip and centrifuged at 375g for 5 minutes. Cells were 
then plated on laminin-coated (1:100; Sigma) tissue culture plates and grown in 
growth media containing 1% N2 supplement (Invitrogen), 20ng/ml EGF 
(Peprotech), 20ng/ml FGF2 (Peprotech), 1% Pen/Strep (Invitrogen) in 
Euromed-N (Euroclone). Growth media was changed every 1.5 days and cells 
were passaged at 70-80% confluency using 1x Trypsin EDTA (Sigma) which 
was neutralised with Trypsin inhibitor (Sigma). After genotyping, any 
NestinCre;Chd7f/f cultures were pooled and Chd7f/f control cultures were pooled. 
Differentiation into neurons was performed as previously described [365] with 
modifications. Briefly, cells were plated onto laminin-coated (1:100) glass 8-well 
chamber slides pre-treated with poly-L-ornithine (Sigma) in neuronal 
differentiation media containing 1% B27 supplement (Invitrogen), 0.5% N2, and 
10ng/ml FGF2 in Euromed-N. Cells were maintained in these conditions for 3 





day period, cells were put into media containing 0.5% N2, 1%B27, 10ng/ml 
FGF2 and 20ng/ml BDNF (Peprotech) in Euromed-N. Cells were maintained in 
these conditions for a further 3 days (6d neuron dff) changing the media once 
throughout the period. 
 
2.4.2. Forebrain processing 
Mice were given a lethal dose of Euthanal (pentobaribital sodium; Merial) and 
perfused with 10ml of ice-cold PBS followed by 10ml ice-cold 4% PFA. Brains 
were then dissected and further fixed in 4% PFA overnight at 4°C. For section in 
situ hybridisation experiments, fixed brains were dehydrated in 70% ethanol and 
equilibriated into paraffin wax using a Leica ASP300 Tissue Processor. Brains 
were then embedded in paraffin wax, sectioned in 10µm steps, and placed on to 
Superfrost+ slides. 
For immunohistochemistry, fixed brains were cryoprotected in 15% sucrose 
(Sigma) at 4°C overnight followed by 15% sucrose and 7.5% gelatine type B 
(Sigma) at 37°C overnight. Brains were then embedded in 15% sucrose and 
7.5% gelatine type B and frozen in methylbutane (Sigma) with dry ice. Frozen 
brains were sectioned in 20µm steps and placed on to Superfrost+ slides. 
 
2.4.3. Neural stem cell histology and immunofluorescence 
All reagents used for immunohistochemistry are shown in Section 2.1.2. Cells 
on 8-well glass chamberslides were fixed in 4%PFA for 5 minutes followed by 
2x 10 minute PBS washes. Cells were permeabilised with a 10 minute wash in 
PBSTx and non-specific antibody binding was blocked by incubating slides in 
blocking solution for 1 hour. Primary antibody was diluted in Ab block at 4°C 
overnight. The following day, unbound antibody was washed off with 3x 10 
minute PBS washes and a 10 minute PBSTx wash. Slides were incubated with 





hour. Unbound secondary antibody was then washed off with 3x 10 minute PBS 
washes and mounted using Citifluor (Citifluor Ltd.). 
 
2.4.4. Frozen section histology and immunofuorescence 
Sections of the DG, SVZ, or OB on Superfrost+ slides were incubated in PBS at 
37°C for 45mins to wash away the gelatine. Sections were then fixed with 4% 
PFA for 10 mins followed by by 2x 10 minute PBS washes. Cells were 
permeabilised with a 10 minute wash in PBSTx and non-specific antibody 
binding was blocked by incubating slides in blocking solution for 1 hour. Primary 
antibody was diluted in Ab block at 4°C overnight. The following day, unbound 
antibody was washed off with 3x 10 minute PBS washes and 2x 10 minute 
PBSTx wash. Slides were incubated with fluor-labelled secondary antibody 
(1:200) and Dapi (1:5000) in Ab block for 1 hour. Unbound secondary antibody 
was then washed off with 3x PBS washes and slides were mounted using 
Citifluor. For BrdU, Ki67 and PCNA detection, tissue sections were antigen-
retrieved with 2N HCl for 15 mins at 37°C prior to blocking sections. Acid was 
then neutralised with 2x 5 minute washes in 0.1M borate buffer pH 8.5. 
 
2.4.5. Section in situ hybridisation 
RNA in situ hybridisation and riboprobe synthesis were performed as described 
previously [363]. Briefly, Digoxigenin-labelled anti-sense and sense riboprobes 
of Er81 were synthesised from a plasmid preparation as shown in Section 
2.3.14 and Section 2.3.15. Er81 plasmid was linearised with SpeI and probe 
was synthesised using T7. Chd7 was synthesised from PCR reaction. Probe 
synthesis from PCR reaction is shown in Section 2.4.6. 
All reagents used for in situ hybridisation on tissue sections are shown in 
Section 2.1.4. All section in situ hybridisations were performed on wax section. 
Sections were rehydrated in a coplin jar through a series of xylene and ethanol 





ethanol, 95% ethanol and 70% ethanol in water, then rinsed twice in water. 
Sections were then fixed in 4% PFA for 10 minutes at room temperature, then 
rinsed for 5 minutes in PBS. To permeabilise cell membranes, slides were 
washed for 10 minutes at 37°C in 50ml PBS with 50µl proteinase K. Slides were 
then rinsed again in PBS followed by incubation with acetylation solution for 10 
minutes to minimise background. Following acetylation, slides were washed 3 
times for 5 minutes each in PBS, then dehydrated through 70% and 95% 
ethanol washes before being left to air dry. Meanwhile, the chosen probe was 
added to hyb at a concentration of 1µg/ml, and then heated at 80°C for at least 
two minutes. Following dehydration, slides were transferred into a preheated 
humid (50% formamide / water solution) chamber. Once in the chamber, 300µl 
of probe/hyb solution was added to each slide and the slide was covered with 
parafilm. Hybridisation was performed at 65°C overnight. 
The following day, slides were washed in 5xSSC solution to gently float off the 
parafilm coverslips. Slides were then washed for 30 minutes at 65°C in a high 
stringency wash to ensure that all the unbound or weakly bound probe was 
washed off the sections. Slides were washed 3 times for 10 minutes in RNase 
buffer at 37°C before undergoing a 30 minute wash in RNase A in RNase buffer 
(100µl of enzyme in 50 ml of buffer) at 37°C, to digest any unbound RNA. 
Slides were washed one last time in RNase buffer at 37°C for 15 minutes 
followed by two high stringency washes at 65°C for 20 minutes. Sides were 
then washed in 2xSSC and 0.1xSSC for 15 minutes at 37°C and a PBSTw 
wash for 15 minutes. Any non-specific antibody binding was then blocked by 
incubating slides in blocking solution (10% heat inactivated goat serum in 
PBSTw) for one hour at room temperature. Blocking solution was then replaced 
with antibody solution (anti-digoxigenin-AP diluted 1/5000 in 1% heat 
inactivated goat serum in PBSTw) and left overnight at 4°C.  
After antibody incubation, slides were washed 4 times in PBSTw for 15 minutes 
each to ensure any unbound antibody was washed away.  The slides were then 





levamisole to minimise background staining. Slides were stained at room 
temperature in the dark until any signal was detected 
Once sections were adequately stained, the BM purple was removed and slides 
were washed twice in PBS, fixed briefly in 4% PFA, then rinsed once more in 
PBS, before counterstaining in 20% nuclear fast red solution for 10 minutes.  
Finally, sections were dehydrated through a series of brief ethanol washes 
(2x70%, 95% and 100%), and washed 3 times for 3 minutes in Xylene before 
mounting with DPX. 
 
2.4.6. Probe synthesis from PCR reaction 
PCR reactions were carried out using a FastStart Taq DNA polymerase kit 
(Promega) according to the manufacturer's recommendations. PCR reactions 
were carried out in 20µl reactions using Promega reagents using the mix 
described in Section 2.1.3. 
All samples were amplified using the following program: 
95oC for 10 minutes 
40 cycles of:  94oC for 45 seconds 
55oC for 45 seconds 
72oC for 1 minute 
Followed by 72oC for 7 minutes. 
 
PCR product was then purified using a QiaQuick PCR purification kit (Qiagen) 
according to the manufacturer's recommendations. Probe was then synthesised 
using the reaction mix detailed in Section 2.1.3. The probe synthesis mix was 
left for 2 hours at 37°C. 1µl of the mix was then removed and resolved on a 
1.5% agarose gel to check for an RNA band, and to estimate the concentration 





DNase I was added to the remaining mix, and the reaction left at 37°C for 15 
minutes in order to digest any DNA still present. Finally, the probe was purified 
by spinning down the solution in SigmaSpin post-reaction Cleanup columns 
(Sigma) according to the manufacturer's recommendations. 
For Chd7, primer sequences span exon 3 and are as follows: 
Chd7 forward - 5' TTGGTAAAGATGACTTCCCTGGTG 3' 
Chd7 reverse - 5' ATTGTAATACGACTCACTATAGGGGTTTTG 3' 
Probe was synthesised using T7 polymerase. 
 
2.4.7. RNA isolation and RT-qPCR 
RNA extraction from approximately 1x106 foetal-derived NSCs was done  with 
Trizol (Invitrogen) according to the manufacturer’s suggested modifications, by 
the addition of ultrapure glycogen (Invitrogen), and prepared for RT-qPCR 
analysis as in Section 2.3.16. 
First-strand complementary DNA was synthesised from 4 μl (200 ng) of RNA 
using the  Precision Nanoscript Reverse Transcriptase kit (PrimerDesign) 
according to manufacturer's recommendations. RT-qPCR was performed on a 
Stratagene Mx3000p Real Time PCR machine (Aglient Technologies), with 
Precision 2 x real-time PCR MasterMix (PrimerDesign) using primers against 
Er81, Hes5, Chd7, Stk25, Prkca, Nrarp, Wnt9a, Cd24a, Ring1, Chd4, Bcan, 
Reln, Smarca2, NeuroD2, Spred1, Trp53, Arid1b, and Gapdh as a 
housekeeping control. Primer sequences are shown in Table 3. 
All reactions for RT-qPCR were performed using the following thermal cycler 
conditions: 95 °C for 10 minutes, 40 cycles of a two-step reaction, denaturation 
at 95 °C for 15 seconds, annealing at 60 °C for 1 minute, followed by a 50°C 
step for 30 seconds at the end. Unless otherwise stated, data are from two 






Target Forward primer (5'-3') Reverse primer (5'-3') 
Er81 TCCATACCAGACAGCACCTAC GTCGGCAAAGGAGGAAAAGAA 
Hes5 AGTCCCAAGGAGAAAAACCGA GCTGTGTTTCAGGTAGCTGAC 
Chd7 TCACCAGCCTTGGGCACAACTC TAGCTGAGCGTTCTGTGCGCTG 
Stk25 ATATCACCCGCTACTTCGGCT GGTGGCAATATAGGTCTCTTCCA 
Prkca AGAGGTGCCATGAGTTCGTTA GGCTTCCGTATGTGTGGATTTT 
Nrarp TTCAACGTGAACTCGTTCGGG TTGCCGTCGATGACTGACTG 
Wnt9a TACAGCAGCAAGTTTGTCAAGG ATTTGCAAGTGGTTTCCACTCC 
Cd24a CTTCTGGCACTGCTCCTACC GGTAGCGTTACTTGGATTTGGG 
Ring1 TCTGCCTGGACATGCTGAAG CGTAGGGACCGCTTGGATAC 
Chd4 GAGGAGGATATGGACGCACTTC TGAGCTTTGGAGTCTCTGCTTC 
Bcan TCTGGAAGAACTGTCCTGGC CTCCTCCAAGCATGTCCCAC 
Reln TTACTCGCACCTTGCTGAAAT CAGTTGCTGGTAGGAGTCAAAG 
Smarca2 TCACGGACGGGTCTGAGAAA CCCAGGTGTTCAGCAAAGG 
NeuroD2 CTCGCATGGCGCTCTGAAG GAACAGGCGGGTCAGCATGG 
Spred1 GAGATGACTCAAGTGGTGGATG TCTGAAAGGTAAGGCCAAACTTC 
Trp53 GCGTAAACGCTTCGAGATGTT TTTTTATGGCGGGAAGTAGACTG 
Arid1b CAACAAAGGAGTCACCCGGC CCCATCCCATACAACTGAGGTC 
Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
Table 3 - RT-qPCR primer sequences 
 
2.4.8. In vivo activation of Cre recombinase 
Unless otherwise stated, adult mice were given one I.P. injection of 120µl of 
20mg/ml tamoxifen (Sigma) diluted in corn oil (Sigma) daily for 5 days. 
 
2.4.9. NSC in vivo cell division analysis 
For analysing SVZ or SGZ proliferation, animals were given one I.P. injection of 
BrdU (Sigma) dissolved in isotonic saline (0.9% NaCl) at a concentration of 
75mg/kg. For the analysis of new cell formation, animals were administered 
BrdU in their drinking water for 3 weeks at a concentration of 1mg/ml, 







2.4.10. Analysis of NSCs and their progeny 
In vitro cultures of foetal-derived NSCs were stained with antibodies to 
determine their stage of differentiation from immature neuron (DCX+) to mature 
neuron (MAP2+). The number of DCX+ or MAP2+ cells was counted per field of 
view and the percentage of cells positive for each marker was calculated by 
counting the total number of cells (Dapi+) per field of view. A minimum of 4 fields 
of view were counted at 20x magnification per culture. A minimum of 1000 cells 
were counted per culture. Each experiment was performed twice with duplicate 
cultures. 
The number of BrdU+, DCX+, PCNA+, Sox2+, CHD7+, GFAP+ or MASH1+ cells 
per dentate gyrus section was calculated by counting the number of cells on 
each dentate gyrus on a minimum of 10 sections at least 40µm apart from the 
anterior to posterior DG. The number of animals used is shown by each 
experiment. The total number of cells per dentate gyrus was then averaged. 
The number of BrdU+, PCNA+, or DCX+ cells in the subventricular zone was 
calculated by counting the number of cells on each SVZ on a minimum of 10 
sections at least 40µm apart from the anterior SVZ. The number of animals 
used is shown by each experiment. The total number of cells per SVZ was then 
averaged. 
The number of TH+, CalR+, or CalB+ cells in the olfactory bulb was calculated by 
counting the number of cells in several 10,000µm2 areas throughout the 
glomerular layer. A minimum of 6 areas were counted per OB for a minimum of 
8 sections at least 40µm apart in the bulk of the OB. The number of animals 
used is shown by each experiment. The total number of cells per defined area 
in the OB was then averaged. 
For analysis of OB sizes, pictures of the forebrain and OB of Chd7gt/+ and WT 
mice were taken after perfusion fixing and prior to preparation for embedding. 






2.4.11. Antibodies and reagents 
The antibodies used are as follows: rat anti-BrdU (1/50, Abcam), mouse anti-
Ki67 (1/50, Abcam), mouse anti-PCNA (1/200, Abcam), mouse anti-Sox2 
(1/800, Abcam), rabbit anti-Chd7 (1/80, Abcam), rabbit anti-tyrosine 
hydroxylase (1/1000, Abcam), rabbit anti-GFAP (1/500, Sigma), mouse anti-
GFAP (1/1000, Abcam), mouse anti-MASH1 (1/200, BD Biosciences), rabbit 
anti-DCX (1/500, Abcam), mouse anti-NeuN (1/100, Chemicon), goat anti-
Calretinin (1/5000, Chemicon), rabbit anti-Calbindin (1/2000 Swant), rabbit anti-
GFP (1/200, Invitrogen), mouse anti-PSA-NCAM (1/100, Sigma). The 
corresponding species-specific Alexa-conjugated (488, 568, 647) secondary 
antibodies (Invitrogen) were used at 1:200 for immunohistochemistry on tissue 
sections and 1:500 for immunohistochemistry on cultured cells. Dapi (Sigma) 
was used at 1:5000. 
 
2.4.12. Genotyping 
All genotyping was performed as in Section 2.3.18. Details of all primer 
sequences and the sizes of products produced from PCR amplification can be 






Gene of interest Primers 
Cre 
Primer A: CCTGGAAAATGCTTCTGTCCG 
Primer B: CAGGGTGTTATAAGCAATCCC 
 
Cre: Primer pair A+B = 390bp 
Wildtype: No product 
 
Chd7gt 
Primer A: CAGGAGAAGAAAGGGTTCCTG 
Primer B: GGCAGGTCCTTCATTGGA 
Primer C: TTTCCCAGTCACGACGTTG 
 
Chd7gt: Primer pair B+C = 1000bp 
Wildtype: Primer pair A+B - 280bp 
 
Chd7flox 
Primer A: GAAGGAGAAGAAAGAGCCCAAGAC 
Primer B: TGAGTTACGGAGAGAACCAAGCAC 
 
Chd7flox : Primer pair A+B - 392bp 
Wildtype: Primer pair A+B - 423bp 
 
RYFP 
Primer A: GCGAGGAGGCGCTCCCAGGTTCCG 
Primer B: CTTTAAGCCTGCCCAGAAGACTCC 
Primer C: GAGGCAGGAAGCACTTGCTCTCC 
Primer D: CATCAAGGAAACCCTGGACTACTG 
 
RYFP : Primer pair C+D =300bp 
Wildtype: Primer pair A+B = 500 bp 
 







2.4.14. Image processing 
All images were processed using NIS Elements Viewer 4.0 and Adobe 
Photoshop CS5 software. 
 
2.4.15. Statistics and data 
Unless otherwise stated, all data are represented as mean ± s.e.m.; *P < 0.05 
**P<0.01 ***P<0.001, student's t-test. For multiple comparisons, analysis of 
variance with Bonferroni’s multiple-comparison post hoc test was used. 














3.1. Skeletal muscle and ageing 
Under normal homeostatic conditions, SCs are completely quiescent [35]. 
However, in response to muscle damage they are capable of rapidly activating 
and proliferating to generate myoblasts [182]. Myoblasts cycle quickly and are 
able to fuse with each other to form new myotubes [182]. Nascent myotubes 
mature into new myofibres to regenerate damaged muscle [182]. Pax7+ SCs 
are essential for the response to skeletal muscle injury and efficient 
regeneration [58, 59, 61]. In addition, SCs are capable of extensive self-renewal 
to retain a stem cell pool, with the ability to undergo the regenerative response 
upon successive myotraumas [53, 54]. However as ageing progresses, the 
regenerative ability of skeletal muscle declines due, at least in part, to impaired 
SC function (see Figure 4) [146, 147]. Activation of aged SCs is delayed in 
response to injury compared with their young counterparts, and their 
proliferative potential is reduced [159, 160]. Thus, aged SCs are less able to 
generate myoblast progeny. In addition, the differentiation capacity of aged SCs 
and their progeny is reduced, with cells fusing to form thinner myotubes which 
are delayed in upregulating mature fibre markers [150, 155, 166]. Furthermore, 
the self-renewal potential of aged SCs may be reduced, leading to further 
declines in regenerative capability following subsequent injuries [153, 155, 156]. 
These changes lead to a loss of skeletal muscle mass and age-associated 
sarcopenia, resulting in impaired skeletal muscle function in aged animals [146]. 
Whether the number of SCs declines with age is still somewhat controversial, 
with studies documenting increased and decreased numbers of SCs depending 
on the species, muscle, and technique of observation [146]. However, it is 
generally accepted that the number of Pax7+ SCs present in skeletal muscle 
undergoes a notable decline in ageing under homeostatic conditions [149-151]. 
Across different species and organ systems the stem cell niche has a critical 
role in the maintenance of stem cell number and function. In invertebrates, age 
associated changes in the niche have been shown to cause a decline in stem 
cell number and function [167, 168]. In mammals, the stem cell niche is a critical 




factor in the maintenance of quiescence, a reversible state of growth arrest 
crucial to the preservation of adult stem cell number and function [20, 366]. 
Changing the aged SC niche can partly restore the proliferation and 
differentiation of aged SCs. For example, exposure to a young systemic 
environment promotes the proliferative expansion and myogenic progression of 
aged SCs in regenerative conditions [10, 148, 150, 164, 169]. Manipulation of 
growth factors and signalling pathways, such as Wnt signalling and Notch 
signalling, can also aid the regeneration of aged skeletal muscle [130, 164, 
174]. The signalling cascades responsible for the decline in SC function in 
regenerating aged muscle have been intensively investigated, yet, in contrast, 
the mechanisms driving SC depletion under homeostatic conditions with age 
remain unknown. 
The following experiments were conducted to investigate how age-associated 
changes in the niche impact SC number and function under homeostatic 
conditions: 
1. Numbers of SCs present in skeletal muscle were determined in adult and 
aged animals and their function was assessed using an in vitro fate 
assay. 
2. The cycling status of SCs was determined in adult and aged animals with 
5-bromo-2'-deoxyuridine (BrdU) studies to determine if impaired function 
could be due to altered quiescence. 
3. Age-associated changes in the SC niche were investigated through the 
use of a purified myofibre extract (PME) in combination with in vitro 
quiescence assays. 
4. The possibility that deregulated FGF expression from the niche was 
responsible for skeletal muscle ageing was investigated through the use 
of pharmalocogical and genetic inhibitors of FGF signalling in 
combination with PME and in vitro quiescence assays. 
  




3.1.1. Satellite cells display a decline in number and function in aged 
skeletal muscle 
To first determine if there was any change in the SC pool with age, TA sections 
of adult (3-8 months old) and aged (24-28 months old) mice were stained with 
antibodies raised against the SC marker, Pax7, and laminin to mark the basal 
lamina (Figure 15a). SCs were identified as Pax7+ cells outside of the myofibre 
but underneath the basal lamina (Figure 15a). The number of Pax7+ SCs per 
section was reduced by almost 50% in aged skeletal muscle compared to adults 
(Figure 15b). The reduction in SC number was also confirmed by isolating 
single muscle fibres from EDL muscle and staining them with antibodies raised 
against Pax7 (Figure 15c). As a further method of confirmation, SCs from aged 
and adult skeletal muscle were FACS-isolated (Figure 15d). Cells were 
positively selected for VCAM-1 and α7-integrin, and negatively selected for 
CD31, CD45, and propidium iodide (PI) to remove endothelial cells, immune 
cells, and dead cells respectively (Figure 15d). This sorting method allowed for 
the isolation of a 95% pure population of Pax7+ SCs, which were all quiescent 
(Ki67-), after staining for Pax7 and Ki67 immediately after sorting (Figure 15e,f 
and data not shown). FACS profiles of VCAM-1+, α7-integrin+, CD31/45-, PI- 
events showed that the percentage of SCs present in aged skeletal muscle was 
reduced by 50% compared to adult (Figure 15d,g). Furthermore, RT-qPCR 
analysis for the expression of Pax7 revealed no difference in aged compared to 
adult FACS-isolated SCs, showing that a reduction in the number of Pax7+ cells 
is not due to a decrease in levels of Pax7 transcript in aged cells (Figure 15h). 
SCs in aged skeletal muscle display impaired regenerative capability [147]. To 
determine the exact cell-autonomous changes in SC function a fate assay was 
performed. FACS-isolated SCs were plated at clonal density in culture 
(DMEM+10%HS) and then stained with antibodies to determine self-renewal 
potential (Pax7), differentiation (MyoG), and apoptosis (cleaved caspase 3; 
aCasp) (Figure 15i). After four days in culture, aged SCs tended to lose 
markers of self-renewal potential (Figure 15j) as the percentage of Pax7+ cells 




was decreased, and instead became more prone to differentiate (Figure 15k) 
and apoptose (Figure 15l). 
Collectively, these data show that the number of SCs is decreased with age and 
the few that remain display a loss of self-renewal potential and increased 
tendency to differentiate or apoptose. 
 










Figure 15 - The number of satellite cells declines in aged skeletal muscle and their 
function is impaired. a, Representative image of Pax7 (white), laminin (green) and Dapi (blue) 
staining of 10µm thick skeletal muscle cross-sections (scale bar, 50µm). b, Quantification of the 
number of Pax7+ cells / muscle cross-section averaged from 30 cross-sections / mouse (n=5-6 
animals / age group). c, Quantification of the number of Pax7+ cells / single muscle fibre from 
adult and aged skeletal muscle. 20-30 single muscle fibres / animal (n=5-6 animals / age 
group). d, FACS profiles for the isolation of purified SCs from adult and aged muscle. Cells were 
positively selected for VCAM-1 and α7-integrin and negatively selected for CD31, CD45 and 
propidium iodide (PI). Note the decrease in double-positive cells in aged muscle compared to 
adult muscle (far right panels). e, Representative image of freshly isolated SCs obtained by 
FACS, plated, immediately fixed and immunostained for Pax7 and Dapi. Scale bar, 20µm. f, 
Quantification of the percentage of Pax7+ cells from the selected gate. Note ~95% of sorted 
SCs from both adult and aged skeletal muscle are Pax7+ (100% were Myogenin-negative). g, 
Relative proportion of SCs sorted from live (PI-) cells derived from adult and aged muscles. h, 
RT-qPCR analysis for the expression of Pax7 in aged relative to adult sorted SCs. i, 
Representative images of sorted SCs cultured for 4 days and stained with anti-Pax7, MyoG, 
MyoD, and cleaved caspase 3 (aCasp). j, Quantification of the percentage of Pax7+, MyoG+ (k) 
and cleaved caspase 3+ (aCasp; l) adult (Ad) and aged (Ag) cells after 4 days in culture. 21–28 
clonal density cultures were examined per condition, performed in triplicate. Scale bar, 20µm. 
All individual experiments were performed in triplicate. All data represented as mean ±s.e.m.; 
*P<0.05 student's t test. 
  




3.1.2. Aged satellite cells cycle more frequently during homeostasis 
Preservation of the quiescent state is a fundamental process that maintains the 
number and function of self-renewing stem cells [367]. Loss of stem cell 
quiescence has been shown to cause a decline in stem cell number and impair 
stem cell function in many systems, including somatic NSCs [252, 259, 260]. 
Therefore, having shown that there is a depletion of the SC pool with age (see 
Figure 15), I sought to investigate whether the cycling status of SCs was 
altered in aged animals under homeostatic conditions. To determine if SC 
quiescence was disrupted under homeostatic conditions during ageing, BrdU 
was administered in the drinking water of adult and aged mice to label 
proliferating cells (Figure 16a). After 6 weeks of BrdU administration, SCs were 
FACS-isolated and immediately fixed and stained with antibodies raised against 
BrdU and Pax7 (Figure 16a). The percentage of aged SCs that were BrdU+ 
was nearly 3-fold greater compared to adult SCs. To further confirm this, 
sections of TA muscle from adult and aged animals were stained with 
antibodies raised against Pax7, laminin, and Ki67 to determine the number of 
SCs that had exited quiescence (Figure 16c). The percentage of Ki67+ SCs 
was increased 4-fold in aged animals compared to adults (Figure 16d), 
therefore showing that aged SCs lose their ability to retain a quiescent state in 
vivo.  
 





Figure 16 - Aged satellite cells cycle more frequently during homeostasis. a, BrdU feeding 
schematic and representative images of freshly isolated SCs obtained by FACS after 6 weeks 
of BrdU feeding, immediately fixed and immunostained for Pax7 and BrdU (Dapi in merge). b, 
Quantification of the percentage of BrdU+ SCs immediately after plating. 300-600 cells were 
assessed per experiment, performed in triplicate. n=4-6 animals / age group. c, Representative 
images of sections from aged muscle stained with anti-Pax7 (red in merge) and Ki67 (green in 
merge; Dapi, blue, in merge) showing a Pax7+Ki67- cell (top panel) and a Pax7+Ki67+ cell 
(bottom panel). d, Quantification of the percentage of Ki67+ Pax7+ SCs per section (n = 4-6 
animals per age group). All scale bars, 20µm. All data represented as mean ±s.e.m.; *P<0.05 
student's t test. 
  




3.2. Formation of a purified myofibre extract to determine age-
associated changes in the satellite cell myofibre niche 
The stem cell niche is essential for quiescence and maintenance of the stem 
cell pool [168, 366]. Skeletal muscle stem cells are located along the length of 
the muscle fibre in close contact with the fibre and basal lamina. The 
association of SCs with a healthy mature muscle fibre is of vital importance to 
maintain adult SCs in a relatively quiescent state during homeostasis [128].  
Hence, the differentiated progeny of SCs, the muscle fibre, functions as a niche 
cell for its own stem cell. To determine if changes in the niche of the SC with 
age account for loss of quiescence under homeostatic conditions and a decline 
in function, all soluble fractions produced by the muscle fibre were extracted 
(purified myofibre extract; PME). Firstly, skeletal muscle of adult and aged mice 
was digested and all contaminating mononucleated cells, including interstitial 
cells and fibroblasts, were washed away. After this step, the presence of any 
contaminating mononuclear cells in the fibre fraction were rare compared to the 
fraction of mononucleated cells that were excluded (Figure 17a-d), showing 
that the myofibre fraction was pure. Purified myofibres were then incubated in a 
high-salt protein extraction buffer (see Section 2.3.3.) to extract all soluble 
components of the niche. 
 





Figure 17 - Purified myofibre extract represents soluble fractions from skeletal muscle 
fibres. a, Representative image from the contents of the fibre fraction or the mononucleated 
fraction (b) of PME prior to the extraction of soluble fractions. Merge of brightfield and Dapi 
shown. Note very few mononucleated cells were present in the fibre fraction, and very few fibre 
fragments were present in the mononucleated fraction. Scale bars, 100µm. c, Quantification of 
the number of mononucleated cells present in the fibre fraction and the mononucleated fraction 
(d). Note that there are over 100-fold fewer mononucleated cells in the fibre fraction than the 
mononucleated fraction, showing efficient removal of contaminating cells. n=1000 cells per 
condition. Data are from 3 experiments conducted in triplicate. All data represented as mean ± 
s.e.m. 
  




3.3. Aged purified myofibre extract induces quiescent satellite 
cells to cycle 
To identify if any soluble muscle-derived factors signal to SCs, PME was 
incubated with sorted SCs in basal media (DMEM+5%HS) for 48 hours and 
assayed for cell cycle entry (Figure 18a,b). In comparison with adult PME, aged 
PME increased the fraction of adult and aged quiescent cells that began to 
cycle (Figure 18c), suggesting that there are pro-mitogenic factor(s) in the aged 
fibre which are absent in the adult fibre. 
Under differentiation conditions in vivo (DMEM+3%HS) myoblasts fuse to form 
myotubes, however, some myoblasts retain Pax7 expression and enter a 
quiescent state and these are termed reserve cells (RSCs) [182]. RSCs are an 
in vitro model of reversible SC quiescence [182]. To further confirm that aged 
PME induces a loss of quiescence, PME was incubated with RSCs and cells 
were assayed for cell cycle entry (Figure 18d,e). Like in sorted SCs, aged 
PME, but not adult PME, caused the loss of RSC quiescence (Figure 18f) and 
did not affect apoptosis (Figure 18g). In contrast to aged PME, aged serum did 
not induce cell cycle entry (Figure 18h) whereas adult serum did, in agreement 
with previous findings on the effect of adult and aged systemic system on SC 
activation [10].  
Adult and aged mononuclear extract caused the activation of RSCs (Figure18i). 
However, in adult and aged PME there are roughly 2.5 contaminating 
mononuclear cells / µl PME (see Figure 17c). When adult and aged 
mononuclear extract was diluted to a level close to what is present in the 
contaminating PME fraction it had no effect on RSC quiescence (Figure 18i), 
further showing the purity of adult and aged PME.  
Collectively, these results demonstrate that the proliferative activity of SCs is 
induced by aged muscle fibre-derived factors. 
  










Figure 18 - The aged niche induces the loss of satellite cell quiescence. a, Strategy to 
assess the mitogenic activity of PMEs with sorted SCs. Adult and aged PME was incubated with 
adult and aged sorted SCs for 48 hours prior to analysing cell cycle entry. b, Representative 
image of an activated SC stained for anti-Pax7, Ki67 and Dapi. Scale bar, 10µm. c, 
Quantification of the percentage of cycling (Ki67+) adult and aged SCs incubated with vehicle 
control (V), adult PME (Ad) or aged PME (Ag). d, Schematic of the experimental strategy to 
assess cycling reserve cells (RSCs) after exposure to adult or aged PME. PMEs were incubated 
with RSCs for 24 hours in basal media (DMEM+3%HS). e, Representative image of RSCs 
stained with anti-Pax7, Ki67 and Dapi. Scale bar, 100µm. f, Quantification of the percentage of 
cycling (Ki67+) RSCs incubated with vehicle control (V), adult PME (Ad) or aged PME (Ag). g, 
Quantification of the percentage of RSC apoptosis (aCasp+) after exposure to vehicle control 
(V), adult PME (Ad) or aged PME (Ag). Note apoptosis is less than 1% under all conditions. h, 
Quantification of the percentage of cycling RSCs after exposure to negligible amounts of serum 
(V, less than 3%), 10% horse serum (Horse), adult (Ad) and aged (Ag) serum directly isolated 
from mice. Note both 10%HS and adult serum can induce RSCs into cycle whereas aged serum 
is less effective. i, Quantification of the percentage of cycling RSCs after exposure to vehicle 
control (V), adult (Ad), or aged (Ag) mononuclear cell protein extract at a 20µg/ml concentration 
or diluted to contaminating concentrations found in adult and aged PMEs. Note no significant 
difference in the ability of diluted Ad and Ag mononucleated protein extract to induce RSCs into 
cycle. For all experiments, n=500-1000 cells per condition conducted in triplicate. All data 
represented as mean ± s.e.m.; *P<0.05 student's t test. 
  




3.3.1. FGF2 is sufficient to drive satellite cells to cycle 
Members of the FGF family of ligands are well-characterised growth factors that 
are known to possess potent SC mitogenic activity (see Section 1.4.3.3. and 
Figure 2). In particular, FGF2 can effectively drive cycling of myogenic 
precursors [100-102]. FGF2 induced SCs on isolated single muscle fibres to 
cycle in a dose dependent manner (Figure 19a) and had a similar effect on 
RSCs (Figure 19b). Addition of FGF2 to sorted adult and aged SCs in basal 
media caused them to lose quiescence (Figure 19c). Furthermore, addition of 
FGF2 to adult PME caused isolated SCs and RSCs to cycle (Figure 19d,e). To 
further demonstrate the sensitivity of the quiescence assay and the potent 
mitogenic capabilities of FGF2, adult and aged sorted SCs were incubated with 
FGF2 or vehicle control for 24, 48, or 72 hours and then assayed for cell cycle 
entry. At 24 and 48 hour time points, SCs in basal media were relatively 
quiescent in the absence of FGF2, and aged and adult SCs lost quiescence in 
response to FGF2 addition (Figure 19f). At a 72 hour time point, many SCs 
were cycling, yet FGF2 still increased the number of cycling SCs (Figure 19f). 
These data show that sorted SCs are relatively quiescent in basal media up to 
48 hours after isolation, and FGF2 can cause a loss of quiescence in a dose-
dependent manner. 
 






Figure 19 - FGF2 acts as a potent mitogen to induce satellite cells to cycle in a dose-
dependent manner. a, Quantification of the percentage of cycling SCs (Ki67+) on isolated 
single muscle fibres. Fibres were incubated with different concentrations of FGF2 in basal 
media (DMEM+5%HS) for 24 hours and stained for anti-Pax7 and Ki67. n=30 fibres per 
condition. b, Quantification of the percentage of cycling RSCs after incubation with different 
concentrations of FGF2 in basal media (DMEM+3%HS) for 24 hours. n=500 cells performed in 
triplicate. c, Quantification of the percentage of aged and adult sorted SCs cycling after addition 
of 40ng/ml FGF2 for 48 hours of culture in basal media (DMEM+5%HS). n =300 cells performed 
in triplicate. d, Quantification of the percentage of cycling sorted SCs and RSCs (e) after 
exposure to Ad PME with or without prior treatment with 40ng/ml FGF2. Note addition of FGF2 
to Ad PME caused the cycling of SCs and RSCs, whereas Ad PME on its own did not. n= 1000 
cells / condition performed in triplicate. f, Quantification of the proportion of cycling sorted SCs 
cultured in basal media (DMEM+5%HS) with or without incubation with 100ng/ml FGF2 for 24, 
48 and 72 hours. Data are from 2 experiments conducted in triplicate. n=1000 cells / 
experiment. All data represented as mean ± s.e.m.; *P<0.05 student's t test. 
 




3.3.2. FGF2 is upregulated in aged skeletal muscle fibres 
To determine if FGF2 is a niche-derived factor which is upregulated in ageing, 
RNA from purified single skeletal muscle fibres from adult and aged mice was 
extracted  and changes in the expression of Fgf ligands were determined by a 
targeted growth factor array. The expression of Fgf1,2,6,13 and 18 was altered 
in aged muscle fibres compared to adult fibres (Figure 20a). Of these, Fgf2 had 
the greatest fold change, being upregulated between 1.5 and 2 fold (Figure 
20a). An increase in the expression of Fgf2 was confirmed by RT-qPCR (Figure 
20b). Furthermore, in situ hybridisation of an anti-sense probe to Fgf2 on 
isolated adult and aged single fibres showed large areas, or 'hotspots', of Fgf2 
expression along the length of aged fibres which were not present in adult fibres 
(Figure 20c,d). Performing immunohistochemistry for Pax7 after in situ 
hybridisation using an anti-sense Fgf2 probe showed that many of these Fgf2 
'hotspots' were close to, but unlikely to be produced by, SCs (Figure 20e). 
To determine if the expression of Fgf2 is altered in aged myofibres compared to 
adult, RT-qPCR for Fgf2 was performed on purified myofibres prior to extracting 
the soluble fraction. Fgf2 was upregulated approximately 2-fold in aged PME 
compared to adult PME (Figure 20f). 
To determine if FGF2 protein was upregulated in aged PME, fibre fragments 
obtained to generate PMEs were immunostained for Pax7 and FGF2 (Figure 
21a). A greater number of aged fibre fragments expressed FGF2 protein 
(Figure 21b), and FGF2 could be seen close to Pax7+ SCs (Figure 21a). 
Interestingly, the number of mononucleated cells expressing FGF2 in the 
mononucleated fraction was slightly decreased (Figure 21c,d). Although this 
was not significant, it argues against an increase in FGF2 outside of the 
myofibre being responsible for a loss of SC quiescence under homeostatic 
conditions. 
To determine if FGF2 increased in aged skeletal muscle under homeostatic 
conditions, adult and aged TA sections were stained with antibodies raised 
against FGF2 and the number of FGF2+ areas were counted. Even though no 
Fgf2 'hotspots' were found on adult single fibres by in situ hybridisation, FGF2+ 




areas were found associated with adult skeletal muscle by immunostain (Figure 
21e). This suggests that either the FGF2 antibody is more sensitive than the 
Fgf2 anti-sense probe, or alternatively it may indicate a degree of non-specific 
antibody binding. Regardless, aged skeletal muscle displayed a 2-fold increase 
in the number of FGF2+ areas associated with muscle fibres (Figure 21e,f). 
Interestingly, the number of interstitial FGF2+ areas was decreased, further 
arguing against an increase in FGF2 expression outside of the myofibre causing 
a loss of SC quiescence. To determine if the areas of FGF2 protein on muscle 
fibres were close to SCs, adult and aged TA sections were stained with 
antibodies raised against FGF2, Pax7, and laminin. Of note, FGF2 protein was 
not detected on SCs (Figure 21f), further suggesting that they do not produce a 
significant amount of FGF2 under homeostatic conditions. However, the 
percentage of SCs found close to a source of FGF2 was increased 2-fold in 
aged skeletal muscle (Figure 21g). 
Together these results show that FGF2 is upregulated in aged skeletal muscle 
under homeostatic conditions and that the aged SC niche, the muscle fibre, is 
the principal source of FGF2. 
 










Figure 20 - Expression of Fgf2 from the muscle fibre increases in aged skeletal muscle. a, 
Table of expression for 17 different FGF ligands from aged relative to adult isolated single 
muscle fibres (Fold A/Ad) from duplicate RT-qPCR based array kits (SAbiosciences). N.A. (not 
attained) designates whereby Cq values were greater than controls provided by the kit. b, 
Quantification of Fgf2 expression in aged relative to adult single muscle fibres by RT-qPCR. 
Data are from 3 reactions conducted in triplicate. c, Representative images of Fgf2 in situ 
hybridisations on adult and aged single muscle fibres. A sense probe was used as a 
background negative control (lower panel). d, Representative image of Fgf2 in situ hybridisation 
on aged single muscle fibres shows increased Fgf2 (brown) in close proximity to Pax7+ (red) 
SCs. Dapi (blue). Scale bar, 20µm. e, Quantification of the number of Fgf2 'hotspots' along the 
length of single muscle fibres. n>30 fibres / animal, n=3 mice / group. f, Expression of Fgf2 in 
adult and aged fibres obtained to generate PMEs as assessed by RT-qPCR. Note the fold 
difference in Fgf2 expression is similar to that observed for purified single muscle fibres (see 
Figure 20b). Data are from 3 reactions conducted in triplicate. All data represented as mean ± 
s.e.m.; *P<0.05. 
 









Figure 21 - Muscle fibre-derived FGF2 increases with age. a, Representative image of aged 
fibres obtained to generate PMEs immunostained for Pax7, FGF2 and Dapi. Merge with 
brightfield. Scale bar, 50µm. Note FGF2 protein close to Pax7+ SCs. b, Quantification of the 
percentage of muscle fibres that contain FGF2+ regions in aged or adult fibres used to generate 
PME. Data are from 3 separate experiments. n=100 fibres / experiment. c, Quantification of 
FGF2+ cells in isolated skeletal muscle mononucleated cells. Note a decrease in the expression 
of FGF2 in aged compared to adult mononucleated compartments. Data are from 3 experiments 
conducted in triplicate. n=1000 cells per condition. d, Representative image of FGF2 expression 
in isolated skeletal muscle mononucleated cells. Scale bar, 100µm. e, Representative 
longitudinal sections of adult and aged skeletal muscle stained with anti-Pax7 (green), laminin 
(white) and FGF2 (red). A white arrow shows a Pax7+ satellite cell close to FGF2 (asterisk). 
Dapi (blue) in merge. f, Quantification of FGF2+ areas in transverse muscle sections showing 
increased muscle fibre-associated, and decreased interstitial-associated, FGF2 in aged muscle 
fibre sections. Note FGF2 protein was not detected (ND) on SCs. n = 5-6 mice / age group. g,  
Quantification of the percentage of SCs near (<20 µm) FGF2+ regions. n = 3 animals / age 
group. All data represented as mean ± s.e.m.; *P<0.05, **P<0.01 student's t test. 
  




3.3.3. Induction of aged niche-derived FGF2 disrupts satellite cell 
quiescence 
I have shown that FGF2 is a niche-derived factor which is upregulated in the 
aged SC niche (see Figure 21). Through in vitro assays, I have shown that the 
aged niche can drive the loss of quiescence of SCs (see Figure 18). From 
these data, I hypothesised that FGF2 was the potent mitogenic factor which 
was causing the loss of SC quiescence with age, leading to altered stem cell 
number and function. To test if FGF2 is directly responsible for the loss of SC 
quiescence, I inhibited FGF signalling genetically and by using chemical 
inhibitors, and I also blocked FGF2 activity directly. 
To investigate whether FGF2 is the factor in the aged niche which is causing 
SC activation, myoblasts from mice where both FgfR1 and FgfR2 alleles are 
floxed (FgfR1/2flox/flox) were generated. Myoblasts were then treated with either 
GFP adenovirus (Ctrl) or Cre-GFP adenovirus (FGFR1/2null) to cause a loss of 
FgfR1 and FgfR2 function. RSCs were then generated to determine the effect of 
the loss of FgfR1/2 on RSC quiescence. FgfR2 is not expressed by myoblasts, 
myotubes, or reserve cells (Figure 22a), so any effects seen from FgfR1/2 
deletion is solely due to abrogation of signalling through FGFR1. Deletion of 
FgfR1/2 completely inhibited the proliferative effect of FGF2 and aged PME in 
transfected cells (Figure 22b-d), suggesting that FGFR1 signalling is necessary 
for RSC activation. Furthermore, incubation of adult and aged sorted SCs with 
the FGFR-specific inhibitor, SU5402 (see Figure 2), prior to addition of adult or 
aged PME completely blocked aged-PME-induced stem cell activation (Figure 
22e) and a similar effect was seen in RSCs treated with SU5402 (Figure 22f). 
Notably, incubation with SU5402 did not affect apoptosis (Figure 22g). These 
results show that signalling through FGFR is responsible for the loss of SC 
quiescence in the aged niche. 
To directly test whether FGF2 was responsible for the altered biological activity 
of aged PME, the extract was treated with a blocking antibody against FGF2 
(αFGF2; see Figure 2) prior to incubating it with RSCs or sorted SCs. 
Neutralisation of FGF2 activity prevented aged PME-induced cell cycle entry in 




RSCs (Figure 22h) and adult (Figure 22i) and aged SCs (Figure 22j).  
Therefore, the increased abundance of soluble muscle-fibre-derived FGF2 in 
aged muscle leads to a loss of quiescence in aged satellite cells. 
 










Figure 22 - FGF2 is an aged niche-derived factor that induces satellite cells to cycle. a, 
Expression of FgfR1 and FgfR2 in myoblasts (MyoB), Myotubes (MyoT), and reserve cells 
(RSCs) as assessed by RT-qPCR. Data are from 3 reactions conducted in triplicate. b, 
Quantification of cycling RSCs after adenoviral Cre-mediated deletion of FgfR1 and FgfR2 from 
RSCs (FGFR1/2null) or control adenovirus (Ctrl) and upon  incubation with vehicle (V), 40µm 
FGF2, or adult (Ad) or aged (Ag) PME (c). N.S., Not significant. n=300-600 cells / condition, 4-5 
separate experiments. d, Representative image of myoblasts from FgfR1/2flox/flox mice treated 
with Cre-GFP adenovirus (FGFR1/2null) or GFP adenovirus (Ctrl) and induced to form RSCs. 
Scale bar, 100µm. e, Quantification of the percentage of cycling adult and aged sorted SCs or 
RSCs (f) treated with adult or aged PME and SU5402. n=1000 cells per condition; n=5 animals 
per group. g, Quantification of the percentage of apoptotic RSCs (aCasp+) after incubation with 
SU5402 or FGF2. Note less than 1% of cells undergo apoptosis in all conditions. Data are from 
3 experiments conducted in triplicate. n=500 cells per condition. h, Quantification of the 
percentage of cycling RSCs or adult (i), or aged (j) sorted SCs treated with adult or aged PME 
and FGF2-blocking antibody (αFGF2). n=1000 cells per condition; n=5 animals per group. All 
data represented as mean ± s.e.m.; *P<0.05, student's t test. 
  





I sought to investigate the influence of ageing on the SC niche and its impact on 
stem cell homeostasis. The data presented here identify a specific and 
functionally important change in the molecular composition of the aged stem 
cell niche. These data show that SCs are relatively dormant during 
homeostasis. By contrast, aged SCs become mitotically active, leading to a loss 
of self-renewal potential and this is a likely mechanism causing the eventual 
diminution of the SC pool with age (Figure 23). I have demonstrated that the 
aged SC niche, the muscle fibre, is pro-mitogenic and capable of driving a 
subset of SCs to break quiescence and lose self-renewing capacity under 
homeostatic conditions. I have identified FGF2 as a key niche-derived mitogenic 
factor that is increased in the aged niche. 
Proliferative exhaustion of stem cell populations is marked by the failure to 
maintain quiescence, impaired self-renewal and eventual loss in numbers [367]. 
Loss of SC quiescence under homeostatic conditions was surprising 
considering their proliferative disadvantage in high-mitogen regenerative 
contexts [88]. Instead, it may have been expected that aged SCs would be even 
more quiescent than their adult counterparts. However, in support of a loss of 
quiescence with age, aged HSCs are more active in the aged niche [368, 369]. 
It is tempting to speculate that a consequence of ageing across stem cell niches 
is their inability to retain stem cells in a quiescent state. 
These data are consistent with a key role for a niche-derived factor, FGF2, that 
is low in the adult SC niche and increases during ageing to drive cells out of 
quiescence and contribute to stem cell loss. SCs in the adult niche do not 
proliferate under homeostatic conditions, indicating that there are no pro-
mitogenic factors in the adult niche. Alternatively SCs could be kept quiescent 
through the expression of Spry1, or quiescence-inducing factors such as Ang1 / 
Tie2 signalling [138], or by certain cell-to-cell contacts such as association with 
a healthy myofibre [128]. Aged SCs cycle, suggesting that the aged niche 
induces the loss of stem cell quiescence. Reducing the level of FGFR 
signalling, through deletion of FgfR1/2 and through chemical inhibitors of FGFR 




and FGF2, altered the degree of cell cycle entry. Therefore, SCs are clearly 
responsive to changes in niche-initiated signalling and altering the level of FGF 
signalling can change stem cell outcome. 
Loss of quiescence is consistent with the impaired function of aged SCs. 
Recent experiments examining the proliferative heterogeneity of SCs has 
uncovered two pools of SCs exist; a quiescent pool (LRC), and a more 
proliferative pool (non-LRC) [124, 127]. The non-LRC SC pool had a decreased 
ability to self-renew and reconstitute the niche after transplantation, whereas the 
LRC pool had an increased tendency to self-renew and were able to generate 
more new myofibres after multiple injuries [124, 127]. These data suggest that 
loss of quiescence can lead to impaired function and a loss of SC number over 
time. 
I have shown that the expression of five Fgfs are altered in ageing (see Figure 
20a). It is possible that the change in the expression of Fgfs other than FGF2 
may account for other aspects of skeletal muscle ageing. For example, in vitro, 
FGF6 slows down the transition to differentiation in myogenic cells [97]. A 
decrease in Fgf6 expression from the myofibre may increase the tendency for 
SCs to prematurely differentiate and contribute to the impaired regenerative 
capability of aged skeletal muscle. It would be interesting to investigate the 
effect of the changes in other Fgf ligands and see how they contribute to 
skeletal muscle ageing alone and in combination with other changes.  
The systemic environment plays a significant role in SC proliferation in vitro and 
during repair. The young systemic environment stimulates SC proliferation, 
whereas the aged systemic environment inhibits SC proliferation (see Figure 
18h) [10, 164]. These data show that the aged niche becomes stimulatory, 
suggesting that the systemic environment and the niche have opposing 
influences on SCs in both adult and aged muscle (Figure 23). During 
homeostasis, adult SCs remain quiescent when in a pro-mitogenic systemic 
environment, and aged SCs  respond to the stimulatory myofibre niche when 
surrounded by an inhibitory systemic environment (Figure 23). These data 
suggest that the niche is dominant. In the context of injury, the relationship 




between niche and systemic environment is disrupted due to breakdown of the 
myofibre after injury, leaving a permissive systemic environment to exert its 
influence on SCs. However, many factors are known to change in muscle 
during ageing including systemic factors, neuromuscular integrity and fibrosis 
(see Section 1.6.2). It will be of interest to determine how these changes may 
act either alone or collectively to affect SC function either directly or indirectly 
through niche modulation and maintenance with age. 
I have partially characterised the muscle stem cell niche during ageing, focusing 
on the elements that control stem cell quiescence and number during 
homeostasis. The reasons behind the increased FGF2 are not known, however, 
based on mRNA distribution, Fgf2 mRNA appears to be located at many sites 
along the fibre (see Figure 20c), rather than localised to discrete regions such 
as the SC microenvironment, muscle-tendon connections or neuromuscular 
junction. I propose that the induction of this potent mitogen is an attempt to 
repair the aged muscle fiber. Since muscle fibres are not regenerated under 
homeostatic conditions there may be an accumulation of low-level chronic 
myofibre damage with age. This may cause the myofibre to upregulate FGF2 
after a certain threshold has been reached in aged skeletal muscle. This 
upregulation of FGF2 is akin to the induction of FGFs during development to 
promote myogenic commitment and differentiation [102, 109, 370-373]. 
However, unlike during development, upregulation of FGF2 occurs at the 
expense of the stem cell number and function in aged skeletal muscle. 
Therefore, strategies to prevent chronic FGF2 production from the aged niche, 
or repress FGF signalling at the level of the aged SC, or prevent damage to the 
aged niche, may reduce stem cell loss during ageing. 
These data suggest that increased niche-derived FGF2 and loss of quiescence 
may be detrimental to stem cell number and function. In order to determine if 
increased FGF2 expression from the niche negatively impacts SC number and 
function with age, I sought to modulate FGF signalling in vivo by altering the 
levels of the negative regulator of FGF signalling, Spry1 (see Figure 2). 




Furthermore, I sought to investigate if the loss of stem cell number with age can 
be halted by inhibiting FGF signalling specifically in SCs. 
 










Figure 23 - The systemic environment and the niche have opposing influences on 
satellite cells in adult and aged skeletal muscle. The systemic environment in adult skeletal 
muscle is pro-mitogenic and can enhance the activation of aged SCs  [10, 164]. However, under 
homeostatic conditions, the basal lamina acts as a barrier to these mitogenic stimuli and SCs 
are maintained in a quiescent state (top panel). The aged SC systemic environment does not 
instruct SCs to cycle and is detrimental to regeneration [10, 164]. The aged SC niche, however, 
upregulates FGF2 and this causes SCs to cycle (bottom panel). This suggests that the niche is 
the dominant signal to SCs. Aged skeletal muscle also displays increased fibrosis, a thickened 
basal lamina and breakdown of the neuromuscular junction, which may all interact to modulate 













4.1. Sprouty proteins modulate FGF signalling 
Sprouty (Spry) proteins are negative regulators of FGF signalling, specifically 
inhibiting Ras-ERK MAPK signalling, leaving phosphoinositide 3-kinase (PI3K) 
and other MAPK pathways unaffected (see Figure 2) [374, 375]. In mammals 
there are four Spry proteins (Spry1-4). The transcription of Spry genes is 
induced by Ras-ERK MAPK signalling (see Figure 2) [376]. However, the 
expression of Spry genes is not always induced by RTK signalling and their 
induction may be controlled differently in various cell types. For example, in 
NIH3T3 fibroblast cells and endothelial cells, the expression of Spry2 is 
upregulated by growth factor addition, and, in contrast, Spry1 is downregulated 
[374, 377]. Tissue-specific transcription factors may also regulate the 
spatiotemporal expression patterns of Spry genes. For example, in mouse 
kidney development, the transcription factor Wilms tumor-suppressor gene 1 
induces the expression of Spry1 by directly binding to the Spry1 promoter [378]. 
This suggests that the different Spry proteins may play distinct roles in these 
cell types. 
Spry proteins have recently been shown to play a role during embryonic 
myogenesis. Studies by Lagha et al. showed that Spry1 is directly regulated by 
Pax3 [370]. The authors identified a role for Spry proteins in forming immature 
myogenic precursors at the expense of more differentiated cells [370]. This 
suggests that modulation of Spry levels may affect myogenic stem cell fate 
decisions. 
Spry1 is robustly expressed in adult quiescent SCs under homeostatic 
conditions with the other Spry family members expressed at much lower levels 
[42, 89]. This suggests that growth factors may be present in uninjured muscle 
and can actively signal to SCs. It is possible that the growth factors present may 
induce SC quiescence rather than activation, or hold them in a state allowing for 
rapid activation upon injury. Alternatively, expression of Spry1 may be 
controlled via transcription factor activity independent of RTK signalling, like in 
kidney development and embryonic myogenesis [370, 378]. 




Spry1 has recently been shown to be an essential regulator of adult SC function 
after myotrauma. Studies by Shea et al. have shown that Spry1 expression is 
downregulated as SCs proliferate in response to injury and re-induced as SCs 
return back to quiescence [42]. Deletion of Spry1 specifically in adult SCs led to 
an increase in the apoptosis of SCs after injury and, therefore, a reduction in the 
SC pool [42]. Collectively, these studies suggest a model whereby Spry1 
normally inhibits the RTK signals required for SC proliferation in homeostasis 
[42]. 
So far, I have shown that FGF2 is upregulated in the aged SC niche and this 
drives a loss of stem cell quiescence (see Figure 23). To investigate the role of 
FGF signalling in adult and aged SCs under homeostatic conditions, I sought to 
manipulate FGF signalling levels in SCs in vivo. This was achieved through the 
conditional deletion and overexpression of Spry1 which allowed for the non-
invasive manipulation of FGF signalling with endogenous regulators. The aims 
for this chapter are to: 
1. Delete Spry1 specifically in Pax7+ SCs to determine if increased FGF 
signalling further disrupts SC quiescence and function, and 
2. Overexpress Spry1 specifically in Pax7+ SCs to determine if blockade of 
FGF signalling under homeostatic conditions can rescue age-related 
changes in SC number and function. 
 
4.1.1. Loss of Spry1 further enhances loss of satellite cell 
quiescence in response to the aged niche in vitro 
To increase the sensitivity of SCs to RTK signalling, Spry1 levels were reduced 
using a Spry1flox/+ myoblast line. Spry1flox/+ myoblasts were induced to form 
RSCs and then cells were treated with either GFP adenovirus (Ctrl-AdV; WT) or 
Cre-GFP adenovirus (Cre-AdV; S1flx) to reduce Spry1 levels (Figure 24a,b). 
Reduction in Spry1 levels increased RSC sensitivity to FGF2 (Figure 24c) and 
aged PME (Figure 24d) and increased their cycling. These results suggested 




that reducing Spry1 levels would further increase stem cell responsiveness to 
the aged niche. 
To determine if SCs are more sensitive to FGF2 in the aged niche, Spry1flox/flox 
mice were crossed with Pax7CreERT2/+ mice to remove Spry1 specifically in SCs. 
Adult and aged Pax7CreERT2/+;Spry1flox/flox (Spry1null) and Cre-negative control 
(WT) mice were given tamoxifen and SCs were isolated four weeks later 
(Figure 25a). Adult and aged Spry1null isolated SCs displayed an increased 
sensitivity to FGF2 (Figure 25b,c) and aged PME (Figure 25d,e) compared to 
WT controls. Interestingly, Spry1null isolated SCs also cycled more in vehicle 
control and adult PME compared to WT controls (Figure 25d,e). This could be 
explained by cells generally becoming more prone to activate after deletion of 
Spry1 for 4 weeks. 
I have previously shown that aged SCs are more prone to differentiate or 
apoptose compared to adult SCs (see Figure 15k,l). To determine if Spry1null 
SCs have an even greater tendency to apoptose or differentiate, Spry1 was 
deleted specifically from adult and aged SCs for four weeks and isolated cells 
were plated at clonal density in culture. Their fate was determined by staining 
with antibodies to determine differentiation (MyoG) and apoptosis (aCasp). After 
four days in culture, Spry1null aged SCs became more prone to differentiate 
(Figure 25f) and apoptose (Figure 25g) compared to WT aged cells, whereas 
Spry1null adult SCs were not significantly different from adult WT cells (Figure 
25f,g). These data suggest that increasing SC sensitivity to RTK signalling, 
through the loss of Spry1, increases SC cycling in the aged niche and further 
exaggerates age-associated changes in SC function. 
 





Figure 24 - Reduction in Spry1 increases reserve cell cycling  in response to the aged 
niche. a, Schematic of the experimental strategy to reduce Spry1 levels in vitro. Spry1flox/+ 
myoblasts were put into differentiation media (DMEM+3%HS) and then treated with Cre-GFP 
adenovirus to reduce Spry1 levels (S1flx) or GFP control (Ctrl).  b, Representative image of 
RSCs and myotubes stained with GFP, Pax7, and Ki67. Scale bar, 50µm. c, Quantification of 
the percentage of cycling (Ki67+) RSCs after incubation with vehicle control (V), FGF2 or adult 
(Ad) or aged (Ag) PME (d). For all experiments, n=500-1000 cells per condition conducted in 
triplicate. All data represented as mean ± s.e.m.; *P<0.05, **P<0.01 student's t test. 
 










Figure 25 - Loss of Spry1 specifically from satellite cells in vivo causes increased 
sensitivity to the aged niche and impaired function. a, Schematic of the experimental 
strategy to delete Spry1 from adult and aged SCs and assess cell cycle entry after incubation 
with PMEs. b, Quantification of the percentage of cycling adult and aged (c) SCs after 
incubation with FGF2. d, Quantification of the percentage of cycling adult and aged (e)  sorted 
SCs after incubation with vehicle control, adult PME, or aged PME. f,  Quantification of the 
percentage of Myogenin+ (differentiated) and apoptotic (cleaved caspase 3+; g) cells from 
Spry1null (S1null) and WT adult and aged cells cultured for 4 days in DMEM+10%HS. 21-28 
clonal density cultures were examined per condition, performed in triplicate. Note aged S1null 
cells display a much greater tendency to differentiate or apoptose compared to aged WT cells. 
For b-e, n=500-1000 cells per condition conducted in triplicate. All data represented as mean ± 
s.e.m. ; *P<0.05, **P<0.01, ***P<0.001 student's t test. 
  




4.1.2. Spry1 inhibits FGF2-FGFR signalling 
The Spry family of proteins inhibit RTK signalling. The data shown so far 
indicate that loss of Spry1 increases SC cycling, differentiation and apoptosis in 
response to the aged niche. To determine if this effect of Spry1 loss was 
through increasing FGF2-FGFR signalling, RSCs from Spry1flox/+ mice were 
generated and Spry1 levels were reduced as in Figure 24a. Cells were treated 
with SU5402 prior to incubation with adult and aged PME to block FGFR 
signalling. Inhibition of FGFR blocked the increased sensitivity to aged PME in 
RSCs with reduced Spry1 levels (Figure 26a). Furthermore, in cells from 
Pax7CreERT2/+;Spry1flox/flox mice treated as in Figure 25a, incubation of isolated 
cells with SU5402 prior to addition of PMEs had a similar effect and inhibited 
increased cell cycle entry in response to aged PME in Spry1null adult (Figure 
26b) and aged (Figure 26c) SCs. To show that Spry1 blocks FGF2-induced 
FGFR signalling, cells from Pax7CreERT2/+; Spry1flox/flox mice treated as in Figure 
25a were isolated and incubated with adult and aged PME that had been 
treated with a blocking antibody to FGF2 (αFGF2). Block of FGF2 inhibited the 
effect of aged PME in WT and Spry1null adult (Figure 26d) and aged SCs 
(Figure 26e). Collectively, these results show that expression of Spry1 is 
essential to maintain the quiescence of SCs in the aged niche by inhibiting 
FGF2 signalling. 
 





Figure 26 - Spry1 inhibits FGF2-FGFR signalling. a, Quantification of the percentage of 
cycling RSCs from Spry1flx or control cells incubated with adult (Ad) or aged (Ag) PME with or 
without the prior treatment with SU5402. b, Quantification of the percentage of cycling sorted 
SCs from Spry1null or control adult or aged (c) mice incubated with adult or aged PME with or 
without the prior treatment with SU5402. d, Quantification of the percentage of cycling sorted 
SCs from Spry1null or control adult or aged (e) mice incubated with adult or aged PME that had 
been treated with a blocking antibody to FGF2 (αFGF2) or vehicle control. n=500-1000 cells per 
condition conducted in triplicate. All data represented as mean ± s.e.m.; *P<0.05, **P<0.01, 
***P<0.001 student's t test. 




4.1.3. Spry1 overexpression inhibits the mitogenic effect of the aged 
niche 
I have shown that loss of Spry1 further increases mitogenic responsiveness of 
SCs to the aged niche (see Section 4.1.1.). Thus, I hypothesised that 
increasing levels of Spry1 in SCs would inhibit cell cycle entry in response to 
FGF2 in the aged niche. To test this, myoblasts were generated from mice 
carrying a transgene encoding a Cre-inducible expression construct for Spry1 
controlled by a chicken β-actin gene (CAG) promoter (CAG–GFPflox;Spry1; 
Spry1OX). Spry1OX myoblasts were treated with GFP adenovirus (Ctrl) or Cre 
adenovirus (Spry1OX) to cause an increase in Spry1 expression (Figure 27a). 
RSCs were then generated to determine the effect of increased Spry1 
expression on RSC quiescence (Figure 27a,b). Overexpression of Spry1 
inhibited the activation of RSCs in response to FGF2 (Figure 27c) and aged 
PME (Figure 27d). 
To further show that overexpression of Spry1 can inhibit the effect of FGF2 in 
the aged niche, SCs from adult Pax7CreERT2/+; Spry1OX (Spry1OX) and cre-
negative control (WT) mice were isolated 10 days after tamoxifen 
administration, incubated with adult and aged PME and assayed for cell cycle 
entry (Figure 28a). Spry1OX SCs did not enter the cell cycle in response to 
aged PME (Figure 28b), showing that overexpression of Spry1 in SCs inhibits 
the mitogenic effect of the aged niche. 
 





Figure 27 - Overexpression of Spry1 inhibits the mitogenic effect of the aged niche. a, 
Schematic of the experimental strategy to overexpress Spry1 levels in vitro. Spry1OX/OX 
myoblasts were treated with Cre adenovirus to overexpress Spry1 levels (Spry1OX) or GFP 
adenovirus as a control (WT) under growth conditions (GM). Cells were then put into 
differentiation media (DMEM+3%HS) to form RSCs and incubated with PMEs or FGF2. b, 
Representative image of RSCs and myotubes stained with GFP, Pax7, and Ki67. Scale bar, 
50µm. Note, the Spry1OX line constitutively expresses GFP and recombination results in Cre-
mediated deletion of GFP. c, Quantification of the percentage of cycling (Ki67+) RSCs after 
incubation with vehicle control (V), FGF2 or adult (Ad) or aged (Ag) PME (d). For all 
experiments, n=500-1000 cells per condition conducted in triplicate. All data represented as 
mean ± s.e.m.; *P<0.05, student's t test. 
  





Figure 28 - Spry1 overexpression in vivo inhibits the mitogenic effect of the aged niche. 
a, Schematic of the experimental strategy to overexpress Spry1 (Spry1OX) from adult SCs and 
assess cell cycle entry after incubation with PMEs. b, Quantification of the percentage of adult 
cycling sorted SCs after incubation with vehicle control, adult PME, or aged PME. n=500-1000 
cells per condition conducted in triplicate. Data represented as mean ± s.e.m.; *P<0.05, 
student's t test. 
  




4.2. Short-term loss of Spry1 in vivo causes increased satellite 
cell cycling and increased Pax7 cell number 
Loss of Spry1 in SCs causes increased FGF signalling and increased cycling in 
response to the aged niche in in vitro quiescence assays (see Section 4.1.1.). 
To test the requirement of Spry1 for maintaining SC quiescence in vivo, 
tamoxifen was administered to adult and aged Pax7CreERT2/+; Spry1flox/flox mice 
(Spry1null) and Cre-negative controls (WT). Mice were sacrificed 10 days later 
and TA sections were stained with antibodies raised against Pax7 and Ki67 to 
determine the number of cycling SCs (Figure 29a). Loss of Spry1 in adult mice 
caused no change in the number of cycling SCs (data not shown), consistent 
with there being no or very little FGF2 present in the adult niche. However, loss 
of Spry1 increased the number of cycling SCs 1.5 fold in aged mice (Figure 
29b). Furthermore, the number of Pax7+ cells on purified single myofibres was 
increased almost 4 fold after short-term deletion of Spry1 in aged SCs, 
consistent with a loss of SC quiescence (Figure 29c). The number of Pax7+ 
cells was not changed in adult single fibres after loss of Spry1, further showing 
that a negligible level of FGF2 is present in the adult niche (Figure 29c). 
 





Figure 29 - Short-term increase in FGF signalling increases satellite cell cycling. a, 
Schematic of the experimental strategy to delete Spry1 from adult and aged SCs. b, 
Quantification of the number of cycling (Ki67+) Spry1null and WT SCs in aged skeletal muscle 
cross-sections. Data are from 4-6 animals / condition. c, Quantification of the number of WT and 
Spry1null Pax7+ cells per isolated myofibre in adult (Ad) and aged (Ag) mice. Note, deletion of 
Spry1 has no effect on adult SCs. Data are from 20-30 single muscle fibres / animal (n=5-6 
animals / condition). All data represented as mean ± s.e.m.; *P<0.05, student's t test. 
  




4.3. Long-term loss of Spry1 in vivo leads to loss of stem cell 
number and impaired satellite cell function 
I have shown that acutely increasing the sensitivity of SCs to FGF2 in the aged 
niche further drives their cycling. Loss of quiescence is associated with 
depletion of the stem cell pool and impaired stem cell function [20, 366]. I 
hypothesised that further driving the loss of quiescence in SCs leads to an even 
greater loss of stem cell number and function under homeostatic conditions. To 
test this, BrdU was administered in the drinking water of adult and aged 
Pax7CreERT2/+; Spry1flox/flox mice (Spry1null) and Cre-negative controls (WT) for 
six weeks (Figure 30a). Mice were then injected with tamoxifen and put back on 
normal drinking water for six more weeks (chase period; Figure 30a). SCs were 
then FACS-isolated and immediately fixed and stained with antibodies raised 
against BrdU and Pax7 to determine loss of quiescence. Any cells that rapidly 
proliferated would have diluted the BrdU label to undetectable levels during the 
chase period (non-LRCs), whereas any cells which did not proliferate would 
have retained the BrdU label (LRCs). Adult Spry1null SCs did not lose 
quiescence and retained the BrdU label, consistent with a negligible amount 
FGF2 being present in the adult niche (Figure 30b). However, aged Spry1null 
cells further lost quiescence over the six week period and diluted the BrdU label 
(Figure 30c). These data show that aged SCs cycle extensively over six weeks 
after loss of Spry1. 
To determine the effect of a further loss of quiescence on SC number and 
function, aged Pax7CreERT2/+; Spry1flox/flox (Spry1null) and Cre-negative control 
(WT) mice were injected with tamoxifen and sacrificed six weeks later (Figure 
30d). The number of Pax7+ SCs was reduced by 50% in aged Spry1null mice 
compared to WT (Figure 30e), consistent with a loss of quiescence further 
driving SC depletion. To examine the effect of long-term Spry1 loss on SC 
function, SCs were isolated from mice treated as in Figure 30d and plated at 
clonal density in culture and stained with antibodies to determine apoptosis 
(aCasp). After four days in culture the percentage of cells undergoing apoptosis 
was almost 3 fold higher in Spry1null cells compared to WT (Figure 30f). To 




further show that long-term loss of Spry1 leads to loss of the SC pool, adult 
Pax7CreERT2/+; Spry1flox/flox mice and WT controls were injected with tamoxifen 
and sacrificed 18 months later (termed a life-long deletion; Figure 30g). TA 
sections were then stained with antibodies raised against Pax7 and laminin to 
determine SC number. Life-long overexposure to FGF signalling caused a 50% 
decline in the number of SCs present in aged skeletal muscle (Figure 30h). 
These data show that prolonged FGF signalling drives SC depletion and impairs 
function under homeostatic conditions. Collectively, these data demonstrate that 
aged-niche-induced FGF signalling leads to an initial loss of quiescence 
followed by a depletion of the stem cell pool. 









Figure 30 - Chronic exposure to FGF signalling leads to depletion of the satellite cell pool 
and impaired satellite cell function. a, BrdU pulse-chase schematic to determine loss of 
quiescence in Spry1null mice. Note, all mice were administered BrdU in their drinking water as 
wild types, before injection of tamoxifen. b, Quantification of the relative percentage of 
Pax7+BrdU+ cells (label retaining cells; LRCs) in adult and aged (c) Spry1null mice relative to 
WT, stained immediately after isolation. n=300-600 cells / experiment performed in triplicate. d, 
Schematic of the experimental strategy to delete Spry1 from aged SCs for 6 weeks. e, 
Quantification of the number of Pax7+ SCs per isolated myofibre in WT mice and in long-term 
deleted Spry1 mice (Spry1 null). n=30-40 fibres / animal. f, Quantification of the percentage of 
Pax7+aCasp+ cells (cell death) in WT mice and in long-term deleted Spry1 null mice after 4 days 
in culture (DMEM+10%HS). g, Schematic of the experimental strategy for a life-long deletion of 
Spry1. h, Quantification of the number of Pax7+ cells per muscle section in WT and life-long 
deleted Spry1 mice (Spry1 null). For all experiments n = 4-6 animals per condition. All data 
represented as mean ±s.e.m.; *P<0.05 student's t test. 
  




4.4. Inhibition of FGF signalling in the aged satellite cell niche 
rescues stem cell number and function 
Upregulation of FGF2 in the aged niche causes a loss of SC quiescence. This 
leads to impaired SC function and a loss of the stem cell pool. I have shown 
that SCs in the aged niche are acutely sensitive to Spry1 levels and the level of 
FGF signalling. Therefore, I hypothesised that inhibiting FGF signalling will 
prevent the age-associated loss of stem cell number and will antagonise the 
decline in SC function. To test this, 18 month old Spry1OX and WT mice were 
injected with tamoxifen and sacrificed 6.5 months later (Figure 31a). BrdU was 
administered in their drinking water in the last 6 weeks of life to determine the 
effect of inhibition of FGF signalling on SC quiescence (Figure 31a). 
Remarkably, the percentage of SCs that had entered the cell cycle was reduced 
by half (Figure 31b). In addition, the number of SCs associated with purified 
single myofibres was increased two fold (Figure 31c). These data show that 
inhibition of FGF signalling in aged SCs partly inhibits the loss of SC 
quiescence and depletion of the stem cell pool. 
To determine if prolonged FGF signalling could be inhibited pharmacologically, 
adult and aged mice were injected with a suspension of 500 µM SU5402 or 
vehicle control adsorbed onto beads (to allow slow SU5402 release)[358]. Mice 
were then administered BrdU in their drinking water for six weeks and sacrificed 
(Figure 31d). Remarkably, the percentage of cycling aged SCs was reduced to 
adult levels after in vivo treatment with SU5402 (Figure 31e). Furthermore, after 
four days in culture, aged SCs that were treated with SU5402 in vivo were less 
prone to apoptose (Figure 31f). 
Collectively, these data show that inhibition of FGF signalling partly retains SC 
quiescence and this leads to maintenance of SC number and function. 
 









Figure 31 - Inhibition of FGF signalling rescues stem cell number and function. a, BrdU 
feeding schematic of aged (18 month old) Spry1OX and WT mice after 5 months of 
overexpression. b, Quantification of the percentage of Pax7+BrdU+ isolated SCs from WT and 
Spry1OX mice stained immediately after isolation. c, Quantification of the number of SCs on 
isolated single myofibres from WT and Spry1OX mice. d, SU5402 (or vehicle control) injection 
and BrdU feeding schematic of adult and aged WT mice. e, Quantification of the percentage of 
BrdU+ SCs and aCasp+ (f) SCs (% SC cell death) isolated from adult (Ad) and aged (Ag) mice 
and stained immediately. For all experiments n = 4-6 animals per condition. All data represented 
as mean ±s.e.m.; *P<0.05 student's t test. 
  




4.5. The adult niche is inhibitory to satellite cell activation 
The aged SC niche is pro-mitogenic and drives SCs out of quiescence causing 
depletion of the stem cell pool. I have shown that incubation of RSCs and 
isolated SCs with FGF2 added to adult PME causes SCs to cycle (see Figure 
19d,e). However, addition of FGF2 to adult PME did not cause as many SCs to 
cycle compared to FGF2 alone. To confirm this, RSCs were incubated with 
different concentrations of FGF2 added to 20µg/ml adult PME and assayed for 
cell cycle entry. Although addition of FGF2 to adult PME induced RSC cycling, 
more RSCs remained quiescent with FGF2 incubated with adult PME compared 
to adult PME alone (Figure 32a). These data indicate that the adult niche is 
inhibitory to FGF2-induced SC activation, suggesting that the loss of SC 
quiescence in aged animals may be due to the increase in the production of 
FGF2 from the niche, and a decrease in the expression of inhibitory factors. 
  





Figure 32 - The adult niche is inhibitory to satellite cell activation. a, Quantification of the 
relative percentage of activated RSCs (Pax7+Ki67+) after incubation with 40µg/ml adult PME 
(red line) or vehicle control (black line) and different concentrations of FGF2. n=500-800 cells 
per condition conducted in triplicate. Data represented as mean ± s.e.m.; *P<0.05 student's t 
test. 
  





The data shown here support a model where FGF2 increases in the aged SC 
niche, the muscle fibre, which causes SCs to break quiescence and proliferate, 
leading to a loss of self-renewal function and eventual SC depletion (Figure 
33). Manipulating Spry1 levels, a negative feedback inhibitor of the FGF 
pathway, in SCs, altered the degree of cell cycle entry and stem cell loss 
(Figure 34). Therefore, a balance between excitatory and inhibitory signals is 
clearly essential to stem cell outcome. 
Remarkably, conditional over-expression of Spry1 in aged Pax7+ SCs was able 
to retain stem cell quiescence and prevent losses in SC number observed with 
age. These observations suggest that cell intrinsic mechanisms, at the level of 
feedback inhibition of niche-derived signalling, manipulated under conditions of 
homeostasis, can promote SC maintenance with age. Furthermore, 
administration of a chemical inhibitor of FGFR, SU5402, also attenuated the 
loss of SC number and inhibited apoptosis of SCs. These results suggest that it 
may be possible to prevent age-related sarcopenia in humans through the use 
of pharmacological inhibitors. 
I have shown that inhibition of FGF signalling is important for the maintenance 
of SC number and function in the aged niche. However, the expression of FGF2 
is also essential for efficient muscle regeneration [68, 100-102, 107, 108]. 
Inhibition of FGF signalling through blockade of FGFR has been shown to result 
in a large decrease in muscle mass and this has been attributed to premature 
terminal differentiation causing a depletion of the pool of myogenic progenitors 
[109-111]. This suggests that in order to maintain functional skeletal muscle, 
aged SCs would have to be unresponsive to FGF2 in the niche under 
homeostatic conditions, but then responsive to FGF2 under regenerative 
conditions. Thus, a temporal switch in sensitivity to FGF signalling would be 
needed to maintain SC number under homeostatic conditions, and regenerative 
capability after myotrauma. 
 




RSCs generated from Spry1flx myoblasts displayed an increased sensitivity to 
FGF2 from the aged niche (see Figure 24d). However, Spry1null myoblasts 
(myoblasts from Spry1flox/flox mice treated with Cre adenovirus) were unable to 
form RSCs (data not shown). These data further confirm previous findings that 
Spry1 is required for a subset of activated SCs to return to quiescence [42]. 
Interestingly, the number of reserve cells formed from Spry1OX myoblasts was 
no different to controls, and, furthermore, the differentiation index for Spry1OX 
myoblasts was also no different to controls (data not shown). These data 
suggest that just the presence of Spry1 is needed for the formation of quiescent 
RSCs and the level of Spry1 does not play a role in specifying which cells will 
return to quiescence. 
I have shown that the adult niche is inhibitory to FGF2-induced SC activation 
(see Figure 32a). Whether inhibitors of FGF signalling are present in the adult 
niche, or whether inhibitors of SC activation are present is unknown. The Ang1 / 
Tie2 signalling pathway is one of the main inhibitors of SC activation [138]. 
Ang1 / Tie2 signalling has been involved in various biological activities, 
including cell survival, proliferation, migration, chemotaxis, and quiescence 
[379, 380]. In skeletal muscle, Ang1 and Tie2 are expressed by quiescent SCs 
and their signalling acts to maintain SC quiescence [138]. However, it has not 
been shown if mature muscle fibres express Ang1 and, therefore, Ang1-Tie2 
signalling may not be the inhibitor of SC activation in adult PME. It is interesting 
to speculate that ageing is associated with an increase in FGF2 expression 
from the niche and a concomitant decrease in inhibitory signalling molecules. 
In this chapter I have identified inhibition of FGFR, either by overexpression of 
Spry1 or by pharmacological methods, as a novel mechanism to maintain the 
number and function of SCs in aged mammals (Figure 34). Collectively these 
data show that inhibition of FGF signalling under homeostatic conditions is 
essential for maintenance of the SC pool during ageing. 
  






Figure 33 - Schematic illustration of the changes in satellite cells with ageing under 
homeostatic conditions. Under homeostatic conditions SCs are quiescent (top panel). 
However, in aged mice, the SC niche upregulates FGF2 (bottom panel). This drives a loss of 
stem cell quiescence and depletion of the stem cell pool as SCs have a decreased tendency to 
self-renew, and an increased tendency to apoptose or differentiate. 
 










Figure 34 - Modulation of FGF signalling affects satellite cell outcome. Short-term loss of 
Spry1 in aged SCs (top panel) causes a further loss of SC quiescence and an increase in the 
number of Pax7+ cells. Long-term loss of Spry1 in aged SCs (middle panel) causes a further 
loss of SC quiescence and depletion of stem cell pool as cells are more prone to differentiate or 
apoptose. The effects of the aged niche can be partly inhibited by pharmacological inhibition of 
FGF signalling or through overexpression of Spry1 in SCs (bottom panel). Inhibition of FGF 
signalling in the aged niche maintains SC quiescence and causes an increase in SC number 
compared to WT and cells are less prone to apoptose. Modulation of Spry1 in adult SCs under 













5.1. Chromatin remodelling in adult neurogenesis 
Chromatin remodelling can engage or maintain particular genetic programs and 
therefore likely plays a critical role in stem cell maintenance as well as daughter 
cell differentiation [286]. Different cellular states may be defined at least in part 
by differential allocation of genomic regions to euchromatic or heterochromatic 
domains [381]. During development, an open chromatin state largely devoid of 
heterochromatin is a hallmark of stem cells, and this has been proposed to 
contribute to  the pluripotency of ES cells [382, 383]. As ES cells differentiate 
they accumulate more areas of heterochromatin [382, 383]. CHD1 is a 
chromatin remodelling enzyme that has recently been shown to be required for 
ES cell self-renewal and pluripotency by maintaining a euchromatic state [384]. 
Knockdown of Chd1 in ES cells caused  the accumulation of large areas of 
heterochromatin and an increased propensity of cells to differentiate [384], 
showing that chromatin remodelling is essential for pluripotency. 
Chromatin remodelling also plays a role in the maintenance and differentiation 
of somatic stem cell populations. For example, the chromatin remodelling 
enzyme CHD4 was shown to positively regulate HSC-specific transcriptional 
signatures, such as the expression of receptors important for HSC niche 
interaction, and negatively regulate genes involved with HSC differentiation, 
such as the cyclin-dependent kinase Ccnd2 [385]. Deletion of CHD4 in HSC 
populations caused the loss of HSC quiescence and skewed their differentiation 
potential to generate mainly erythroid cells [385]. These data show that 
chromatin remodelling is a process which can potentially modulate many areas 
of somatic stem cell function. 
The mRNA expression levels of many genes encoding chromatin remodelling 
proteins are changed as cells progress along the SVZ-OB adult neural lineage, 
from the SVZ to the RMS to the OB [287]. Furthermore, transcriptional profile 
analysis has revealed that the expression of genes encoding chromatin 
remodelling proteins are different between NSCs and non-neurogenic cells 




[287]. These data suggest that chromatin remodelling is an active process in 
adult neurogenesis. 
Chromatin remodelling proteins are generally categorised into one of two 
groups; trithorax group (TxG) proteins, which usually cause the activation of 
their target loci, and polycomb group (PcG) proteins which tend to repress gene 
activation [289]. Mixed lineage leukemia 1 (Mll1) is a TxG chromatin 
remodelling enzyme with H3K4 methyltransferase activity and is associated with 
epigenetic transcriptional activation. Lim et al showed that Mll1 is required in 
postnatal neurogenesis to suppress the accumulation of repressive H3K27me3 
at the locus of gene encoding the neuron-specific transcription factor Dlx2 in 
postnatal SVZ cells [316]. Loss of Mll1 resulted in the accumulation of 
H3K27me3 and repression of Dlx2, causing impaired neuroblast differentiation 
and migration [316]. Bmi1 is a PcG protein and a member of the PRC1 complex 
which positively regulates H2Aub1 [307]. Bmi1 has been shown to be required 
for embryonic and post-natal NSC self-renewal [288, 308, 309]. Bmi1 
overexpression increased the self-renewal of embryonic NSCs and maintained 
their ability to produce neurons in culture after many passages [312]. These 
data suggest that chromatin remodelling plays a critical role in embryonic and 
postnatal neurogenesis. However, the role of chromatin remodelling in adult 
neurogenesis is unknown. 
The chromatin remodelling enzyme CHD7 has been implicated in the regulation 
of embryonic brain development as Chd7-/- mice exhibit severe brain defects 
[344]. Chd7-/- mice die before E10.5 [344], but adult mice heterozygous for 
Chd7 (Chd7+/-) display a decreased brain size and decreased olfactory bulb 
(OB) length [345, 346]. In addition, studies by Layman et al. showed that 
Chd7+/- mice displayed a reduction in tyrosine hydroxylase (TH) expression in 
the OB (Figure 35) [345]. The authors showed that CHD7 was expressed by 
MASH1+ stem cells in the olfactory epithelium, and reduction in Chd7 
expression led to decreased proliferation of the epithelial stem cells [345]. This 
resulted in a decrease in the number of mature olfactory sensory neurons, 
which normally signal to dopaminergic interneurons [345]. Hence, a loss of 




signal to dopaminergic interneurons resulted in a decrease in TH-production 
(Figure 35) [345]. These data implicate CHD7 in regulation of stem cells in 
adults. However, due to the role of postnatal and adult SVZ-OB neurogenesis in 
formation of OB interneurons, misregulation of olfactory epithelial stem cells 
may not be the sole cause of the OB defects seen in these mice (Figure 36). 
The authors did not address the contribution of SVZ-OB neurogenesis to the 
formation of new OB interneurons in Chd7+/- mice and so the role of CHD7 in 
adult neurogenesis remains unknown (Figure 36). In support for CHD7 playing 
a role in adult neurogenesis, CHD7 has been shown to directly interact with 
Sox2, a protein important in the maintenance and differentiation of NSCs [386-
389]. 
I hypothesised that CHD7 plays a role in adult SVZ-OB neurogenesis and that 
loss of Chd7 results in impaired formation or differentiation of OB interneurons 
(Figure 36). 
The aims for this chapter are to: 
1. Characterise gross changes in brain sizes and analyse the changes in 
OB interneuron number in Chd7 heterozygous mice. 
2. Determine the expression profile of CHD7 in SVZ-OB neurogenesis. 
3. Determine changes in SVZ-OB neurogenesis by analysing the 
proliferation of cells in the SVZ and generation of immature neurons in 
Chd7 heterozygous mice. 
4. Establish whether CHD7 expression in adult NSCs is necessary for the 
production of OB interneurons by restoring Chd7 function specifically in 
NSCs to rescue OB defects. 










Figure 35 - Reduced expression of Chd7 leads to a decrease in tyrosine hydroxylase+ 
interneurons due to decreased olfactory epithelial stem cell proliferation. CHD7 is 
expressed in olfactory epithelial stem cells (OESC) in the olfactory epithelium (OE) [345]. 
OESCs form olfactory sensory neurons (OSN). OSNs signal to dopaminergic interneurons 
(green circles) in the glomerular layer (GL) of the olfactory bulb (OB) to maintain their activity 
and production of tyrosine hydroxylase (TH; top panel). Layman et al. proposed that a reduction 
in Chd7 expression led to the decreased proliferation of OESCs (bottom panel) [345]. This led 
to a decreased formation of OSNs and loss of signal to dopaminergic interneurons, resulting in 
either a decreased production of TH, or a loss of these interneurons (bottom panel) [345]. LV, 
lateral ventricle. 
  










Figure 36 - A reduction in Chd7 expression may cause a decrease in SVZ-OB 
neurogenesis leading to a loss of interneuron production. Neurogenic cells in the SVZ and 
rostral migratory stream (RMS; red dots) contribute to new interneuron formation in the olfactory 
bulb (OB), including the formation of tyrosine hydroxylase+ dopaminergic interneurons (green 
dots; top panel). Reduced SVZ-OB neurogenesis can lead to a decrease in the production of 
OB interneurons (bottom panel). 
 
5.2. Chd7 heterozygous mice display reduced olfactory bulb 
length and reduced number of tyrosine hydroxylase+ 
interneurons 
Loss of Chd7 function is embryonic lethal and is associated with defects in 
many developing tissues [344]. Therefore, to determine if there were any gross 
changes in adult forebrain size, mice heterozygous for a genetrap Chd7 allele 
were utilised (Figure 37a; Chd7gt/+) [356]. The genetrap allele contains a beta-
geo fusion cassette with a floxed splice acceptor inserted into intron 36 of Chd7, 
presumably resulting in the translation of an unstable, truncated, non-functional 
protein which is rapidly degraded (Figure 37a) [356]. Mutations in CHD7 have 
been implicated in the development of CHARGE syndrome [330]. Mice carrying 
the Chd7gt allele have been previously shown to display phenotypes associated 
with Chd7 haploinsufficiency such as abnormalities in pharyngeal arch arteries 
and other phenotypes associated with CHARGE syndrome [356]. Therefore, the 
Chd7gt/+ mouse line is presumed to have a reduced Chd7 expression in all 
tissues. Furthermore, RT-qPCR analysis of dissected OB showed that Chd7 
expression is significantly reduced in adult (10-12 weeks old) Chd7gt/+  mice 
compared to WT (Figure 37b). Hence, adult Chd7gt/+ mice will be described as 
having a decrease in Chd7 expression. Adult Chd7gt/+ mice display a very slight 
reduction in forebrain size (data not shown), but most notably display a 20% 
reduction in OB length (Figure 37c,d), with no change in OB width compared to 
WT littermates (data not shown). These data are in agreement with previous 
findings [345]. 




To determine if the reduction in OB length was progressive from postnatal 
stages to adulthood, the brain sizes of P21 Chd7gt/+ mice and WT littermates 
were analysed. A slight reduction in OB length could be seen in P21 Chd7gt/+ 
mice compared to WT (Figure 37e), suggesting that the reduction in OB length 
is progressive with age. Importantly, the overall brain size of Chd7gt/+ mice at 
P21 was not significantly different to WT littermates (Figure 37f), arguing 
against a decrease in Chd7 expression causing a general developmental delay. 
Collectively, these data show that a reduction in Chd7 expression mostly affects 
the OB size, and a decrease in the length of the OB is reduced from postnatal 
stages through to adulthood. 
The olfactory bulb is composed of three main types of interneurons: TH+ 
(dopaminergic), CalR+ (GABAergic), and CalB+ (GABAergic) interneurons [223]. 
Cells born in the adult SVZ are capable of differentiating into one of these three 
types of interneuron in the OB [223]. The integration of these interneurons 
presumably contributes to proper OB formation, and the size of the OB is 
normally maintained throughout life through the turnover of OB interneurons 
[210]. To determine if a reduction in OB size was due to a reduction in the 
production of TH+, CalR+, or CalB+ interneurons, sections of OB from Chd7gt/+ 
and wildtype littermates (WT) were stained with antibodies raised against TH, 
CalR, and CalB (Figure 38a,c,d). The OB of Chd7gt/+ mice displayed a 
reduction in the number of cells expressing TH in the glomerular layer 
compared to WT (Figure 38a,b), in agreement with findings by Layman et al. 
[345]. Interestingly, reduction in Chd7 expression had no effect on the 
expression of CalR (Figure 38c,d) and CalB (Figure 38e,f) in the glomerular 
layer. These data show that CHD7 specifically regulates TH-producing 
interneurons, leaving other OB interneuron populations unaffected. 
To confirm that the production of cells in the TH-lineage is impaired, I performed 
an in situ hybridisation using an anti-sense Er81 probe on OB sections of adult 
Chd7gt/+ and WT mice. Er81 is a transcription factor that is required for TH-
expression in the mouse OB and is used as an early marker of TH-lineage cells 
[390, 391]. Expression of Er81 was decreased in the RMS and in areas of the 




OB of Chd7gt/+ mice compared to WT, including in the glomerular layer where 
TH+ interneurons are found (Figure 39a). Furthermore, RT-qPCR analysis of 
dissected OB from Chd7gt/+ and WT mice confirmed that Er81 expression was 
reduced by 33% in Chd7gt/+ mice (Figure 39a). These data show that a 
reduction in Chd7 expression results in a decrease in the formation of cells of 
the TH+ interneuron lineage. 
Alternatively, a decrease in Er81 expression may lead to a decrease in TH 
expression from interneurons in the OB, rather than a loss of the interneurons 
themselves and this will be discussed in Section 5.6.2.  
 
  










Figure 37 - Reduction in Chd7 expression causes a decrease in olfactory bulb length. a, 
Schematic diagram of the Chd7xk403 allele. The genetrap construct contains a beta-geo cassette 
with a floxed (not shown) splice acceptor (SA). The Chd7xk403 line has a genetrap insertion site 
between exons 36 and 37, and produces a protein containing all exons, except 37 and 38, 
fused to the gene trap cassette. Adapted from [356]. b, RT-qPCR expression level of Chd7 from 
dissected OB of adult Chd7gt/+  relative to wild type (WT) mice. n=2 animals / condition. Data are 
from 2 reactions conducted in duplicate. Note that Chd7 expression is around 50% of WT levels 
in Chd7gt/+  OB. c, Representative image of brains from adult Chd7gt/+ and control mice (WT). 
Scale bar, 1mm. d, Quantification of OB lengths from adult Chd7gt/+ and WT mice. Each mark 
represents the length of 1 OB. n=6-8 animals / condition. e, Quantification of the OB length and 
forebrain length (f) of P21 Chd7gt/+ and WT mice. Each mark represents the length of 1 OB or 
forebrain hemisphere. n=8-11 animals / condition. All data represented as mean ± s.e.m.; 
*P<0.05 student's t test. 
 










Figure 38 - Reduction in Chd7 expression specifically affects tyrosine hydroxylase+ 
olfactory bulb interneurons. a, Representative image of a 10µm thick coronal section of OB 
glomerular layer stained with antibodies raised against TH, CalR (c), and CalB (d). Scale bar, 
50µm. b, Quantification of the number of TH+, CalR+ (d), and CalB+ (f) cells / defined area in 
Chd7gt/+ and WT mice per 10µm section. n=3-4 animals / condition. All data represented as 
mean ± s.e.m.; ***P<0.001 student's t test. 
  






Figure 39 - Reduction in Chd7 expression results in a decrease in TH-lineage cells. a, 
Representative image of an in situ hybridisation using an anti-sense Er81 probe on OB sections 
of Chd7gt/+ and WT mice. Note a decrease in Er81 expression in Chd7gt/+ OB compared to WT. 
Scale bar, 1mm b, Quantification of Er81 expression from RT-qPCR experiments in Chd7gt/+ 
relative to WT OB. Data are from 3 reactions conducted in duplicate. Data represented as mean 
± s.e.m.; **P<0.01 student's t test. 
  




5.3. CHD7 is expressed in the dorso-lateral aspect of the 
subventricular zone and in the rostral migratory stream 
SVZ-OB neurogenesis is critical for the formation of new OB interneurons 
throughout life [183]. It is estimated that the number of newly formed 
interneurons that are added to the OB from cells born in the SVZ ranges from 
10,000 to 30,000 per day in adult mice [208]. Adult NSCs residing in different 
areas of the SVZ give rise to different types of periglomerular and glomerular 
OB interneurons [223]. Of note, cells in the dorso-lateral aspect of the SVZ and 
RMS have a greater tendency to form tyrosine hydroxylase-positive 
interneurons in the glomerular layer of the OB (see Figure 11) [207]. My data 
so far shows that a reduction in Chd7 expression is associated with a specific 
decrease in the number of TH-expressing cells in the OB (see Section 5.2.). 
Therefore, I hypothesised that a reduction in Chd7 expression results in a loss 
of TH-producing interneurons in the OB due to abnormalities in SVZ-OB 
neurogenesis. To first determine if Chd7 was expressed in cells in the SVZ 
neurogenic lineage, an in situ hybridisation using an anti-sense Chd7 probe was 
performed on coronal sections of adult WT (CD1 mouse strain) brains. Chd7 
was expressed in the dorso-lateral aspect of the SVZ and in the RMS (Figure 
40a), which is the area of the SVZ associated with the production of TH+ OB 
interneurons (see Figure 11) and this was confirmed by antibody staining 
(Figure 40b). In situ hybridisation using an anti-sense Chd7 probe on coronal 
sections of the RMS and OB showed that Chd7 was expressed in the RMS and 
glomerular layer of the OB, as well as in the granular cell layer to a lesser extent 
(Figure 40c,d). This was confirmed by staining sagittal sections of WT adult 
brains with an anti-CHD7 antibody (Figure 40e). These data show that CHD7 is 
expressed in the area of the SVZ associated with production of TH+ OB 
interneurons, as well as in the RMS and glomerular layer of the OB. 
 









Figure 40 - CHD7 is expressed in the subventricular zone, rostral migratory stream, and 
olfactory bulb. a, Diagram of an in situ hybridisation using an anti-sense Chd7 probe (blue) in 
the SVZ from a'. a' In situ hybridisation using an anti-sense Chd7 probe (blue) in the SVZ. The 
boxed area is enlarged in a''. Scale bars, 100µm. b, Coronal adult SVZ section stained with an 
anti-CHD7 antibody and Dapi. The boxed area is enlarged in b'. Scale bars, 50µm c, In situ 
hybridisation using an anti-sense Chd7 probe (blue) in a coronal section of the RMS and OB 
(d). Scale bars, 1mm. e, Diagram of a sagittal adult mouse brain showing the SVZ, RMS, and 
OB (adapted from http://neurochirurgie.charite.de/forschung/arbeitsgruppen/ag_endogene_ 
neuronale_stammzellen/). Green areas represent where neurogenic cells can be detected. The 
boxed area depicts the area shown in f. f, Sagittal adult RMS and OB section stained with an 
anti-CHD7 antibody and Dapi. Scale bars, 100µm GCL, granule cell layer; GL, glomerular cell 
layer. 
  




5.3.1. CHD7 is expressed at high levels in transit-amplifying cells in 
the subventricular zone 
My data so far demonstrate that CHD7 is expressed in the SVZ-OB neurogenic 
niche (see Section 5.3.). To determine which cell types in the SVZ express 
CHD7, a series of co-localisation experiments were performed by staining SVZ 
sections with antibodies raised against CHD7 and various markers of cells in 
the neurogenic lineage (see Figure 7). Around 10% of GFAP+ NSCs and 
astrocytes expressed CHD7 (Figure 41a,b), suggesting that CHD7 may be 
expressed in a subset of NSCs. However, GFAP+ astrocytes were not the 
primary cell type that expressed CHD7 (Figure 41a,c). Sox2 is expressed by 
NSCs and type C cells (see Figure 7). CHD7 was expressed in nearly 40% of 
Sox2+ cells (Figure 41d,e), and the majority of CHD7+ cells were Sox2+ (Figure 
41d,f). Type C cells proliferate rapidly and the majority of type C cells express 
markers of cell cycle entry such as Ki67 and PCNA. CHD7 was expressed by 
the majority of proliferating (Ki67+) cells (Figure 41g,h) and most cells that 
expressed CHD7 were proliferating (Figure 41g,i). MASH1 also marks 
activated NSCs and type C cells. CHD7 was expressed by almost all MASH1+ 
cells (Figure 41j,k), and many CHD7+ cells expressed MASH1 (Figure 41j,l). 
CHD7 was expressed in many type A cells, as shown by its expression in the 
RMS where type A cells migrate to the OB (see Figure 40e), but this was at a 
much lower level than other cells in the SVZ. CHD7 was not expressed at high 
levels by PSA-NCAM+ neuroblasts (Figure 41m,n), and few highly-expressing 
CHD7+ cells also expressed PSA-NCAM (Figure 41m,o). These data show that 
CHD7 is expressed mainly in proliferating type C cells in the SVZ, and CHD7 
expression is downregulated as cells proceed through the neurogenic lineage 
(Figure 42). 










Figure 41 - CHD7 is expressed by proliferating cells and type C cells. a, Representative 
image of SVZ sections stained with antibodies raised against CHD7 and GFAP, Sox2 (d), Ki67 
(g), MASH1 (j), and PSA-NCAM (m). The yellow arrow head shows a GFAP+CHD7+ cell. Scale 
bars, 20µm. b, Quantification of the percentage of GFAP+, Sox2+ (e), Ki67+ (h), MASH1+ (k), 
and PSA-NCAM+ (n) cells that also express CHD7. c, Quantification of the percentage of 
CHD7+ cells that also express GFAP, Sox2 (f), Ki67 (h), MASH1 (l), and PSA-NCAM (o). n = 
100-150 cells analysed by confocal microscope. All data represented as mean ± s.e.m. 
  





Figure 42 - Schematic of CHD7 expression in the SVZ. CHD7 is expressed mostly in type C 
cells and is expressed at much lower levels in type A cells. CHD7 is also expressed at low 
levels in interneurons in the glomerular cell layer of the OB (not shown). 
  




5.4. Reduction in Chd7 expression results in a decrease in 
immature neuron production in the subventricular zone 
My data so far suggests that a reduction in Chd7 expression causes a decrease 
in the number of TH+ OB interneurons (see Section 5.2.). CHD7 is expressed 
by transit amplifying cells in the area of SVZ associated with TH-interneuron 
production (see Section 5.3.), and therefore likely plays a role in fate decisions 
and the differentiation of SVZ cells. I therefore hypothesised that CHD7 
regulates the generation of new neurons in SVZ-OB neurogenesis. To 
determine if a reduction in Chd7 expression affects the generation of immature 
interneurons, sections of the SVZ of WT and Chd7gt/+  mice were stained with 
antibodies raised against DCX, a marker of immature neurons (type A cells; 
Figure 43a). Chd7gt/+ mice had fewer DCX+ cells specifically in the area of the 
lateral ventricle where CHD7 is expressed (Figure 43b-d). These data suggest 
that cells with reduced Chd7 expression may have an impaired differentiation 
capability. Alternatively, there may be a defect in progenitor proliferation 
causing impaired formation of new immature neurons, or there may be an 
increase in the apoptosis of type A cells. To determine if the proliferation of SVZ 
cells was affected by a decrease in Chd7 expression, sections of the SVZ of 
WT and Chd7gt/+  mice were stained with antibodies raised against PCNA to 
label proliferating cells, the majority of which are type C transit amplifying cells 
[183]. Interestingly, SVZ proliferation was increased in the lateral wall and RMS 
(Figure 43e-g). These data show that proliferation in the SVZ is not impaired 
and suggests that a decrease in immature neuron formation may instead be 
due to impaired differentiation. That the number of proliferating cells in the SVZ 
increases suggests that there is a block in differentiation which causes an 
accumulation of proliferating type C cells. To determine if a reduction in Chd7 
expression leads to changes in apoptosis, an activated caspase 3 stain will 
need to be performed (see Section 6.11.6.). Collectively, these data reveal a 
role for CHD7 in SVZ-OB neurogenesis, with Chd7gt/+ mice exhibiting a 
decrease in the generation of type A cells possibly due to a block in 




differentiation which results in a decrease in the production of TH+ interneurons 
in the OB. 
  





Figure 43 - Reduction in Chd7 expression affects SVZ neurogenesis. a, Representative 
image of the lateral wall of the SVZ of Chd7gt/+ and WT mice stained with antibodies raised 
against PCNA and DCX. Scale bar, 20µm. b, Quantification of the number of DCX+ cells in the 
lateral wall of the lateral ventricle and RMS, and in the medial wall (c), and dorsal wall (d) of the 
lateral ventricle of Chd7gt/+ and WT mice per 10µm section. Note, there is no change in the 
number of DCX+ cells in the medial and dorsal walls of the lateral ventricle as CHD7 is not 
expressed there. n=3 animals / condition. e, Quantification of the number of PCNA+ cells in the 
lateral wall of the lateral ventricle and RMS, and in the medial wall (f), and dorsal wall (g) of the 
lateral ventricle of Chd7gt/+ and WT mice per 10µm section. n=3 animals / condition. All data 
represented as mean ± s.e.m.; *P<0.05 **P<0.01 student's t test. 




5.4.1. Loss of Chd7 in NSCs blocks their differentiation 
Chd7gt/+ mice have reduced Chd7 expression in all cell types, including in 
olfactory epithelial stem cells (OESCs), and so the phenotypes seen may be 
due to effects on cells other than those in the SVZ neural lineage. Therefore, to 
exclude the possibility that the reduction in the number of TH-expressing 
interneurons is due to effects on OESCs, I sought to delete Chd7 specifically 
from adult NSCs using a GLAST::CreERT2 mouse line [253]. GLAST is 
expressed by NSCs and astrocytes and so upon tamoxifen injection Cre-
mediated recombination should only take place in NSCs [253]. To first 
determine its efficiency in the SVZ, the GLAST::CreERT2 line was crossed to a 
RYFP reporter line to generate GLAST::CreERT2;RYFP/+ mice. Adult 
GLAST::CreERT2;RYFP/+ mice were given 5 injections of tamoxifen to induce 
recombination and expression of YFP and sacrificed 5 days after the last 
tamoxifen injection (Figure 44a). Sections of the SVZ were stained with 
antibodies raised against GFP along with GFAP to label NSCs (Figure 44c). 
YFP could be detected in around 75% of GFAP+ cells (Figure 44b), however, 
this is likely to be an underestimation due to the difficulty in seeing individual 
GFAP+ cells in these sections. YFP+GFAP- cells were also present in the SVZ 
which are presumably type C daughter cells (Figure 44c). Therefore, my 
tamoxifen injection regime in GLAST::CreERT2 mice results in efficient 
recombination in SVZ cells. 
To delete Chd7 specifically from adult NSCs, GLAST::CreERT2 mice were 
crossed with a mouse line where exon 3 of Chd7 is floxed (Chd7f/f) [EUCOMM 
ID: 35714] to generate a GLAST::CreERT2;Chd7f/f mouse line (Figure 45a). 
Tamoxifen injection causes Cre-mediated recombination and formation of a 
truncated, non-functional CHD7 protein specifically in NSCs and astrocytes 
(Chd7null; see Section 6.3.). Chd7null and Cre-negative control mice (WT) 
were treated with tamoxifen and sacrificed 11 weeks later (Figure 45b). BrdU 
was administered in the drinking water of mice in the last 3 weeks of life to label 
all newly generated cells (Figure 45b). The number of BrdU+ cells was reduced 
in the SVZ and RMS of Chd7null mice compared to WT, suggesting that loss of 




Chd7 from NSCs results in a decrease in the number of new cells formed 
(Figure 45c,d). These data are consistent with decrease in SVZ neurogenesis 
in Chd7gt/+ mice.  





Figure 44 - Efficient recombination in the GLAST::CreERT2 mouse line. a, Schematic of 
the experimental strategy to induce recombination and YFP expression in SVZ NSCs. Adult 
GLAST::CreERT2;RYFP mice were given one injection of 80mg/kg tamoxifen a day for 5 days 
and sacrificed 5 days after the last tamoxifen injection. b, Quantification of the percentage of 
GFAP+ cells that were also GFP+. At least 60 GFAP+ cells were counted. n=2 animals. Data 
represented as mean ± s.e.m. c, Representative image of a sagittal section of the lateral 
ventricle (LV) of GLAST::CreERT2;RYFP mice treated as in a stained with antibodies raised 
against GFP and GFAP. Note the large overlap between GFAP and GFP in the SVZ and RMS. 
The boxed area is enlarged in the merge and shows a GFP+GFAP+ cell. Lat SVZ, lateral wall of 
the SVZ. Scale bar, 100µm. n=2 animals.  









Figure 45 - Loss of Chd7 in neural stem cells affects subventricular zone neurogenesis. 
a, Schematic of the Chd7 flox allele (EUCOMM ID: 35714). The selection cassette was removed 
by crossing with Flp deleter mice. Exon 3 is flanked by loxP sites to allow for conditional 
inactivation and the formation of a truncated, non-functional protein after Cre-mediated 
recombination. b, Schematic of the experimental strategy to delete Chd7 from adult NSCs and 
label newly born cells by administering BrdU in the drinking water of mice. c, Representative 
image of a section of the SVZ and RMS of GLAST::CreERT2;Chd7f/f mice treated with tamoxifen 
(Chd7null) and Cre-negative controls (WT) stained with antibodies raised against BrdU. Scale 
bar, 50µm. d, Quantification of the number of BrdU+ cells in the lateral wall and RMS of WT and 
Chd7null mice per 20µm section. n=2 animals / condition. Data represented as mean ± s.e.m.; 
*P<0.05 student's t test. 
  




5.5. Restoration of Chd7 function partially rescues the 
expression of tyrosine hydroxylase in the olfactory bulb 
The data shown so far suggests that the reduction in TH expression in the OB 
likely reflects changes in SVZ-OB neurogenesis. I hypothesised that restoration 
of Chd7 specifically in NSCs and their progeny could restore the number of TH-
producing cells in the SVZ. To test this, Chd7gt/+ mice (which have 50% reduced 
Chd7 expression (see Figure 37b)) were crossed to GLAST::CreERT2 mice to 
generate a GLAST::CreERT2;Chd7gt/+ mouse line. Injection of tamoxifen results 
in restoration of Chd7 function specifically in NSCs and their progeny 
(GLAST::CreERT2;Chd7+/+ ; Rescue; Figure 46a,b), however, I did not have 
the mice to confirm by RT-qPCR to what extent the expression of Chd7 is 
restored. GLAST::CreERT2 mice were used as controls (WT) (Figure 46b). 
Restoration of Chd7 function in NSCs partially rescued the number of TH+ 
interneurons compared to GLAST::CreERT2;Chd7gt/+ mice (Figure 46c,d). 
Collectively, these data show that CHD7 regulates TH+ interneuron production, 
and restoration of Chd7 function specifically in NSCs can partly rescue the 
deficit of TH+ interneurons in the OB of Chd7gt/+ mice. Alternative explanations 
are possible and these will be discussed in Section 5.6.2. 









Figure 46 - Restoration of Chd7 function in neural stem cells partly rescues tyrosine 
hydroxylase production in the olfactory bulb. a, Schematic of the Chd7xk403 allele before (top 
panel) and after (bottom panel) recombination. Cre-mediated recombination results in deletion 
of the splice acceptor (SA) site (green triangles flanking the SA) and loss of β-galactosidase 
activity, thereby allowing for the production of functional and stable CHD7 protein. Adapted from 
[356]. b, Schematic diagram of the strategy to assess the effect of restoration of Chd7 function 
on OB neurogenesis. Three cohorts of adult mice were used:1. GLAST::CreERT2 mice were 
used as controls (WT) and taken at 5 months of age (top panel); 2. GLAST::CreERT2;Chd7gt/+ 
mice (Chd7gt/+) taken at 5 months of age (middle panel); 3. GLAST::CreERT2;Chd7gt/+ mice 
treated with tamoxifen at 2 months of age and sacrificed 3 months later (Rescue). c, 
Representative picture of OB glomerular sections stained with antibodies raised against TH 
(green), and Dapi (blue). Scale bar, 100µm. d, Quantification of the number of TH+ interneurons 
per area of WT, Chd7gt/+ and Rescue mice per 10µm section. n=3 animals / condition. Data 
represented as mean ± s.e.m.; *P<0.05 ***P<0.001 student's t test. 
  





I sought to investigate the role of the chromatin remodelling enzyme CHD7 in 
adult neurogenesis. The data presented here depict a specific role for CHD7 in 
the regulation of the production of TH+ interneurons from SVZ cells (Figure 47). 
These data show that CHD7 is expressed mainly by type C cells in the dorso-
lateral aspect of the SVZ and in the RMS, the area associated with production 
of TH+ OB interneurons [207]. Reduction in Chd7 expression results in a 
decrease in OB length whilst having very little effect on the size of other areas 
of the brain. My data suggests that Chd7 is required for the formation of 
immature neurons of the TH-lineage (Figure 47). I have shown that loss of 
Chd7 specifically in NSCs results in a loss of the formation of new cells in the 
SVZ and restoration of Chd7 function specifically in adult NSCs results in an 
increase in TH+ interneurons in the OB compared to Chd7gt/+ mice. These 
results show that Chd7 does indeed regulate adult neurogenesis. 





Figure 47 - Reduction in Chd7 expression affects subventricular zone neurogenesis. 
Under homeostatic conditions, SVZ neurogenesis is required for the formation of new OB 
interneurons (top panel). However, a reduction in Chd7 expression results in a loss of TH+ 
interneurons and a decrease in the number of immature neurons (type A cells) (bottom panel). 
Additionally, a reduction in Chd7 expression also leads to an increase in the number of 
proliferating cells in the SVZ, possibly due to a block in differentiation (red block).  




5.6.1. The reduction in olfactory bulb size and number of tyrosine 
hydroxylase+ interneurons may be progressive with age 
The OB length is around 10% shorter in P21 Chd7gt/+ mice compared to WT 
littermates (see Figure 37e). That the forebrain length of P21 Chd7gt/+ mice is 
not significantly shorter (see Figure 37f) argues that this is not due to a 
developmental delay, but instead reflects a specific effect of a reduction of Chd7 
expression on the formation of the OB. By adulthood the OB of Chd7gt/+ mice is 
33% shorter than controls, suggesting that the decline in OB size is progressive 
with age (see Figure 37d). SVZ-OB neurogenesis is presumably required for 
maintenance of OB structure and size since the OB interneuron population is 
constantly turned over [210-212]. Furthermore, the decline in number of 
interneurons producing TH also appears to decline with age in Chd7gt/+ mice 
compared with controls (compare the number of TH+ interneurons in Chd7gt/+ 
mice in Figure 38b with Figure 46d). These data imply that a reduction in Chd7 
expression leads to a decline in the formation of TH+ interneurons that is 
progressive with age and further indicate that a reduction in Chd7 leads to 
impaired SVZ-OB neurogenesis. 
I have shown that restoration of Chd7 function, specifically in NSCs, results in a 
significant increase in TH-expressing interneurons in just 3 months compared to 
Chd7gt/+ mice. If the reduction in TH+ interneurons is progressive with age in 
Chd7gt/+ mice, then the restoration of Chd7 function may reinstate a normal level 
of OB neurogenesis and maintain the production of TH+ interneurons, whereas 
the number of TH+ interneurons would continue to decline in Chd7gt/+ mice. A 
fourth cohort of Chd7gt/+ mice taken at 2 months of age, at the very start of the 
experiments, would be needed to test this. 
 
 




5.6.2. A reduction in Chd7 expression may result in a loss of cells of 
the tyrosine hydroxylase lineage, or a loss of tyrosine hydroxylase 
production 
I have shown that Chd7gt/+ mice display a reduction in Er81 expression, which is 
an early marker for cells of the TH-lineage [390, 391]. However, Er81 is also 
required for the expression of TH in cells [390, 391]. Hence, an alternative 
explanation for the loss of TH-producing cells in Chd7gt/+ mice could be that a 
reduction in Chd7 expression results in decreased expression of TH from cells 
rather than a decrease in the formation of TH-expressing cells (Figure 48). 
These points can be addressed by staining OB sections of Chd7gt/+ and WT 
mice with markers to specifically label cells that would produce TH (such as 
dopamine decarboxylase (DDC), an enzyme involved in the production of TH). 
This would reveal if the TH-expressing interneurons are still present in Chd7gt/+ 
mice, but just not producing TH. However, preliminary experiments performed 
using DDC antibodies have shown them to be very non-specific and they do not 
overlap with TH expression. Therefore, other antibodies such as dopamine 
transporter (DAT) [392], will be required to distinguish between a reduction in 
TH-expression or a reduction in interneurons. 
A reduction in Chd7 expression causing a decreased expression of TH from 
cells (Figure 48), may also mean that restoration of Chd7 function in NSCs 
results in a significant increase in TH-expressing interneurons due to restoration 
of Chd7 function reinitiating the signalling programs required for the production 
of TH, such as expression of Er81. To determine if the reduction in TH+ 
interneurons in Chd7gt/+ mice was due to a reduction in neurogenesis, the 
number of type A cells would need to be counted in Rescue mice. If restoration 
of Chd7 results in an increase in the number of type A cells compared to 
Chd7gt/+ mice it would suggest that CHD7 regulates the formation of TH+ 
interneurons. To fully conclude this, labelling newly born cells in Rescue mice 
through BrdU pulse-chase experiment would allow for the analysis of the 
number of newborn neurons that have integrated into the OB [228]. If CHD7 
regulates the formation of TH+ interneurons, an increase in the number of BrdU+ 




cells would be seen in the OB in Rescue mice. Additionally, using a marker to 
specifically label cells that would produce TH would reveal if the TH-expressing 
interneurons are still present in Chd7gt/+ mice, but just not producing TH. To fully 
appreciate the role of CHD7 in dopaminergic OB neuron production, lineage 
tracing using a GLAST::CreERT2;Chd7f/+;RYFP/+ would need to be performed. 
This would allow for the analysis of the contribution of cells with reduced Chd7 
expression to OB neurogenesis, and so the number of newly formed TH+ OB 
interneurons can be calculated. 
To fully determine if the reduction in Er81 expression seen in Chd7gt/+ mice is 
due to a decrease in its expression in immature neurons, the transcription of 
Er81 would need to be determined in isolated type A cells. 





Figure 48 - Regulation of Er81 expression by CHD7. CHD7 may bind to Er81 promoter 
elements or distal enhancers to induce Er81 expression in cells of the SVZ-OB neurogenic 
lineage. Er81 then directly induces the expression of tyrosine hydroxylase in dopaminergic OB 
cells (top panel). In Chd7gt/+ mice, a reduction in Chd7 expression may limit the expression of 
Er81, thereby causing a reduction in the expression of tyrosine hydroxylase from OB cells 
without affecting the production of cells (bottom panel).  




5.6.3. CHD7 regulates subventricular zone - olfactory bulb 
neurogenesis 
Studies by Layman et al. showed that CHD7 was expressed by MASH1+ stem 
cells in the olfactory epithelium [345]. The data presented here show that CHD7 
is expressed in MASH1+ cells in the SVZ. It is interesting to speculate that 
CHD7 has a conserved role in MASH1+ cells to drive the neurogenic program. 
The authors also found that reduction in Chd7 expression led to decreased 
proliferation of the epithelial stem cells [345]. Whilst I have not calculated the 
proliferation specifically of NSCs in the SVZ, my data indicate that proliferation 
in the SVZ is generally increased, perhaps suggesting differences in the role of 
Chd7 in different stem cell populations. Layman et al. attributed a decline in TH 
expression in the OB of Chd7gt/+ mice to a decrease in the proliferation of 
olfactory epithelial stem cells and a loss of signalling to dopaminergic 
interneurons (see Figure 35) [345]. Restoration of Chd7 function specifically in 
NSCs and astrocytes, partially rescued the deficiency in TH in the OB, and 
argues against a decrease in olfactory epithelial stem cell proliferation being the 
sole reason for a loss of TH in the OB. An alternative explanation to these 
findings is that CHD7 may affect GLAST+ mature astrocyte function, which may, 
in turn, regulate stem cells and their progeny in the olfactory epithelium. 
However, in preliminary studies using a GLAST::CreERT2;RYFP mouse line, I 
could not detect YFP expression in the olfactory epithelium 3 months after 
tamoxifen-induced recombination (data not shown). These data suggest that 
this Cre is not active in the olfactory epithelium, and therefore restoration of 
Chd7 in GLAST+ cells does not directly affect the olfactory epithelium. 
Furthermore, the finding that very few GFAP-expressing cells also express 









5.6.4. Loss of Chd7 results in a large reduction in olfactory bulb 
neurogenesis 
Recently, CHD7 was shown to play a role in adult SVZ-OB neurogenesis in 
mice. Feng et al. observed that CHD7 was expressed in few GFAP+ cells and 
also in the majority of proliferating cells as well as in neuroblast cells [386], 
which is in agreement with my data. The authors utilised NestinCreERt2;Chd7f/f 
and Tlx-CreERt2;Chd7f/f mouse lines to specifically delete Chd7 from adult 
NSCs and progenitors [386]. Feng et al. saw that 8 weeks after tamoxifen 
injection, the OB of Tlx-CreERt2;Chd7f/f mice had a reduction in the number of 
TH+, CalR+, and CalB+ interneurons [386]. I have shown that a reduction in 
Chd7 expression leads to a decrease in the number of TH+ OB interneurons 
without affecting other types of interneurons (see Figure 38). These data 
suggest that the effect of CHD7 on adult neurogenesis may be dependent on 
the level of Chd7. I have shown that the transcript of Chd7 is reduced by 50% in 
Chd7gt/+ mice (see Figure 37b), whilst Feng et al. observed a complete 
absence of CHD7 protein in the SVZ of Tlx-CreERt2;Chd7f/f mice that had been 
injected with tamoxifen [386]. Therefore, a reduction in Chd7 levels to 50% of 
WT levels may preferentially affect TH+ interneuron production, whereas 
ablation of Chd7 may affect all types of OB interneuron production. These data 
suggest that cells of the TH-lineage may be more sensitive to the Chd7 gene 
dosage. I have shown that loss of Chd7 from adult NSCs using a 
GLAST::CreERT2;Chd7f/f mouse line leads to a reduction in the formation of 
newly formed cells (see Figure 45d), in agreement with Feng et al. [386], and 
so further analysis of neurogenesis in this mouse line will allow for greater 
comparisons to be made. 
 
5.6.5. CHD7 in adult subventricular zone neurogenesis 
Collectively, these data show that CHD7 plays a role in the neurogenic 
progression of SVZ cells, specifically affecting production of TH-expressing OB 
interneurons. In order to determine the full role of CHD7 in adult neurogenesis, I 




sought to analyse the effect of loss of Chd7 in hippocampal neurogenesis. This 
will allow for similarities and differences to be drawn between the role of CHD7 
in the regulation of different NSC populations which serve different brain 














6.1.  Quiescence of a somatic stem cell population is essential 
for maintenance of the stem cell pool 
Quiescence is a property of somatic stem cell populations that is essential for 
the maintenance of stem cell number and function. In support of this, I have 
previously shown that loss of muscle stem cell quiescence can lead to a loss of 
stem cell number and function (see Chapter 4). In the SVZ and SGZ 
neurogenic niches NSCs are in a relatively quiescent state, which has been 
shown to be essential to prevent proliferative exhaustion and premature 
differentiation of the stem cell pool [201, 253]. 
 
6.1.1. Maintenance of neural stem cell quiescence 
Notch signalling is a critical regulator of NSC quiescence. For example, NSCs 
express Notch receptor, and signalling from Notch ligand-expressing 
progenitors in the niche is crucial for preserving NSC quiescence and 
preventing their proliferative exhaustion [252, 253, 256, 260]. Deletion of Rbpj, 
the transcriptional activator of Notch signalling, specifically from adult NSCs 
results in the loss of NSC quiescence, a transient increase in neurogenesis, 
followed by an eventual loss of the NSC pool and a decline in neurogenesis 
[252, 256]. This was shown to be due to premature conversion of NSCs to 
transit-amplifying progeny, showing that a loss of quiescence coupled with 
differentiating (non-self-renewing) divisions can lead to depletion of the stem 
cell pool [252, 256]. These data are in contrast to what is seen in p21 mutant 
mice. p21-/-  mice display an increase in NSC proliferation and initially exhibit an 
increase in NSC number, suggesting that a loss of NSC quiescence can also 
lead to an increase in the NSC pool if coupled with self-renewing divisions. In 
middle-aged p21-/-  mice however, NSCs also undergo proliferative exhaustion 
and neurogenesis declines [393]. Collectively, these data indicate that the 
maintenance of NSC quiescence and regulation of NSC fate decisions is critical 
for the maintenance of adult neurogenesis. 




6.1.2. Neural stem cell proliferation and ageing 
Low-level proliferation of hippocampal NSCs and the generation of new granule 
neurons is vital for specific types of hippocampal function [224-227]. 
Proliferative exhaustion of stem cells has been suggested to be the primary 
cause of ageing [18, 394]. Ageing is associated with reduced NSC proliferation 
and a decrease in newly generated neurons [187, 395-397], leading to cognitive 
decline [17, 398, 399]. Whether there is a decrease in the numbers of NSCs 
with age is largely disputed, with some studies reporting a strong reduction in 
cell numbers in the ageing hippocampus of rodents [400-402], and others 
reporting a change in their proliferative state, but not in their absolute numbers 
[253, 403]. The cell cycle entry and associated depletion of NSCs has been 
contested in two recent models. Encinas et al. proposed a 'disposable stem cell 
model' where quiescent NSCs enter the cell cycle, undergo a limited number of 
asymmetric cell divisions, and terminally differentiate into mature astrocytes, 
thus leading to depletion of the stem cell pool during life [404]. In vivo clonal 
analyses by Bonaguidi et al. by a low dose of tamoxifen injection in a NSC 
reporter mouse reported a diverse behavior of NSCs [196]. The authors 
observed some depletion of the NSC pool with time but also noted that some 
NSCs that had cycled did not terminally differentiate but instead persisted for 
long periods of time [196]. Therefore, investigating the mechanisms which 
regulate NSC quiescence and differentiation under homeostatic conditions in 
adults may help to better understand the signalling pathways which lead to 
proliferative exhaustion of stem cells and cognitive decline with ageing. 
 
6.1.3. Regulation of neural stem cell fate decisions 
In addition to proliferation, regulation of NSC fate decisions can modulate levels 
of neurogenesis in the adult forebrain. This can be achieved, for example, by 
changing the proportion of cells undergoing proliferative versus differentiative 
divisions, symmetric versus asymmetric divisions, and gliogenic versus 
neurogenic divisions (Figure 49). 




With ageing, two opposing scenarios have been proposed with regards to 
changes in NSC fate decisions. Some studies have reported a decrease in the 
number of newborn neural cells with age [230, 405]. Other studies reported that 
the proportion of differentiated cell types generated from the pool of cycling 
NSCs is similar or only slightly changed, even if the number of proliferating 
NSCs and absolute number of newborn neurons decreases during aging [16, 
406-408]. 
Nevertheless, before developing approaches to combat the age-related decline 
in NSC activity and possible changes in function, it is important to first identify 
the mechanisms involved in the regulation of NSC proliferation, maintenance, 
and cell fate decisions under homeostatic conditions in adults. I have shown 
that CHD7 plays a role in adult SVZ neurogenesis, by regulating the 
proliferation and differentiation of SVZ cells (see Chapter 5). However, the role 
of CHD7 and chromatin remodelling in hippocampal neurogenesis remains 
unknown. I hypothesised that, like in the SVZ, CHD7 plays a role in adult 
hippocampal neurogenesis and that loss of Chd7 results in impaired formation 
or differentiation of SGZ cells. The aims for this chapter are to: 
1. Determine the expression profile of CHD7 in SGZ cells. 
2. Characterise of the effects of a loss of Chd7 on adult hippocampal 
neurogenesis specifically examining the effects on neurogenesis and the 
NSCs themselves. 
3. Use in vitro NSC cultures to model the phenotypes seen after loss of 
Chd7 in vivo. 
  










Figure 49 - Schematic diagram of the fate decisions of adult neural stem cells. a, In vivo 
clonal analysis has shown that neural stem cells (NSCs) can self-renew, differentiate into 
astroglia, or form precursor cells capable of expanding their population and differentiating into 
neurons. b, NSCs are capable of undergoing different types of division. Symmetric self-
renewing divisions amplify the population of NSCs at the expense of forming differentiated cell 
types. Conversely, symmetric differentiative divisions lead to an increase in the progenitor pool 
but also lead to a depletion of the NSC pool. Asymmetric cell divisions allow for the 
maintenance of the NSC pool as well as the production of differentiated cell types. Adapted 
from [196]. 
 
6.2. CHD7 is expressed in transit amplifying cells in the 
subgranular zone 
To first determine if Chd7 was expressed in the hippocampus, in situ 
hybridisation using an anti-sense Chd7 probe was performed on coronal 
sections of adult WT (CD1 mouse strain) brains. Chd7 was expressed in the 
SGZ of the dentate gyrus (DG) where NSCs and progenitors reside (Figure 
50a). This result was confirmed by antibody staining (Figure 50b). Of note, the 
expression of CHD7 was much lower in the SGZ than in the SVZ as determined 
by immunofluorescence intensity (data not shown). 
To determine which cell types in the SGZ express CHD7, a series of co-
localisation experiments were performed by staining hippocampal sections of 
adult WT mice with antibodies raised against CHD7 and various markers of 
cells in the neurogenic lineage (see Figure 9). NSCs in the SGZ can be readily 
identified based on GFAP immunoreactivity and the presence of GFAP+ 
processes extending through the granular layer of the DG. CHD7 was not 
detected in any GFAP+ NSCs in the SGZ (Figure 51a-c). Sox2 is a marker of 
NSCs and transit amplifying progeny (type 1 and type 2 cells; see Figure 9). 
CHD7 was expressed in 6% of Sox2+ cells (Figure 51d,e). However, the 
majority of cells which expressed CHD7 also expressed Sox2, meaning that 
most CHD7+ cells are Sox2+ (Figure 51d,f). MASH1 is a marker of type 2a cells 
(see Figure 9). CHD7 was expressed by around half of all MASH1+ cells in the 
SGZ (Figure 51g,h), but almost all cells which expressed CHD7 also expressed 




MASH1 (Figure 51g,i). Therefore, most CHD7+ cells are Sox2+MASH1+, 
suggesting that CHD7 is present in transit amplifying type 2a cells (Figure 52). 
Furthermore, CHD7 was not detected in mature NeuN+ granule neurons in the 
dentate gyrus (Figure 51j-l), suggesting that CHD7 is downregulated as SGZ 
cells differentiate. Due to the low expression of CHD7 in the SGZ I have not yet 
analysed the expression of CHD7 in proliferating cells and type 3 cells. 
However, my data suggests that CHD7 will be expressed in proliferating cells 
since CHD7 is expressed in MASH1+ cells which are proliferative, and may be 
expressed in type 3 cells but at lower levels similar to in the SVZ (see Figure 
41). 
  





Figure 50 - CHD7 is expressed in the subgranular zone of the dentate gyurs. a, In situ 
hybridisation using an anti-sense Chd7 probe (blue) in the SVZ. The boxed area is enlarged in 
a'. Scale bars, 50µm. b, Coronal adult DG section stained with an anti-CHD7 antibody and 
Dapi. The boxed area is enlarged in the far right panel. Yellow arrow heads show CHD7+ cells 
with clear nuclear staining. SGZ, subgranular zone; Hi, hilus; GL, granular layer; ML, molecular 
layer. Scale bar, 20µm. 









Figure 51 - CHD7 is expressed by a subset of type 2a cells. a, Representative image of 
dentate gyrus sections stained with antibodies raised against CHD7 and GFAP, Sox2 (d), 
MASH1 (g), and NeuN (j). Yellow arrow heads show CHD7+GFAP- cells, purple arrow head 
shows a likely NSC with a GFAP+ process protruding through the granular layer of the dentate 
gyrus. A lower magnification image of (a) compared to other pictures was chosen to show 
GFAP+ processes through the dentate gyrus. Scale bars, 20µm. b, Quantification of the 
percentage of GFAP+, Sox2+ (e), MASH1+ (h) and NeuN+ (k) cells that also express CHD7. c, 
Quantification of the percentage of CHD7+ cells that also express GFAP, Sox2 (f), MASH1 (h) 
and NeuN (l). n = 100-150 cells analysed by confocal microscope. All data represented as 
mean ± s.e.m. 
  





Figure 52 - Schematic of CHD7 expression in the dentate gyrus. CHD7 is expressed in a 
subset of type 2a cells. 
  




6.3. The GLAST::CreERT2;Chd7f/f mouse line allows for efficient 
deletion of Chd7 in the dentate gyrus 
I have shown that CHD7 is expressed by transit amplifying cells in the SGZ (see 
Figure 52) and therefore CHD7 likely plays a role in hippocampal 
neurogenesis. To determine if CHD7 is an essential regulator of adult 
hippocampal neurogenesis, I sought to delete Chd7 specifically from adult 
NSCs using a GLAST::CreERT2 mouse line [253]. GLAST is expressed by 
NSCs and astrocytes and so upon tamoxifen injection Cre-mediated 
recombination should only take place in NSCs [253]. To first determine its 
efficiency in the DG, the GLAST::CreERT2 line was crossed to a RYFP reporter 
line to generate GLAST::CreERT2;RYFP/+ mice. Adult 
GLAST::CreERT2;RYFP/+ mice were given 5 injections of tamoxifen to induce 
recombination and expression of YFP and sacrificed 7 days and 28 days after 
the last tamoxifen injection (Figure 53a). Sections of the SVZ were stained with 
antibodies raised against GFP along with GFAP to label NSCs (Figure 53c,d). 
7 days after the last tamoxifen injection 86% of radial GFAP+ cells were YFP+, 
showing efficient recombination in NSCs (Figure 53b). Additionally, some YFP+ 
cells which were not GFAP+ were observed, and these are presumably NSC 
progeny (Figure 53c). 28 days after the last tamoxifen injection, YFP+ cells in 
the granular layer (GL) of the DG were visible (Figure 53d). As cells born in the 
SGZ differentiate they migrate to deeper layers of the granular layer, and so 
YFP+ cells in the GL are presumably new neurons formed from NSCs. 
Furthermore, at this time point many GFAP+ cells were still YFP+, showing that 
recombination is stable (Figure 53d). Therefore, my tamoxifen injection regime 
in GLAST::CreERT2 mice results in efficient recombination in SGZ cells. 
To delete Chd7 specifically from adult NSCs, GLAST::CreERT2 mice were 
crossed with Chd7f/f mice to generate a GLAST::CreERT2;Chd7f/f mouse line 
(see Figure 45a). Tamoxifen injection causes Cre-mediated recombination and 
the formation of a truncated, non-functional CHD7 protein specifically in NSCs 
and astrocytes (Chd7null). To test if the deletion of Chd7 was efficient, the DG 
of GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control mice (WT) was 




stained with antibodies raised against CHD7 and the number of CHD7+ cells 
was counted 1 week and 4 weeks after tamoxifen administration. Hardly any 
CHD7+ cells were detected in the DG of Chd7null mice both 1 weeks and 4 
weeks after Chd7 deletion, indicating that deletion of Chd7 was efficient (Figure 
54a-d). Therefore using the GLAST::CreERT2;Chd7f/f mouse line allows for 
efficient deletion of Chd7 and recombination in a large portion of NSCs. 
  









Figure 53 - Efficient recombination in the dentate gyrus of GLAST::CreERT2 mice. a, 
Schematic of the experimental strategy to induce recombination and YFP expression in SGZ 
NSCs. Adult GLAST::CreERT2;RYFP mice were given one injection of 80mg/kg tamoxifen a 
day for 5 days and sacrificed either 7 days or 28 days after the last tamoxifen injection. b, 
Quantification of the percentage of radial GFAP+ cells that were also GFP+ in the SGZ. At least 
90 GFAP+ cells were counted. n=2 animals. Data represented as mean ± s.e.m. c, 
Representative image of a coronal section of the dentate gyrus of GLAST::CreERT2;RYFP 
mice 7 days or 28 days (d) after tamoxifen injection stained with antibodies raised against GFP 
and GFAP. GFP antibodies recognise YFP protein. White arrow heads show GFAP+GFP+ 
astrocytic processes. Note the large overlap between GFAP and GFP. Also note the presence 
of YFP+ cells in the granular cell layer (light blue arrow head which is GFAP-) in (c), indicating 
that recombined NSCs have produced new mature neurons. Scale bar, 100µm. n=2 animals / 
condition. 
  










Figure 54 - The GLAST::CreERT2;Chd7f/f mouse line allows for efficient deletion of Chd7. 
a, Representative image of a section of the SGZ stained with antibodies raised against CHD7 
and MASH1 in WT and Chd7null (b) adult brains 4 weeks after tamoxifen administration. 
Sections were stained with antibodies raised against MASH1 to fully identify CHD7+ cells since 
the majority of CHD7+ cells also express MASH1. c, Quantification of the number of CHD7+ 
cells in the SGZ of WT and Chd7null mice 1 week and 4 weeks (d) after the last tamoxifen 
injection. n=2-4 animals / condition. All data represented as mean ± s.e.m. 
 
6.4. Loss of Chd7 in neural stem cells causes a reduction in 
neurogenesis 
CHD7 is expressed in neurogenic SGZ cells and so I hypothesised that CHD7 
likely plays a role in hippocampal neurogenesis. To analyse the effect of loss of 
Chd7 on hippocampal neurogenesis, GLAST::CreERT2;Chd7f/f (Chd7null) and 
Cre-negative control mice (WT) were treated with tamoxifen and sacrificed 12 
weeks later (Figure 55a). Sections of the hippocampus were stained with 
antibodies raised against DCX to label immature neurons (type 3 cells). 
Chd7null mice displayed a 45% reduction in the number of immature neurons in 
the DG compared to WT (Figure 55b,c), showing that CHD7 is a critical 
regulator of neurogenesis. A decrease in neurogenesis could be due to 
impaired differentiation of neuronal progenitors or impaired proliferation of cells 
in the SGZ. To determine if proliferation in the SGZ was altered after loss of 
Chd7, Chd7null and WT mice were treated with tamoxifen and sacrificed 12 
weeks later. BrdU was injected 24 hours before sacrifice to label proliferating 
cells (Figure 55a). A 24 hour BrdU pulse labels the majority of progenitors 
without labelling a significant number of neurons [228]. Despite a large 
decrease in neurogenesis, the number of proliferating cells (BrdU+ or PCNA+) in 
the SGZ was not altered (Figure 55d,e). These data suggest that the formation 
and/or survival of DCX+ type 3 cells is impaired. Alternatively, it is possible that 
CHD7 may regulate DCX expression, and loss of Chd7 results in the inability of 
cells to express DCX. This will be addressed in Section 6.5. 
To determine if the formation of new mature neurons is affected after loss of 
Chd7, adult GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (WT) 




mice were injected with tamoxifen and sacrificed 11 weeks later, giving BrdU in 
their drinking water for the last 3 weeks of life to label newly born cells (Figure 
55f). The number of newborn cells (BrdU+) in the DG was reduced by 55% in 
Chd7null mice (Figure 55h), showing that the formation of new cells is impaired 
in Chd7null mice. To fully determine if the formation of new neurons was 
impaired, sections of the DG of Chd7null and WT mice were stained with 
antibodies raised against BrdU and NeuN. Any cells which are BrdU+NeuN+ 
cells are new granule neurons [228]. The percentage of newly formed cells that 
were mature neurons (%BrdU+NeuN+) was reduced by 33% (Figure 55g,i). 
These data show that the production of newborn cells is decreased in Chd7null 
mice, and the percentage of newly formed cells that become neurons is 
adversely affected by the loss of Chd7. 
A decrease in the percentage of newly formed cells that become neurons could 
be due to: 
1. An increase in apoptosis (see Section 6.11.6.) 
2. A delay or block in neurogenesis (see Section 6.6.) 
3. Decreased expansions of neural progenitors (see Section 6.5.) 
4. A fate change of SGZ cells (see Section 6.8.) 
These possibilities will be discussed in the following sections. 









Figure 55 - Chd7 regulates adult hippocampal neurogenesis. a, Schematic diagram of the 
experimental strategy to delete Chd7 from adult NSCs for 12 weeks (long-term) and label 
proliferating cells by injecting BrdU 24 hours prior to sacrifice. b, Representative image of a 
section of the DG of GLAST::CreERT2;Chd7f/f mice treated with tamoxifen (Chd7null) and Cre-
negative controls (WT) stained with antibodies raised against DCX. Scale bar, 100µm. c, 
Quantification of the number of DCX+ cells in the DG of Chd7null and WT mice per 20µm 
section. n=4 animals / condition. d, Quantification of the number of BrdU+ and PCNA+ (e) cells 
in the SGZ of Chd7null and WT mice per 20µm section. n=4 animals / condition. f, Schematic 
diagram of the experimental strategy to delete Chd7 from adult NSCs and label newly born cells 
by administering BrdU in the drinking water of mice. g, Representative image of a section of the 
DG stained with antibodies raised against BrdU and NeuN. Scale bar, 20µm. h, Quantification 
of the number of BrdU+ cells and the percentage of BrdU+ cells that were NeuN+ (i) in the DG of 
Chd7null and WT mice per 20µm section. n=2 animals / condition. All data represented as mean 
± s.e.m.; **P<0.01 ***P<0.001 student's t test. 
 
6.5. Loss of Chd7 leads to a transient increase in neurogenesis 
I have shown that the loss of Chd7 in NSCs leads to a decrease in the number 
of immature neurons in the dentate gyrus (see Figure 55c). One possible 
explanation is that the decrease in the number of DCX+ cells formed may 
indicate that CHD7 regulates DCX expression. Hence, a loss of Chd7 
expression would cause a loss of DCX+ cells. To test this, adult 
GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (WT) mice were 
injected with tamoxifen and sacrificed 1 week later to determine if impaired DCX 
expression was a primary defect caused by the loss of Chd7 (Figure 56a). At 
this time point there was no change in the number of DCX+ immature neurons in 
Chd7null mice compared to WT (Figure 56b), suggesting that the expression of 
DCX and formation of immature neurons is not impaired after the loss of Chd7. 
However, it could be argued that at this time point, only a very small percentage 
of recombined NSCs would not have formed type 3 cells, and so this is why no 
effect on immature neurons is seen in Chd7null cells [228]. To address this 
point, adult Chd7null and WT mice were injected with tamoxifen and sacrificed 4 
weeks later (Figure 56c). At this time point many NSCs should have formed 
type 3 cells [228]. Furthermore, 4 weeks after tamoxifen injection in 
GLAST::CreERT2;RYFP/+ mice I have shown that recombined cells can be 




observed in the granular layer of the DG, indicating that some SGZ NSCs have 
formed new mature neurons (see Figure 53c). Therefore, if CHD7 regulates the 
expression of DCX, abnormalities should be seen 4 weeks after Chd7 deletion. 
Interestingly, 4 weeks after Chd7 deletion, there was an increase in the number 
of DCX+ immature neurons (Figure 56d), showing that loss of Chd7 does not 
lead to a loss of DCX+ cells. Collectively, these data show that loss of Chd7 in 
NSCs leads to a transient increase in neurogenesis followed by a large decline 
in new neuron formation. This transient increase in neurogenesis could be 
explained by an increase in the number of progenitors in the SGZ, or by an 
increase in NSC proliferation leading to a general increase in formation of more 
DCX+ cells, or by a decrease in the apoptosis of DCX+ cells, or by a block in the 
differentiation of immature neurons. To determine if the number of progenitors 
was altered in the SGZ, adult Chd7null and WT mice were injected with 
tamoxifen and sacrificed 4 weeks later (Figure 56c). DG sections of Chd7null 
and WT mice were stained with antibodies raised against the transit amplifying 
type 2a cell type MASH1. Four weeks after loss of Chd7 there was no change in 
the number of type 2a cells in the SGZ (Figure 56f), suggesting that the 
transient increase in neurogenesis was not due to an increase in the number of 
progenitors. These data also argue that the eventual loss in neurogenesis seen 
in Chd7null cells is not due to an impaired expansion of immature progenitors, 
since the number of MASH1+ cells is not altered. 
A transient increase in neurogenesis due to a decrease in apoptosis seems 
unlikely as the loss of Chd7 eventually leads to the depletion of DCX+ cells and 
a decreased number of newly born cells forming neurons, which may imply that 
there is possibly an increase in apoptosis at this time point. However, this will 
need further investigation (see Section 6.11.6.). 
Lastly, the hypothesis that an increase in NSC proliferation may lead to a 
transient increase in neurogenesis will be discussed in Section 6.7. 








Figure 56 - Loss of Chd7 results in a transient increase in neurogenesis. a, Schematic of 
the experimental strategy to delete Chd7 from adult NSCs for 1 week (short-term). b, 
Quantification of the number of DCX+ cells in the DG of Chd7null and WT mice 1 week after the 
last tamoxifen injection per 20µm section. n=4 animals / condition. c, Schematic of the 
experimental strategy to delete Chd7 from adult NSCs for 4 weeks (mid-term) and label 
proliferating cells by injecting BrdU 24 hours prior to sacrifice. d, Representative image of a 
section of the DG of GLAST::CreERT2;Chd7f/f mice treated with tamoxifen (Chd7null) and Cre-
negative controls (WT) 4 weeks after the last tamoxifen injection stained with antibodies raised 
against DCX. Scale bar, 100µm. c, Quantification of the number of DCX+ cells in the DG of 
Chd7null and WT mice per 20µm section. n=4 animals / condition. d, Quantification of the 
number of BrdU+ cells in the SGZ of Chd7null and WT mice 4 weeks after the last tamoxifen 
injection per 20µm section. n=4 animals / condition. e, Quantification of the number of MASH1+ 
cells in the DG of Chd7null and WT mice 4 weeks after the last tamoxifen injection per 20µm 
section. n=4 animals / condition. All data represented as mean ± s.e.m.; **P<0.01 student's t 
test. 
 
6.6. Loss of Chd7 impairs mature neuron formation 
I have shown that the loss of Chd7 lead to a transient increase in immature 
neuron formation followed by a large decline in neurogenesis. The data so far 
suggest that a block in neuronal differentiation occurs when immature neurons 
proceed to full maturation. To further confirm this I employed the use of an in 
vitro model of NSCs which allows for the analysis of cell proliferation and 
differentiation in defined conditions [365]. Cultured NSCs are therefore a good 
model for analysing if CHD7 is an essential regulator of neurogenesis. To obtain 
this cell line, foetal NSCs from the cortex and striatum of E16.5 
NestinCre;Chd7δ/δ  (Chd7null) and Cre-negative embryos (WT) were isolated 
and cultured to form foetal-derived NSCs. These cells  retain multi-lineage 
differentiation capacity after prolonged expansion [364] and give a high yield of 
neurons when put under certain conditions [365]. To determine if Chd7 was 
expressed by cells in growth conditions and under differentiation conditions, 
RNA was extracted from Chd7null and WT cells and RT-qPCR for Chd7 was 
performed. Chd7 expression was upregulated as cells were put into 
differentiation conditions and expression was then downregulated as cells 
differentiated further (Figure 57a). These data show that in this in vitro culture 




system, Chd7 is expressed in more neuronally committed cells, which is 
consistent with Chd7 being expressed in neuronally-committed type 2a cells in 
vivo (see Figure 52). These data suggest that the expression of Chd7 in the in 
vitro culture of NSCs reflect that seen in vivo. Importantly, the expression of 
Chd7 was completely absent in Chd7null cells (Figure 57a). To confirm that 
CHD7 protein expression was absent in Chd7null cells, a western blot of CHD7 
in total cell lysates of Chd7null and WT cells after being placed in neuronal 
differentiation conditions for 3 days (where expression of Chd7 was at its 
greatest) was performed. CHD7 protein was completely absent from Chd7null 
cells (Figure 57b), confirming that these mutant cells do not express CHD7. 
To confirm that CHD7 is an essential regulator of neurogenesis, Chd7null and 
WT cells in growth medium, neuronal differentiation conditions for 3 days, or 
neuronal differentiation conditions for 6 days were stained using antibodies 
raised against the mature neuron marker MAP2. Chd7null cells displayed a 
decreased tendency to form mature neurons compared to WT cells (Figure 
57c), showing that CHD7 regulates mature neuron formation. 
I have previously shown that loss of Chd7 results in a transient increase in 
neurogenesis and I have suggested that loss of Chd7 expression leads to an 
inability of immature neurons to fully mature. To test this in vitro, Chd7null and 
WT cells in growth medium, neuronal differentiation conditions for 3 days, or 
neuronal differentiation conditions for 6 days were stained using antibodies 
raised against the immature neuron marker DCX. Chd7null cells displayed a 
large increase in the number of DCX+ cells (Figure 57d,e). These data show 
that loss of Chd7 does not negatively affect DCX expression. Instead, these 
data suggest that impaired neurogenesis in Chd7null cells is a result of 
immature neurons being unable to fully differentiate. The block in the 
differentiation of DCX+ cells may lead to their accumulation before an increase 
in apoptosis leads to a decline in DCX+ cells 









Figure 57 - CHD7 is essential for neurogenesis in vitro. a, RT-qPCR expression level of 
Chd7 from cultured foetal-derived NSCs from NestinCre;Chd7δ/δ (Chd7null) and Cre-negative 
(WT) E16.5 embryos under growth conditions (Growth), differentiation conditions for 3 days (3d 
neuron diff) and 6 days (6d neuron diff) relative to WT. Note Chd7 expression is completely 
absent from Chd7null cells. n = 2 cultures performed in duplicate. b, Western blot for CHD7 on 
total cell lysates of cultured foetal-derived NSCs from Chd7null (NestinCre Chd7-/-) and WT 
(Chd+/+) cells under differentiation conditions for 3 days. Cleavage and polyadenylation 
specificity factor 100 (CPSF100) was used as a loading control. c, Quantification of the number 
of MAP2+ mature neurons formed from Chd7null and WT cells under growth conditions 
(Growth), differentiation conditions for 3 days (3d neuron diff) and 6 days (6d neuron diff). n = 2 
cultures performed in duplicate. d, Representative image of cultured foetal-derived NSCs from 
Chd7null and WT E16.5 embryos under differentiation conditions for 6 days stained with 
antibodies raised against DCX. Scale bar, 50µm. e, Quantification of the number of DCX+ 
immature neurons formed from Chd7null and WT cells under growth conditions (Growth), 
differentiation conditions for 3 days (3d neuron diff) and 6 days (6d neuron diff). n = 2 cultures 
performed in duplicate. All data represented as mean ± s.e.m.; ***P<0.001 student's t test. 
 
6.7. CHD7 regulates neural stem cell quiescence 
I have shown that CHD7 is a critical regulator of adult neurogenesis. Loss of 
Chd7 leads to a transient increase in neurogenesis followed by a large decline 
in neuron formation. I have shown that the number of MASH1+ cells is 
unaffected after the loss of Chd7 (see Figure 56f), suggesting that changes in 
progenitor number are not the cause of the transient increase in the number of 
DCX+ cells. I have suggested that the accumulation of DCX+ cells may be due 
to a block in differentiation before their numbers are reduced by an increase in 
apoptosis. One remaining possibility for the transient increase in neurogenesis 
is that an increase in NSC proliferation may cause an increase in the number of 
immature neurons formed. To first determine if the numbers of proliferating cells 
was altered shortly after loss of Chd7, adult GLAST::CreERT2;Chd7f/f 
(Chd7null) and Cre-negative control (WT) mice were injected with tamoxifen 
and sacrificed 1 week later. BrdU was injected 24 hours before sacrifice to label 
proliferating cells (Figure 58a). The number of proliferating cells (BrdU+) was 
over 2-fold greater in the SGZ of Chd7null mice compared to WT (Figure 
58b,c). These data show that loss of Chd7 initially causes an increase in the 




number of proliferating cells in the SGZ. To determine if an increase in 
proliferation in the SGZ leads to an alteration in the total number of NSCs and 
progenitors after a short-term deletion of Chd7, sections of the DG were stained 
with antibodies raised against Sox2 to label type1 and type2 cells. There was 
no change in the number of Sox2+ cells in Chd7null mice compared to WT 
(Figure 58d). These data suggest that the total number of NSCs and 
progenitors was not altered, meaning that the increase in the proliferation of 
SGZ cells was not due to changes in the cellular composition of the niche. 
However, analysing the number of NSCs and progenitors separately is needed 
to fully conclude if there is a change in these cell populations. Collectively, 
these results show that loss of Chd7 initially affects proliferation in the SGZ. 
An increase in the number of proliferating cells in the SGZ could reflect a loss of 
NSC quiescence or an increase in progenitor proliferation. To determine which 
cell types are proliferating, DG sections of mice treated as in Figure 58a were 
stained with antibodies raised against BrdU, Sox2 and GFAP to determine the 
number of NSCs (GFAP+Sox2+ SGZ cells with a radial morphology) and 
progenitors (GFAP-Sox2+ SGZ cells) that had cycled in the 24 hour period 
(BrdU+; Figure 59a). The number of BrdU+ radial NSCs was over 2.5 fold 
greater in Chd7null mice compared to WT (Figure 59b). Interestingly, the 
number of cycling progenitors (GFAP-Sox2+) was no different between Chd7null 
and WT mice (Figure 59c), suggesting that the primary effect of loss of Chd7 is 
a loss of NSC quiescence, with no effect on progenitor cycling. These data 
show that loss of Chd7 in NSCs leads to a loss of NSC quiescence. Further 
experiments to investigate if there are any changes in the number of type 1 and 
type 2 cell populations separately at this stage will be useful in determining if a 
loss of NSC quiescence results in an increase in NSC number or progenitor 
number.  





Figure 58 - Loss of Chd7 initially results in increased subgranular zone proliferation. a, 
Schematic diagram of the experimental strategy to delete Chd7 from adult NSCs for 1 week 
(short-term) and label proliferating cells by injecting BrdU 24 hours prior to sacrifice. b, 
Representative image of a section of the DG of GLAST::CreERT2;Chd7f/f mice treated with 
tamoxifen (Chd7null) and Cre-negative controls (WT) stained with antibodies raised against 
BrdU. Scale bar, 20µm. c, Quantification of the total number of BrdU+ cells and Sox2+ cells (d) 
in the SGZ of Chd7null and WT mice per 20µm section. n=2-3 animals / condition. All data 
represented as mean ± s.e.m.; ***P<0.001 student's t test. 
  





Figure 59 - CHD7 regulates neural stem cell quiescence. a, Representative image of a 
section of the DG stained with antibodies raised against BrdU, Sox2, and GFAP with Dapi. 
Yellow arrow heads shows a BrdU+ NSC (BrdU+Sox2+GFAP+ cells in the SGZ), purple arrow 
heads shows a BrdU- NSCs, light blue arrow heads show a BrdU+ progenitor 
(BrdU+Sox2+GFAP-). Scale bar, 20µm. b, Quantification of the percentage of BrdU+ NSCs and 
progenitors (c) in the SGZ of Chd7null and WT mice. n=4 animals / condition. All data 
represented as mean ± s.e.m.; *P<0.05 student's t test. 
  




6.8. Loss of Chd7 results in an increase in the number of neural 
stem cells 
I have shown that the loss of Chd7 in NSCs results in the loss of stem cell 
quiescence, followed by a transient increase in neurogenesis and then a large 
decrease in neurogenesis in the long-term. One remaining possibility for the 
eventual loss of neurogenesis and decreased tendency for SGZ to form 
neurons is that there may be a fate change of NSCs. For example, NSCs may 
have an increased tendency to self renew or form glial cells in Chd7null mice, 
and immature neurons may have an impaired differentiation capacity, leading to 
a transient increase in immature neuron formation and a decrease in mature 
neuron formation. Alternatively, loss of stem cell quiescence may lead to 
depletion of the NSC pool due to proliferative exhaustion and differentiation of 
NSCs [259, 393]. To distinguish between these possibilities, 
GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (WT) mice were 
treated with tamoxifen and sacrificed 12 weeks later (Figure 60a). Sections of 
the dentate gyrus were stained with antibodies raised against Sox2 and GFAP 
and the number of non-neurogenic, non-radial radial astrocytes (GFAP+Sox2-) 
were counted to determine if there was a fate change to glial cells. There was 
no change in the number of mature astrocytes in the DG of Chd7null compared 
to WT mice, indicating that loss of Chd7 does not result in a fate change to glial 
cells. To further confirm this, a S100β stain, to mark only mature astrocytes, 
would be needed. 
To determine if the loss of Chd7 leads to an increase in self-renewal or a 
decrease in the number of NSCs, sections of the dentate gyrus were stained 
with antibodies raised against Sox2 and GFAP and the number of radial NSCs 
(GFAP+Sox2+ cells with a cell body in the SGZ and astrocytic processes 
through the GL) in the SGZ were counted. Surprisingly, the number of NSCs 
present in Chd7null SGZ was increased by over 20% (Figure 60b,d), and the 
number of Sox2+GFAP- progenitors was decreased compared to WT (Figure 
60e). These data suggest that pool of NSCs has expanded due to increased 
symmetric divisions forming more NSCs. Alternatively, it may be possible that 




the pool of NSCs has been maintained over a 12 week period in Chd7null mice, 
whereas the pool of NSCs in WT mice has undergone division-coupled 
astrocytic differentiation (Figure 61). This mechanism of NSC loss in WT mice 
has been proposed to be the reason for the loss of NSCs with age and states 
that NSCs only undergo limited rounds of division before differentiating into 














Figure 60 - Loss of Chd7 results in an increase in the number of neural stem cells. a, 
Schematic diagram of the experimental strategy to delete Chd7 from adult NSCs for 12 weeks 
(long-term). b, Representative image of a section of the DG of GLAST::CreERT2;Chd7f/f mice 
treated with tamoxifen (Chd7null) and Cre-negative controls (WT) stained with antibodies raised 
against GFAP and Sox2 with Dapi 12 weeks after Chd7 deletion. Scale bar, 10µm. c, 
Quantification of the number of GFAP+Sox2-  non-radial cells (mature astrocytes) in the DG of 
Chd7null and WT mice per 20µm section. n = 4 animals / condition. d, Quantification of the 
number of GFAP+Sox2+  radial NSCs and GFAP-Sox2+ progenitors (e) in the SGZ of Chd7null 
and WT mice per 20µm section. n = 4 animals / condition. All data represented as mean ± 
s.e.m.; *P<0.05 **P<0.01 student's t test. 
  






Figure 61 - The disposable stem cell hypothesis may account for an increase in the 
number of neural stem cells in Chd7 mutants over time. The disposable stem cell 
hypothesis states that NSCs, once activated, undergo a few rapid rounds of division to generate 
progenitors before differentiating into post-mitotic astrocytes (left panel) [404]. In the Chd7null 
dentate gyrus, it is possible that instead of undergoing differentiation into post-mitotic 
astrocytes, the NSCs are instead maintained, leading to a relative increase in the number of 
NSCs over time compared to wild type (right panel).  




6.9. Loss of neural stem cell quiescence may be due to loss of 
Notch signalling 
Notch signalling is a conserved regulator of NSC quiescence in the SVZ and 
SGZ [252, 253, 256, 260]. Loss of Notch signalling is associated with loss of 
NSC quiescence [252, 253, 256, 260]. Therefore, it may be possible that altered 
Notch signalling is responsible for a loss of NSC quiescence. To test this 
hypothesis, GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative control (WT) 
mice were treated with tamoxifen and the DG was then microdissected three 
weeks later and RNA was extracted (Figure 62a). A three week time point was 
chosen because CHD7 is predominantly expressed in MASH1+ type 2 cells, and 
so by three weeks after recombination a sufficient number of GLAST+ NSCs 
should have formed type 2 daughter cells [196, 233]. RT-qPCR analysis for the 
downstream effector of Notch signalling, Hes5 was performed to determine if 
Notch signalling was altered in Chd7null mice in vivo. Interestingly, the 
expression of Hes5 tended to be decreased by around 50% (Figure 62b), 
suggesting that loss of Notch signalling may be the reason for a loss in NSC 
quiescence. 
  





Figure 62 - Loss of Chd7 leads to a decrease in Notch signalling. a, Schematic of the 
experimental strategy to delete Chd7 from adult NSCs for 3 weeks. b, RT-qPCR expression 
level of Hes5 from dissected DG of GLAST::CreERT2;Chd7f/f (Chd7null) and Cre-negative 
control (WT) mice treated with tamoxifen and sacrificed 3 weeks later. n=2-3 animals / 
condition. Data are from 2 reactions conducted in duplicate. Data represented as mean ± s.e.m. 
  




6.10. A decrease in Chd7 expression may be linked to 
intellectual disability in CHARGE syndrome 
De novo mutations in CHD7 is one of the leading causes of CHARGE 
syndrome, a congenital defect characterised by coloboma of the eye, heart 
defects, atresia of the nasal choanae, retardation of growth, genital and ear 
abnormalities and deafness [330]. 90% of patients with CHARGE syndrome 
also present with intellectual disability [330], suggesting that CHD7 is a key 
regulator of brain development and neurogenesis in humans. 
Neurogenesis in the adult hippocampus plays an important role in certain types 
of learning tasks, memory formation, and pattern separation [224-227]. 
Therefore, defects in adult hippocampal neurogenesis likely contribute to 
intellectual disability [17, 398, 399]. I have shown that CHD7 is an essential 
regulator of adult neurogenesis and loss of Chd7 in NSCs results in a loss of 
neurogenesis (see Section 6.4.). Therefore, I hypothesised that a loss of CHD7 
and a decrease in hippocampal neurogenesis is at least partly responsible for 
the intellectual disability phenotypes seen in CHARGE syndrome patients. 
However, CHARGE syndrome is caused by heterozygous mutations and 
deletions of the CHD7 gene [330], and so a complete loss of Chd7 does not 
model the syndrome accurately. To address this point, I utilised a mouse line 
heterozygous for a genetrap Chd7 allele (Chd7gt/+). This genetrap allele 
presumably results in the translation of an unstable, truncated, non-functional 
protein which is rapidly degraded (see Figure 37a). Mice carrying the Chd7gt 
allele have been previously shown to display phenotypes associated with Chd7 
haploinsufficiency such as abnormalities in pharyngeal arch arteries and other 
phenotypes associated with CHARGE syndrome [356]. I have previously shown 
that Chd7gt/+ mice have a 50% reduction in Chd7 expression in the olfactory 
bulb (OB) compared to WT (see Figure 37b), and so Chd7gt/+ mice presumably 
have decreased Chd7 expression in all brain regions. 
To determine if a reduction in Chd7 expression affects the generation of 
immature interneurons in the DG, sections of the DG of adult WT and Chd7gt/+  
mice were stained with antibodies raised against DCX (Figure 63a). Chd7gt/+ 




mice had fewer DCX+ cells compared to WT, suggesting that hippocampal 
neurogenesis is impaired (Figure 63b). To determine if the number of 
proliferating cells in the SGZ is altered in Chd7gt/+ mice, sections of the DG of 
adult WT and Chd7gt/+  mice were stained with antibodies raised against PCNA 
(Figure 63a). A reduction in Chd7 expression had no effect on the number of 
proliferating cells in the SGZ of Chd7gt/+ mice (Figure 63c), suggesting that the 
main phenotype of decrease in Chd7 expression is a reduction in neurogenesis. 
Further experiments subjecting Chd7gt/+ mice to hippocampal-dependent 
learning tasks would show if a decrease in Chd7 expression causes impaired 
learning and memory. 
Collectively, these data indicate that impaired hippocampal neurogenesis in 
Chd7gt/+ mice may reflect the intellectual disability associated with in CHARGE 
syndrome.  
  





Figure 63 - Reduction in Chd7 expression affects hippocampal neurogenesis. a, 
Representative picture of the DG of adult Chd7gt/+ and WT mice stained with antibodies raised 
against PCNA and DCX. Scale bar, 50µm. b, Quantification of the number of DCX+ and PCNA+ 
(c) cells in the DG of WT and Chd7gt/+ mice per 10µm section. n=3 animals / condition. All data 
represented as mean ± s.e.m.; *P<0.05 student's t test. 
  





I sought to investigate the role of the chromatin remodelling enzyme CHD7 on 
adult hippocampal neurogenesis. The data presented here show that CHD7 is a 
key regulator of the maintenance and differentiation of hippocampal NSCs. 
These data show that upon Chd7 loss, NSC quiescence is disrupted and this 
leads to a transient increase in neurogenesis. In addition, a long-term loss of 
Chd7 results in a large decline in neurogenesis and an increase in the number 
of NSCs, consistent with an increase in self-renewing divisions and a block in 
neurogenesis (Figure 64). 









Figure 64 - Schematic diagram of the role of CHD7 in adult hippocampal neurogenesis. 
Under homeostatic conditions, adult hippocampal neurogenesis depends on the balance 
between NSC (pink) activation (mitotic spindles) and daughter cell differentiation to form 
immature neurons (blue; top panel). Proliferating NSCs can generate additional NSCs or new 
neurons (arrows). During maturation, many neurons undergo apoptosis (crosses). 1-4 weeks 
after the deletion of Chd7 from NSCs, NSCs lose quiescence and neurogenesis is transiently 
increased (middle panel). This may be due to the inhibition of apoptosis of cells, or their 
increased formation. 12 weeks after deletion of Chd7 the number of NSCs is increased and the 
number of immature and mature neurons formed is decreased (bottom panel). Adapted from 
[184]. 
 
6.11.1. Chd7 may regulate neural stem cell quiescence cell 
autonomously or non-cell autonomously 
I have shown that CHD7 could not be detected in GFAP+ NSCs in the SGZ (see 
Section 6.2). However, the expression of CHD7 in the SGZ is much lower than 
in the SVZ, and so it is possible that SGZ NSCs may express a low level of 
CHD7. Furthermore, a subset of MASH1+ cells also display NSC properties and 
are capable of producing differentiated progeny as well as maintaining their own 
pool by self-renewal [409]. Since CHD7 was mostly detected in MASH1+ cells, it 
is possible that CHD7 is expressed by MASH1+ NSCs. Therefore, a loss of NSC 
quiescence after Chd7 deletion may be a cell-autonomous effect. However, the 
niche also largely regulates NSC quiescence [410]. I have shown that the total 
number of Sox2+ cells does not change initially after loss of Chd7 in NSCs (see 
Figure 58d), thus a loss of NSC quiescence is unlikely to be due to a change in 
the cellular composition of the niche. It is possible, however, that intrinsic 
changes in progenitors may induce a loss of NSC quiescence. For example, 
type 2 cells in the dentate gyrus express Notch ligand such as Jag1 and Dll1 
and signal to NSCs which express Notch receptor such as Notch 1 [259]. Notch 
signalling is a crucial regulator of NSC quiescence [259]. I have shown that 
Notch signalling is reduced in Chd7null mice (see Figure 62b), and this may be 
due to changes in the expression of Notch ligands on type 2 cells, or changes in 
the expression of Notch receptors on type 1 cells. RT-qPCR analysis of Notch 




receptors and ligands will show if Notch signalling is altered due to the 
expression of receptors on type 1 cells or ligands on type 2 cells. 
 
6.11.2. Decreased Notch signalling only accounts for some of the 
phenotypes seen after the loss of Chd7 
A loss of Notch signalling has been shown to cause a loss of NSC quiescence 
and a transient increase in neurogenesis followed by a large decline in 
neurogenesis and depletion of the stem cell pool due to proliferative exhaustion 
[252]. I have shown that in Chd7null mice, loss of NSC quiescence leads to a 
transient increase in neurogenesis followed by a large decline in neurogenesis 
and maintenance of the stem cell pool, possibly through an increase in self-
renewal (see Figure 64). Therefore, a decrease in Notch signalling only 
accounts for some of the phenotypes seen in Chd7null mice. However, it is 
possible that CHD7 regulates different aspects of neurogenesis by  regulating 
the expression of genes associated with self-renewal and lineage priming in 
NSCs. In agreement with this concept, the CHD family member CHD4 has been 
shown to regulate the expression of genes associated with self-renewal and cell 
fate decisions in HSCs [385]. Alternatively, CHD7 may have separate roles in 
NSCs and differentiating progeny. 
 
6.11.3. Chd7 may have separate roles in the self-renewal, 
maintenance of quiescence, and differentiation of neural stem cells 
I have shown that the loss of Chd7 specifically in NSCs results in the loss of 
NSC quiescence, an increase in the NSC pool, and a decrease in the formation 
of new neurons (see Figure 64). I hypothesise that these phenotypes are not all 
regulated by one single mechanism, but instead CHD7 has different effects on 
NSCs and their differentiating progeny (Figure 65). Therefore, analysing the 
role of CHD7 in different aspects of neurogenesis would reveal the full role of 
CHD7 in adult neurogenesis. 






Figure  65 - The role of CHD7 in adult hippocampal neurogenesis. CHD7 can regulate NSC 
quiescence (1), the self-renewal of NSCs (2), and the differentiation of daughter cells (3). 
Adapted from [196]. 
  




6.11.3.1. CHD7 regulates the differentiation of immature neurons 
My data show that a loss of Chd7 in NSCs leads to a decrease in mature 
neuron formation and an increase in immature neuron formation in vitro (see 
Section 6.6). Therefore, I hypothesise that CHD7 plays a role specifically in 
immature neurons to regulate their differentiation into mature neurons. This 
could be addressed by deleting NSCs specifically from more differentiated cells 
and analysing the differentiation potential of recombined cells. 
 
6.11.3.2. CHD7 regulates NSC quiescence 
I hypothesise that CHD7 regulates NSC quiescence independently of the role of 
CHD7 on progenitor cell differentiation and NSC self-renewal. Although I have 
not been able to detect CHD7 in GFAP+ NSCs in the dentate gyrus, CHD7 is 
expressed in MASH1+ cells, a subpopulation of which is capable of long-term 
neurogenic potential [409]. Therefore, CHD7 may regulate NSC quiescence 
cell-autonomously. This possibility can be directly tested in vitro by inducing 
cells into quiescence by adding BMP4 to the culture media [411], and then 
deleting Chd7. I have generated CreERT2;Chd7f/f;RYFP/+ foetal-derived NSCs, 
and so addition of 4-hydroxy-tamoxifen to the culture should result in deletion of 
Chd7 within all cells. Utilising this cell line, It will be possible to examine whether 
Chd7null cells are capable of returning to quiescence in this assay. This assay 
provides a powerful tool for the analysis of the role of CHD7 in quiescent and 
activating NSCs. 
 
6.11.3.3. CHD7 regulates NSC self-renewal 
I hypothesise that the self-renewal of NSCs is regulated by CHD7 
independently of the effects of CHD7 on the formation of new neurons. The 
signalling pathways which regulate adult NSC self-renewal in vivo are not well 
understood, and so analysis of direct CHD7 targets may reveal novel pathways 
required for the maintenance of the stem cell pool. In vivo clonal analysis 
(described below) can be performed to address this. 




6.11.4. In vivo clonal analysis of adult neural stem cells 
I have demonstrated that CHD7 is expressed in 50% of MASH1+ cells (see 
Figure 51). This may reflect a unique subset of type 2a cells that require CHD7, 
or it may reflect a stage in the cell cycle or the degree of differentiation of type 2 
cells (i.e. CHD7 may just be expressed by MASH1+ cells that are cycling or less 
differentiated MASH1+ cells for example). It is tempting to speculate that CHD7 
is required by a subset of MASH1+ cells to activate the neurogenic 
differentiation program and, without CHD7, cells instead revert to a more stem 
cell-like state, leading to an increase in NSC number in the long-term (see 
Figure 64). In vivo clonal analysis of NSCs after Chd7 deletion is needed to test 
this hypothesis. This involves injection of a small amount of tamoxifen in 
GLAST::CreERT2;Chd7f/f;RYFP/+ mice to label only a few cells in the SGZ and 
analysing the fate of recombined cells [196]. 
 
6.11.5. Neural stem cell quiescence and maintenance of the stem 
cell pool 
The data presented here describes a unique scenario where loss of NSC 
quiescence is not coupled to a depletion of the stem cell pool. I have shown that 
the neural stem cell pool is increased 3 months after loss of Chd7 (see Figure 
64). However, it is possible that this time point is not long enough to see 
proliferative exhaustion of NSCs and a loss of the stem cell pool. In agreement 
with this, loss of cell cycle regulators, such as p21, also leads to the loss of 
NSC quiescence and an increase in NSC self-renewal followed by depletion of 
the stem cell pool [393]. p21-/- mice display a greater number of NSCs up to 5 
months of age compared to WT mice due to increased NSC proliferation [393]. 
Thereafter, however, the number of NSCs in p21-/- mice decline and are 
reduced at 16 months of age relative to WT mice [393]. p21-/- NSCs initially 
display an increased self-renewal capacity in vitro [393]. However, the self-
renewal of  p21-/- NSCs eventually becomes limited and cells only survive a few 
passages [393]. Interestingly, foetal-derived NSCs from NestinCre;Chd7δ/δ 
embryos are able to be passaged for many months (data not shown), 




suggesting that in vitro, NSC self-renewal potential is not affected, or, at least, 
not reduced. However, in vitro, cells are grown in high amounts of FGF2 and 
EGF, and so small changes in self-renewal may be masked by the culture 
conditions. These data show that Chd7null and p21-/- mice share many 
similarities in changes in neurogenesis. Therefore, it will be interesting to 
examine and changes in the expression of p21 in the DG of Chd7null mice. 
Furthermore, I am preparing to determine the number of NSCs present in the 
SGZ of Chd7null mice over 6 months after deletion to determine if NSCs without 
Chd7 eventually succumb to proliferative exhaustion. 
 
6.11.6. CHD7 and the regulation of apoptosis 
I have shown that the loss of Chd7 results in a transient increase in immature 
neuron formation, followed by a large decrease in the number of immature 
neurons compared to wild type (see Figure 64). It is possible that apoptosis is 
employed as a mechanism to attenuate the accumulation of immature neurons, 
resulting in an eventual decline in the number of DCX+ cells. In the DG, 
programmed cell death is largely responsible for the numbers of new neurons 
formed and it has been shown that less than 30% of newborn cells in the 
hippocampus survive to be mature neurons [229, 233, 264]. There are two 
critical periods of survival of precursors and neurons, with most apoptosis taking 
place at the transit-amplifying to neuroblast stage, where newly born cells are 
between 2 and 4 days old, and a second at the stage of maturation of immature 
neurons, where cells are between 1 and 3 weeks old [264]. Therefore, an 
increase in apoptosis may be responsible for a decrease in neurogenesis. I 
hypothesise that the eventual reduction in DCX+ cells in Chd7null mice is due to 
increased apoptosis in the second stage of maturation of immature neurons due 
to the inability of cells to form new mature neurons. To test this, sections of the 
DG of Chd7null and WT mice would need to be stained with an antibody such 
as cleaved caspase-3 along with markers of cells in the neurogenic lineage to 
determine if the apoptosis of certain populations is altered. All sections for this 
experiment have been prepared but not completed in time for writing this thesis. 




6.11.7. CHD7 may regulate adult hippocampal and olfactory bulb 
neurogenesis in a similar fashion 
My data suggests that CHD7 plays a similar role in the SGZ and SVZ. The 
reduction in the number of newly formed cells after the loss of Chd7, and the 
reduction in immature neuron formation in the SVZ and dentate gyrus of Chd7 
heterozygous mice, indicates that CHD7 may regulate hippocampal 
neurogenesis and SVZ-OB neurogenesis in a similar fashion. These findings 
may be surprising considering that NSCs in the hippocampus and SVZ serve 
different purposes and brain systems, and are regulated by different 
mechanisms [412, 413]. It would also be interesting to see if CHD7 is a 
conserved regulator of adult somatic stem cell function in niches outside of the 
brain. In support of this idea, it has been observed that CHD7 is widely 
expressed in many tissue-specific stem cell niches like hair follicles and 
bronchioles in the adult lung [414]. 
 
6.11.8. CHD7 and human disease 
I have suggested that a decrease in Chd7 expression and a consequent 
reduction in hippocampal neurogenesis may be responsible for a part of the 
intellectual disability observed in CHARGE syndrome. This shows that 
analysing the effect of CHD7 on hippocampal NSCs and the differentiation of 
daughter cells may help to better understand CHARGE syndrome. Additionally, 
CHD7 may also be involved in other syndromes. Batsukh et al. recently showed 
that CHD7 directly interacts with CHD8 [348]. De novo mutations in CHD8 has 
been heavily implicated in autism spectrum disorder [327, 415], a disorder of 
neural development characterised by impaired social interaction, 
communication, and repetitive behaviour. Mouse models of autism exhibit 
defects in learning and memory and synaptic plasticity [416]. Since SGZ 
neurogenesis is important for certain types of hippocampal-dependent learning 
tasks [224-227], these findings indicate that interactions between CHD7 and 
CHD8 may play a role in hippocampal neurogenesis and autism spectrum 
disorder. 




6.11.9. CHD7 regulates adult hippocampal neurogenesis via SoxC 
transcription factors 
Recently, CHD7 has been shown to play an important role in adult hippocampal 
neurogenesis through the regulation of the chromatin structure around SoxC 
transcription factors [414]. In agreement with the data shown here, Feng et al. 
showed that CHD7 was expressed by type 2 and type 3 cells but was not 
conclusively shown to be present in NSCs [414].  
After deletion of Chd7, Feng et al. showed that there was a decrease in the 
number of newly formed neurons along with a slight increase in the number of 
Ki67+ cells in the DG [414]. The authors suggested that there was an 
accumulation of proliferating cells due to a blockage in neuronal differentiation 
[414]. Twelve weeks after deletion of Chd7 I see no change in the number of 
proliferating cells in the SGZ (see Figure 55). Furthermore, I show that there is 
in fact a decrease in the number of progenitors in the SGZ (see Figure 60e). 
The increase in proliferation seen by Feng et al. may be increased proliferation 
of NSCs, but the authors have not analysed specifically which cells are 
proliferating. Alternatively, the phenotypes seen by Feng et al. may be different 
to the phenotypes I see because of the different time points at which the mice 
were taken. Of note, Feng et al. do not show that loss of neurogenesis is a 
primary phenotype after loss of Chd7 in adult NSCs since a decrease in type 3 
cells was only observed 14 weeks after the loss of Chd7, and the authors did 
not examine any earlier time points [414]. 
 
6.11.9.1. CHD7 regulates the chromatin state around the promoter of Sox4 
and Sox11 
From the Cancer Genome Atlas project, focusing specifically on gliomas, the 
SoxC transcription factors, Sox4 and Sox11, were greatly downregulated with 
Chd7 [414]. Sox4 and Sox11 have been previously shown to play an essential 
role in adult neurogenesis by binding directly to the Dcx promoter and inducing 
its expression [417]. Feng et al. showed that loss of Chd7 from the adult 




neurogenic lineage was associated with decreased expression of Sox4 and 
Sox11 [414]. Transfection of cells lacking Chd7 with Sox4 or Sox11 expression 
constructs rescued the impairment in neuronal differentiation in cells lacking 
Chd7 [414]. Importantly, Sox4 and Sox11 function to increase the expression of 
Dcx [417]. My data suggest that the number of DCX+ cells is not impaired 
immediately after loss of Chd7, and is even increased slightly 4 weeks after 
Chd7 deletion, suggesting that the effect of CHD7 on Sox4 and Sox11 may not 
be crucial for neurogenesis in vivo. Despite this, it may be possible that Sox4 
and Sox11 activate other transcriptional programs required for proper neuronal 
differentiation, and so further investigation into the role of Sox4 and Sox11 in 
adult neurogenesis is needed. 
 
6.11.9.3. Notch1 expression is correlated with Chd7 expression 
Feng et al. found that Notch1 was highly positively correlated with CHD7, 
meaning that a decrease in Chd7 expression is found with a decrease in Notch1 
expression [414]. These data suggest that loss of NSC quiescence in Chd7null 
mice could be due to a decrease in the expression of Notch1 on NSCs. These 
data also suggest that overexpression of Chd7 would lead to a increase in 
Notch1 expression and increased NSC quiescence. These points can be 
addressed by examining the expression of Notch ligands and receptors on 
NSCs and their progeny. Furthermore, I have access to a Chd7 overexpression 
construct, and so transfection of foetal-derived NSCs with the construct would 
show if overexpression of Chd7 results in an increase in quiescence in vitro. 
 
6.12. CHD7 regulates different aspects of adult neurogenesis 
The data presented here indicate a role for CHD7 in the maintenance of the 
NSC pool, regulation of NSC quiescence, and regulation of the terminal 
differentiation of daughter cells. Furthermore, I have suggested that a decline in 
neurogenesis in mice heterozygous for Chd7 may be responsible for the 
intellectual disability associated with CHARGE syndrome.  Although a recent 




study has shown a role for CHD7 in the differentiation of NSC progeny [414], I 
have identified a novel role for CHD7 in the regulation of NSC quiescence and 
cell fate decisions. This suggests that CHD7 may potentially regulate the 
transcription of diverse sets of genes, and so further investigation into the 
















Ageing is a physiological process whereby the composition of many somatic 
stem cell niches is disrupted and the stem cells display intrinsic changes [9]. 
Ageing leads to alterations in stem cell number and function, often having a 
negative impact on tissue homeostasis. In addition, the numbers of stem cells 
present in various tissues generally declines with age [17-20]. Still very little is 
known about age-related changes in mammalian stem cell niches and how this 
impacts on stem cell number. Furthermore, the mechanisms controlling stem 
cell quiescence and fate decisions are not completely understood. In this thesis 
I attempted to examine intrinsic and niche influences on stem cell quiescence 
and differentiation using skeletal muscle SCs and adult NSCs. 
 
7.1.1. Quiescence is a property of many somatic stem cells essential 
for stem cell function and maintenance of the stem cell pool 
As ageing progresses, the regenerative ability of skeletal muscle declines due, 
at least in part, to impaired SC function [146, 147]. The physiological changes 
which lead to impaired SC function in aged animals have been intensely 
investigated [10, 148, 150, 164, 169]. However, the changes which lead to a 
decline in the number of SCs, and the relevance of a loss of SCs, with ageing, 
were unknown. Here, I have identified a specific and functionally important 
change in the molecular composition of the aged stem cell niche. Upregulation 
of FGF2 by the muscle fibre drives a subset of SCs to break quiescence and 
lose self-renewal capacity under homeostatic conditions in aged animals. This 
results in an increased tendency of SCs to differentiate or apoptose (see Figure 
33). 
Chakalakal et al. have shown that two pools of SCs exist in adult skeletal 
muscle; a label retaining cell (LRC) population, and a non-LRC population [418]. 
Upon transplantation, aged LRCs seeded approximately threefold more SCs 
and differentiated myonuclei than did non-LRC transplant recipients [418], 





cell function. These data also indicate that the quiescent, label-retaining 
population may represent the true regenerative stem cell population. 
As ageing progresses in adult skeletal muscle there is a diminution of highly 
functioning LRCs and a gain of committed non-LRCs [418]. That non-LRCs self 
renew poorly and tend to differentiate, suggests that the relative increase of 
non-LRCs in aged muscle occurs through proliferation of LRCs [418]. These 
data indicate that the transition of LRCs into the non-LRC compartment due to a 
loss of quiescence is responsible for impaired regeneration in aged animals. 
However, these studies show that in aged animals there still exists a subset of 
SCs with great regenerative capacity, but the decline in SC number may limit 
full regeneration. 
Label retention is a characteristic which allows for the identification of adult 
stem cells in other tissue systems, such as NSCs in the adult forebrain, hair 
follicle bulge cells, and HSCs [419-422]. Interestingly, like in the SC niche, 
quiescent HSCs and NSCs are often found alongside more proliferative tissue-
specific stem cells [253, 423], suggesting that heterogeneity based on 
proliferative history within adult stem cell populations may be a common feature 
in adult stem cell niches. Investigating whether the more proliferative tissue-
specific stem cells are formed from the quiescent population, or whether they 
represent a completely different population of cells, independent of the 
quiescent stem cell lineage, would give a better insight into the role of 
heterogeneity within adult tissue-specific stem cells. 
Interestingly, quiescence is not a feature of SCs in all muscles. Satellite cells in 
the extraocular muscles remain proliferative under homeostatic conditions and 
add myonuclei to the uninjured myofibre [116] and these muscles are 
unaffected in Duchenne muscular dystrophy [117]. These studies indicate that 
SCs of the extraocular muscles may display mechanisms to prevent 
proliferative exhaustion of the stem cell population which are not present in SCs 
of the limb, perhaps reflecting their different ontogeny from limb muscles. 
Indeed, quiescence is not a universal feature of all adult somatic stem cells. 





small intestine and colon, with these cells displaying self-renewal ability and the 
capacity to generate differentiated cell types [424, 425]. These studies suggest 
that quiescence is not an obligatory feature of stemness. 
The incorporation and retention of DNA analogues, such as BrdU, is often used 
to study cell-cycle kinetics. However, these DNA labels can only be visualised in 
fixed and permeabilised cells. Furthermore, in many tissues, fully differentiated 
cells often retain label [422, 426]. Therefore, as an alternative strategy, we have 
labelled chromatin in vivo using a doxycycline-inducible transgenically 
expressed EGFP-tagged histone 2B (H2B-GFP) [418, 420]. This approach 
enables fractionation of live LRC and non-LRC populations by FACS and has 
been used in several tissues [420-422]. This technique allows for additional 
identification of different stem cell populations based on proliferative history and 
will give a better understanding of the differences between quiescent and 
proliferative stem cell populations. 
 
7.1.2. Maintenance of the stem cell pool is essential for tissue 
function 
Loss of tissue-specific stem cells and their impaired function has been proposed 
to be one of the primary causes of ageing [18, 394]. This has been suggested to 
be due to a combination of heritable intrinsic events, such as DNA damage, as 
well as extrinsic influences, such as changes in the stem cell niches. These 
events collectively lead to a decline in tissue function under homeostatic and 
regenerative conditions. Several effects of ageing on the brain, skeletal muscle 
and blood organ have been described in humans, and have been suggested to 
be due to, in part, impaired stem cell function. Impaired HSC function has been 
suggested to contribute to decreased immunity [427], increased incidence of 
bone marrow failure [428], and moderate anaemia [429, 430], whereas impaired 
NSC function with age has been suggested to contribute to cognitive decline 
[17, 398, 399], and impaired SC function has been proposed to be the main 





My data shows that increasing the sensitivity of aged SCs to niche-derived 
FGF2 leads to increased depletion of the SC pool (see Section 4.3). 
Chakalakal et al. have shown that further diminution of the aged SC pool, 
achieved by long-term Spry1 deletion in aged SCs, impairs muscle regenerative 
capacity and further exacerbates ageing [418]. Conversely, muscle injury after a 
short-term (10 day) deletion of Spry1 in aged mice, when the number of Pax7+ 
cells had increased owing to the initial loss of quiescence (see Section 4.2), led 
to a greater regenerated muscle fibre size compared to aged controls [418]. 
These data show that the exacerbated loss of the SC pool, due to a long-term 
increase in FGF signalling in aged uninjured muscle, becomes limiting on 
regeneration. Therefore, strategies to maintain the quiescence of SCs under 
homeostatic conditions should result in maintenance of the SC pool and allow 
for efficient regeneration. These data also show that increasing the SC pool in 
aged animals such as through transplantation should also allow for efficient 
regeneration. 
I have shown that inhibition of FGF signalling led to decreased cycling of the 
aged SC pool and a decreased tendency to apoptose (see Section 4.4). 
Chakalakal et al. tested whether long-term inhibition of FGF-signalling would 
improve SC regenerative capacity by injuring adult and aged mice after six 
weeks of FGFR inhibition [418]. After injury, muscle fibre size was 30% smaller 
in FGFR-inhibited mice compared with controls, suggesting that repression of 
FGF signalling inhibits myofibre repair [418]. This is in agreement with data 
showing that FGF signalling is important for efficient skeletal muscle 
regeneration [113, 114]. In contrast, the number of self-renewing SCs was 
greater in aged FGFR-inhibited mice than in controls [418]. This result 
demonstrates that repressing FGF-signalling during ageing improves the self-
renewal capacity of satellite cells during regeneration. Therefore, investigating 
changes in stem cell niches with age, and their effects on resident stem cells, 
will give an insight into the reasons behind altered stem cell number and 






7.1.3. Upregulation of FGF2 in the aged satellite cell niche may be 
due to accumulated myofibre damage  
I hypothesised that upregulation of FGF2 with age may be due to the 
accumulation of chronic myotrauma over time (see Section 3.4). Under 
homeostatic conditions there is no turnover of skeletal muscle, and so low-level 
myotrauma, which may not elicit a regenerative response, may accumulate on 
the myofibre throughout life. The promoter region of Fgf2 has binding sites for 
many transcription factors, including AP1, c-Jun, and p53 (as predicted by 
SABiosciences' Text Mining Application). The transcription factor with the 
greatest number of predicted binding sites on the Fgf2 promoter is Signal 
Transducer And Activator Of Transcription 1 (STAT1). STAT1 is a transcription 
factor upregulated in stress and is involved in interferon signalling. Interestingly, 
Stat1 expression increases in aged single fibres compared to adult (data not 
shown), suggesting that accumulated myofibre damage may cause the fibre to 
upregulate STAT1 which then induces the transcription of Fgf2. It is important to 
note that STAT1 is only active as a transcription factor in its phosphorylated 
form, so an upregulation of Stat1 does not necessarily mean an upregulation in 
its activity. It would be interesting to further investigate the role of STAT1 in 
aged skeletal muscle. 
 
7.1.4. Ageing in the hippocampus is associated with altered neural 
stem cell function and cognitive decline 
The hippocampus is one of the areas in the brain that is most susceptible to 
functional and structural alterations in ageing, which are often accompanied by 
learning and memory problems [431]. It has been proposed that an age-related 
decline in neurogenesis may underlie age-associated learning and memory 
declines [395, 406, 432] and may contribute to pathological conditions such as 
Alzheimer’s disease [433-435]. Decreased neurogenesis has been correlated 
with decreased proliferation of neural precursors in the DG [395], but the 
reasons for this decrease in proliferation, and exactly which cells are affected, 





immature neuron production can be seen in WT mice with age (compare the 
number of DCX+ cells in the WT DG from Figure 55c  to Figure 56bd) as well 
as a slight reduction in the number of proliferating cells (compare the number of 
BrdU+ cells in the WT SGZ from Figure 55d to Figure 58c). Furthermore, It is 
generally accepted that the number of NSCs declines with age [196, 404] and 
decreased dentate neurogenesis has been proposed to be a result of increased 
quiescence of NSCs [403]. Therefore, strategies to increase NSC number and 
their proliferation may ameliorate age-related phenotypes to a certain extent. 
Increased progenitor proliferation in aged rats has been achieved through 
infusion of IGF1[436] and exposure to environmental enrichment, which has 
been associated with improved performance in spatial learning tasks [15, 230, 
437]. Physical exercise can increase progenitor proliferation and neurogenesis 
in adult animals and has a similar effect in the aged DG [405, 438]. I have 
shown that loss of Chd7 specifically in NSCs results in an increase in NSC 
proliferation and an increase in the NSC pool (see Figure 64). These results 
suggest that a loss of Chd7 in aged animals may temporary ameliorate age-
related phenotypes. However, loss of Chd7 also results in a decrease in 
neurogenesis. Dissecting out the pathways by which CHD7 regulates aspects of 
neurogenesis, from NSC proliferation, to stem cell self-renewal, to daughter cell 
differentiation may give a better insight into how to reverse age-related changes 
in NSCs and their daughter cells. 
 
7.1.5. Ageing in the hippocampus is associated with changes in the 
chromatin landscape 
Changes in the structure of chromatin has been proposed to be one of the 
reasons for the age-related changes to biological functions in cells and the 
increased incidence of disease [439]. During ageing, somatic stem cells display 
decreased chromatin stability and extensive chromatin remodelling which 
occurs with changes in cellular gene expression profiles [440]. These changes 





In contrast to stable genetic changes to the DNA sequence, epigenetic changes 
are reversible and, therefore, are an interesting therapeutic target for the 
treatment of age-related diseases. Individuals with Hutchinson-Gilford progeria 
syndrome (HGPS) display characteristics of premature ageing. Aged individuals 
and HGPS patients exhibit disrupted cellular chromatin structure and nuclear 
organisation, suggesting that there may be a link between altered chromatin 
structure and ageing [443]. Furthermore, the spacing of nucleosomes may 
become more irregular with age in mammalian cells, and chromatin fibres in 
ageing fibroblasts become less dense, suggesting a loosening of chromatin 
structure with age [444, 445]. Aged mice generally have a decreased ability to 
maintain heterochromatin, as shown by less efficient X-inactivation [446]. 
Collectively these data suggest that changes in chromatin structure may lead to 
aberrant age-related changes in cells. Further evidence for this came from 
analysis of chromatin remodelling complexes with age. NUcleosome 
Remodelling Deacetylase (NURD) is a protein complex with ATP-dependent 
chromatin remodelling activity and histone-deacetylase activity [447]. HGPS 
cells exhibit decreased levels of NURD subunits, which has been proposed to 
cause a loss of H3K9me3, associated with heterochromatic regions, and 
elevated levels of DNA damage foci [448]. Healthy aged cells also demonstrate 
a decline in levels of NURD subunits, such as retinoblastoma binding protein 4 
(RBBP4) and RBBP7 [449]. It is not known how decreased NURD activity 
causes ageing phenotypes, but these studies highlight the importance of 
chromatin modifications in ageing. It would be interesting to see if the 
expression of Chd7 changes with age. It is tempting to speculate that a gradual 
loss of Chd7 expression may lead to decreased formation and impaired 
maturation of neurons with age. Indeed, mice heterozygous for Chd7 display a 
decreased formation of immature neurons in the dentate gyrus (see Section 
6.10), and newly formed neurons from NSCs lacking Chd7 display abnormal 
dendrite morphology [414], which may cause an increased incidence of age-






7.1.6. CHD7 and the regulation of bHLH factors in neurogenesis and 
myogenesis 
I have shown that CHD7 is highly expressed in a subset of MASH1+ cells in the 
SGZ and suggest that CHD7 may be required to allow for proper differentiation 
and self-renewal of these cells (see Figure 65). CHD7 is also highly expressed 
in proliferating cells in the SVZ and SGZ [414]. From preliminary experiments in 
adult myogenic cells, Chd7 is expressed at very low levels in quiescent SCs 
and RSCs, greatly increases in proliferative myoblasts, and is then 
downregulated as myoblasts fuse to form myotubes (data not shown). This 
suggests that CHD7 may have a similar role in myogenesis and neurogenesis 
as they are expressed in bHLH-expressing progenitors. However, Chd7gt/+ mice 
do not show any changes in myofibre diameter, indicating that a decrease in 
Chd7 expression does affect developmental myogenesis at least (data not 
shown). CHD7 loss of function mutations have been associated with CHARGE 
syndrome [330]. CHARGE syndrome patients generally do not display gross 
muscle abnormalities, but do have a low muscle tone with muscles unable to 
maintain a contraction for as long as normal tone muscles [450]. It has not been 
shown that CHARGE syndrome patients with CHD7 mutations have decreased 
muscle tone, but it is tempting to speculate that, like in neurogenesis, loss of 
Chd7 results in impaired maturation of newly formed cells, leading to impaired 
contractile properties in skeletal muscle. Crossing a Chd7f/f mouse line with a 
Pax7CreERT2/+ mouse line would allow for deletion of Chd7 specifically in SCs. 
Analysing muscle regeneration in these mice would show whether CHD7 is 
involved in SC or daughter cell function. 
 
7.1.7. CHD proteins in adult neurogenesis 
Recently, CHD5 has been shown to play a similar role in neurogenesis as 
CHD7 [451]. CHD5 was shown to be expressed in type2b, type3, and mature 
neurons in the DG [451]. shRNA-mediated knockdown of Chd5 in vitro led to 
impaired neuronal differentiation, suggesting that CHD5 plays a critical role in 





Chd5-depleted cells showed that mutant cells were unable to activate many 
genes involved in late-stage neuronal differentiation, including genes with roles 
in the regulation of synapse development and neuron projections [451]. 
Furthermore, the authors showed that a cohort of PcG target genes 
characteristic of non-neuronal lineages were upregulated in mutant cells, 
suggesting that proper neuronal differentiation is dependent on the capacity of 
CHD5 to facilitate the activation of pro-neurogenic genes and maintain the 
repression of Polycomb-repressed genes [451]. Considering that CHD7 is 
expressed predominantly by type2a cells (see Figure 52), CHD5 is expressed 
by type2b, type3, and mature cells [451], and CHD8 appears to be expressed 
by mature neurons in the DG (data not shown), it is tempting to speculate that 
CHD proteins act in a temporal manner to regulate neurogenesis and proper 
neuron formation. Interestingly, overexpression of CHD5 failed to promote 
neurogenesis, suggesting that it lacks the inductive capacity of proneural factors 
such as MASH1. Whether CHD7 also lacks inductive capacity for neurogenesis 
remains to be determined. Together, these results show that CHD proteins play 
important roles in neurogenesis and neuronal maturation. 
 
7.1.8. CHD7 may play a role in autism spectrum disorder and 
neurodegenerative disorders 
Adult neurogenesis has been shown to play a significant role in various 
neurological disorders and diseases, including epilepsy and depression [452]. 
Furthermore, neurodegenerative disorders such as Huntington's disease and 
Parkinson's disease exhibit specific alterations in neurogenic areas leading to 
changes in dendrite morphology and synaptic plasticity. 
I have shown that a reduction in Chd7 expression results in a decrease in 
immature neuron formation and suggested that impaired neurogenesis in these 
mutants may be responsible for the intellectual disability seen in CHARGE 
syndrome patients (see Section 6.10). Preliminary data from a microarray of 
misregulated transcripts from Chd7null and wild type dentate gyrus shows many 





are altered in Chd7null mice compared to controls (data not shown). These data 
are consistent with an involvement of CHD7 in the efficient differentiation of 
neural progenitors. Additionally, pathway analysis showed that misregulated 
transcripts were involved in Huntington's, Alzheimer's, and Parkinson's diseases 
(data not shown), implicating a role for Chd7 in the regulation of many 
neurodegenerative diseases and neuron maturation. 
Recently, impaired neuronal maturation and misregulation of ion channels has 
been implicated in some of the phenotypes associated with ASD [453, 454]. For 
example, MARK1 (microtubule affinity-regulating kinase 1), which is 
upregulated in the DG of Chd7null mice (data not shown), has been found to be 
overexpressed in the prefrontal cortex of patients with autism and causes 
changes in the function of cortical dendrites [455]. AUTS2 (Autism susceptibility 
candidate 2) has been found to be disrupted in patients with ASD and a loss of 
AUTS2 function has been implicated in intellectual disability [456, 457]. Auts2 is 
downregulated in the DG of Chd7null mice (data not shown). Shank3 is a 
postsynaptic protein found to be downregulated in the DG of Chd7null mice 
(data not shown) and haploinsufficiency of Shank3 leads to deficits in synaptic 
function, social interaction, and social communication [458]. These data 
implicate a role for CHD7 in ASD. Recently, mutations in another CHD family 
member, CHD8, have been shown to play a role in autism spectrum disorder, 
and may account for up to 0.4% of cases [327]. It is tempting to speculate that 
CHD7 may play a role in ASD through interactions with CHD8. Examining the 
binding partners and direct targets of CHD7 would be useful for uncovering the 
role of CHD7 in ASD. 
 
7.1.9. Intrinsic and extrinsic changes affect somatic cell function 
In this thesis I set out to examine the fundamental properties of somatic stem 
cells and explore the mechanisms regulating stem cell quiescence and 
differentiation. The data presented in this thesis display the necessity for strict 
control of the intrinsic chromatin landscape and the extrinsic niche environment 





of SC quiescence and depletion of the SC pool. I have shown that loss of the 
chromatin remodelling enzyme CHD7 leads to a loss of NSC quiescence and a 
loss of neurogenesis. Both changes lead to alterations in the tissue associated 
with ageing, such as impaired regenerative capability in skeletal muscle, and a 
decrease in neurogenesis in the hippocampus. Furthermore, based on 
expression profiles, I have suggested that CHD7 may play a similar role in 
myogenesis as it does in neurogenesis. Collectively, these data help to better 
understand the regulation of stem cell quiescence and cell fate decisions, two 
fundamental properties of somatic stem cells which allow for the maintenance of 
a functional stem cell pool throughout life. 
 
7.2. Future work 
The data presented in this thesis establish a role for CHD7 in the regulation of 
NSC quiescence, self-renewal, and differentiation. However, how CHD7 
regulates these separate events is not completely understood. Recently, CHD7 
has been shown to be essential for the differentiation of neural progenitors 
through the regulation of SoxC transcription factors [414], but the role of CHD7 
in NSCs remains largely unexplored. Future experiments aim to examine how 
CHD7 regulates NSC quiescence and self-renewal, and the long-term effects of 
the loss of Chd7 from NSCs. 
 
7.2.1. In vivo clonal lineage analysis 
I have shown that the loss of Chd7 results in an increase in the number of 
NSCs compared to WT (see Figure 64). To fully determine whether this is due 
to an increase in NSC self-renewal, an in vivo clonal analysis assay can be 
performed [196]. This involves injecting GLAST::CreERT2;Chd7f/f;RYFP/+  and 
Cre-negative (WT) mice with a small amount of tamoxifen to induce 
recombination in only a small number of cells. Sacrificing mice 3 months after 





of the YFP allele. If the loss of Chd7 is associated with increased NSC self-
renewal, I would expect to see two or more RYFP+ cells with a radial glia 
morphology next to each other in the SGZ. I have generated 
GLAST::CreERT2;Chd7f/f;RYFP/+  and Cre-negative control mice to begin in 
vivo lineage tracing. These experiments will also show the exact extent of the 
decrease in neurogenesis in Chd7null mice at the single cell level. Due to the 
complexity of generating these mice, I have not been able to complete this 
experiment before writing my thesis. 
 
7.2.2. The long-term effect of a loss of Chd7 on the neural stem cell 
pool 
I have shown that there is an increase in the number of NSCs 3 months after 
deletion of Chd7 compared to WT (see Figure 64). However, it is possible that 
this increase in the stem cell pool may only be temporary, and NSCs eventually 
succumb to proliferative exhaustion and the pool is depleted. Therefore, 
analysing the number of NSCs present in Chd7null and WT mice longer than 3 
months after deletion is necessary to fully understand the role of CHD7 in adult 
neurogenesis. Due to the length of time needed for this experiment, I have not 
yet been able to collect the samples. However, I have planned to take 
GLAST::CreERT2;Chd7f/f and Cre-negative control mice 8 months after 
tamoxifen injection and count the number of stem cells present in the 
hippocampus.  
 
7.2.3. The role of CHD7 on neural stem cell quiescence 
I have shown that the loss of Chd7 in NSCs results in a loss of NSC quiescence 
(see Figure 64). It has been recently shown that NSCs in culture can be 
induced into a state of reversible quiescence through the replacement of EGF 
with BMP4 in the culture media [411]. Using this technique, I plan to examine if 
Chd7null cells display any defects in quiescence induction by staining for 





media. Furthermore, I have generated foetal-derived NSCs from 
CreERT2;Chd7f/f;RYFP/+ mice to delete Chd7 after quiescence induction and 
examine any inability to remain quiescent. These experiments will determine the 
role of CHD7 in the maintenance of NSC quiescence. 
 
7.2.4. Chromatin immunoprecipitation of CHD7 in cultured neural 
stem cells 
Chromatin immunoprecipitation (ChIP) with massively parallel DNA sequencing 
(ChIP-Seq) can be used to determine the binding sites of DNA-binding proteins 
across the genome. ChIP-seq analysis of CHD7 binding sites in cultured ES-
cells showed that CHD7 binds to areas associated with genes involved in Notch 
signalling and progression through the neurogenic lineage, including Hes1, 
Hes5, Mash1 and NeuroD1 [341]. Therefore ChIP-Seq analysis of Chd7null 
(negative control) and WT cells cultured under growth conditions and 
differentiation conditions, will suggest possible direct targets of CHD7 and show 
how the distribution of CHD7 across the genome changes as cells are induced 
to differentiate. Furthermore, this technique can also be used in combination 
with the in vitro quiescence assay, as detailed in Section 7.2.3, to determine if 
CHD7 associates with regulatory regions that control the expression of genes 
important for the maintenance of NSC quiescence. The chromatin state around 
identified CHD7 binding sites can then be analysed by micrococcal nuclease 
digestion, which examines the density of chromatin.  These experiments will 
help to identify primary changes caused by loss of Chd7 and will also identify 
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